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ABSTRACT
The zinc ion is an important emerging signaling molecule for biological processes. In
this work we engineered improved zinc sensors based on our previously developed
fluorescent sensor GZnP1 to provide sensors with a higher fluorescent readout, faster
kinetics, and a superior sensitivity to zinc. We utilized these zinc sensors and further
developed the sensors to answer questions pertaining to biological zinc. We showed the
labile zinc concentration in the mitochondrial matrix was less than 1 pM while the labile
zinc concentration in the cytosol and mitochondrial IMS were comparable (~100 pM)
across four different cell lines. Using these zinc sensors we found that exposure to high
labile zinc only overloaded the cytosol and the mitochondrial IMS with zinc while the
mitochondrial matrix did not sequester excess labile zinc. We highlighted the importance
of mitochondrial labile zinc dynamics and concentrations across different mitochondrial
locations and distinguished the mitochondria as not being a storage site for zinc.
In this work we revealed, for the first time, a novel vital role zinc plays in the
regulation of cellular trafficking. High load of zinc can arrest the motility of
mitochondria, lysosomes and vesicles in both HeLa cells and neurons. The zincmicrotubule interaction was found to prevent motor proteins from landing on
microtubules obstructing microtubule-based motility. Zinc was identified as interacting
with two histidine residues on the α-tubulin monomer of microtubules. This finding
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resolved the long lasting controversy regarding the signaling roles of labile zinc and
provided solid, direct and strong evidence confirming that zinc act as a significant
intracellular signaling molecule. In addition to zinc, polyamines were investigated as a
potential specific regulator of mitochondrial microtubule-based trafficking.
We found a correlation between mitochondrial microtubule-based trafficking and
abnormal polyamine concentrations resulting from Alzheimer’s disease (AD) in a Down
syndrome (DS) cell model. Decreased mitochondrial motility was found in primary
cultured rat hippocampal neurons as well as in the DS mouse hippocampal neuron model
with increased polyamines. Polyamine production can be blocked using
difuoromethylornithine (DFMO) a drug that inhibits ornithine decarboxylase (ODC)
preventing the production of polyamines. DFMO restored mitochondrial motility in the
DS mouse model. Mitochondrial motility in relation to polyamines has never been
connected prior to these results indicating a novel pathway for the pathology of AD in DS
brains. Two new regulatory mechanisms for axonal motility and exposure of previously
unknown zinc mitochondrial relationships were discovered which has magnified our
understanding of how the cell functions.
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CHAPTER ONE: INTRODUCTION of ZINC BIOLOGY
1.1 BIOLOGICAL ROLE OF ZINC
Zinc biology is a new and exciting upcoming field that scientists are quickly realizing
is an integral part of numerous cellular processes. Zinc is the second most abundant
heavy metal within cells and has been bioinformatically linked to over 2800 proteins, yet
our understanding of how the interaction between zinc and these proteins modulate
various cellular functions is still in its infancy [1]. Emerging studies have shown that zinc
affects a multitude of cellular processes including: the alteration of enzymatic function
[2], regulation of mitochondrial function [3], [4], [5], modulation of cell division [6], and
facilitation of apoptosis [6]. The breadth of cellular processes that require zinc has
defined zinc as a necessary trace element or micronutrient for all plants and higher
animals such as humans [7]. Zinc was found to be an essential micronutrient in plants in
1869, in animals in 1934, and humans in 1961 [8]. Many of the human organ systems
require zinc such as the epidermal, gastrointestinal, central nervous, immune, skeletal,
and reproductive systems [9]. Unlike other biological metals such as iron where the metal
is concentrated into certain tissues or locations within cells zinc is found ubiquitously
throughout the body. Deficiency in zinc cause impaired growth [10], increase risk for
infections [11], slow wound healing, and diarrhea [12]. Overabundance of ingested zinc
can cause nausea, vomiting, headaches, or in the scenario of ischemic events can act as a
potent neurotoxin [13]. The brain as a whole relies on zinc although specific regions are
1

more dependent on zinc such as the hippocampal neurons where zinc can impact
learning, neurogenesis, memory, and neuronal survival [14] [15]. For this reason dietary
zinc has been found to influence proper brain development in an age-dependent manner
[16]. One of the reasons for breast milk containing high concentrations of zinc is for the
proper neural development of the child. Zinc deficiencies are more prevalent in youth,
pregnant, and lactating women [8]. Deficiency in serum zinc has been linked to
neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease [17, 18] while
overabundance of zinc causes excitotoxic neuronal damage as observed in head trauma,
ischemia, and seizures [19, 20].
Specific regions of the brain have higher concentrations of zinc and hence rely
heavily on zinc to properly function as described above for the hippocampus region. The
neurons that contain the majority of brain zinc are glutamatergic/gluzinergic neurons or
neurons that package zinc in vesicles and release both zinc and glutamate [21]. These
gluzinergic neurons are mainly present in the cerebral cortex and limbic system
(hippocampus, amygdala, thalamus, etc.) [22, 23]. Either the zinc in these zinc-vesicles
[24] or other intracellular stores of zinc [25] can modulate neurons by regulating key
neuronal receptors such as N-methyl-d-aspartate (NMDA) receptors, alpha-amino-3hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors, and gammaaminobutyric acid (GABA) [22, 26].
The NMDAR's contain two binding sites for the extracellular zinc allowing the zinc
to bind according to the concentrations present and affect the receptor. The NMDAR's
can sense zinc from nano molar levels to micro molar levels affecting the receptor
dramatically, from lower concentrations causing inhibition of the pore to becoming a
2

pore blocker at higher levels of zinc [27]. The GABAA receptor or type A receptor at the
synaptic terminal where an alpha and beta subunit act as a zinc binding site which when
bound inhibits the GABAR from transporting GABA across the membrane [28]. This is
thought to occur from spill over from nearby synapses containing zinc that then inhibit
the GABA from another synaptic region from transporting across the cell membrane of
the postsynaptic terminal. This is believed to be necessary for long term potentiation of
the neurons involved in auditory fear conditioning [29]. How this is accomplished is
neurons that contain vesicular zinc to be released are nearby GABA and GABAR's
thereby permanently being present juxtaposed to each other allowing zinc to be released
and to have spillover into the nearby neuron inhibiting the GABA receptors. This will
allow for a permanent long lasting effect where the receptor is inhibited via the zinc and
allow the LTP to be maintained [29, 30]. AMPA receptors can also be modulated by zinc
upon zinc release into the synaptic cleft. AMPA receptors have been linked to nearly all
aspects of brain development, neural plasticity, and function making a modulator such as
zinc extremely important in proper neural development and function. Zinc will interact
with AMPA receptors and inhibit them when contacting the channel [31]. Due to these
important neural channels being regulated by zinc many have decided zinc is essential in
proper excitatory and inhibitory synaptic transmission [32, 33]. Zinc under physiological
conditions has been shown to be highly important for brain development although
pathologies such as Alzheimer’s disease have been linked to zinc in the brain.
Alzheimer’s disease is characterized by oligomerization of amyloid-β plaques as well
as intracellular accumulation of a protein named Tau. These Aβ deposits are localized at
synapses and are not ubiquitous within the brain in all regions [34]. One of the reasons
3

for this localization of the Aβ deposits is believed to be in the metallochemistry
associated with the protein. When zinc binds to the Aβ deposit oligomerization occurs
between the proteins and the oligomer formed is resistant to tryptic cleavage at the
synapse where the zinc is released [35]. This results in aggregates of the protein at
synapses where zinc is released and the aggregates cannot be degraded by the cells. The
zinc ion is the major ion responsible for these aggregates at physiological pH (7.4) at
slightly lower pH copper and iron can bind to the Aβ proteins and cause the aggregates
[36, 37]. The reuptake of the zinc from the synapse is an energy dependent process
meaning it requires mitochondria to produce ATP to reuptake the zinc. As the
mitochondria have reduced efficiencies seen in older patients which is commonly the
case with Alzheimer’s disease zinc will dwell in the synaptic space longer allowing
longer times for the zinc to interact with the Aβ protein and further form plaques of
insoluble protein oligomers. Therapies utilizing zinc chelators such as Clioquinol have
been employed although with little success to treat Alzheimer’s disease [38]. Parkinson’s
disease is another example of zinc impacting the pathology.
Parkinson’s disease has been linked to zinc through mitophagy in a study performed
on Drosophila Melanogaster flies exhibiting Parkinson’s disease where the flies were
supplemented with zinc and the symptoms associated with Parkinson’s disease were
reduced [39]. A specific type of Parkinson’s disease called Kufor-Rakeb Parkinson’s
disease where there is a defect in a protein, ATP13A2, responsible for segregating zinc
within the lysosomes of cells [40]. In ATP13A2 deficient cells (form of Parkinson’s
disease) the mitochondria are quickly overwhelmed with zinc due to excess zinc not
being properly sequestered into the lysosomes [41]. Due to the excess zinc the
4

mitochondrial membrane potential decreases thereby decreasing the ATP production
without a strong proton gradient present to produce the ATP via the electron transport
chain [3-5, 42-45]. This causes mitochondria fragmentation, increased ROS production,
reduced energy production, and eventual cell death [3-5, 42, 45]. In these PARK9
deficient patients there is a reorganization of the ZnT's and ZIP proteins to accommodate
for the lack of sequestration of zinc in the lysosomes [41], although by removing one of
the main storage sites for zinc the cells can are more susceptible to zinc toxicity causing
mitochondrial dysfunction leading to Parkinson’s disease. Another event that hinges on
zinc are excitotoxic events such as brain trauma, ischemia, and seizures.
Insults to the brain such as direct mechanical damage i.e. concussion or ischemic
events depriving the cells of proper blood and nutrients results in excitotoxicity. These
neurological conditions currently lack adequate intervention once the damage has
occurred and can result from a variety of etiologies [46, 47]. Following ischemia or brain
damage the damaged neurons spill glutamate and zinc into the extracellular fluid flooding
nearby neurons with the neurotransmitters such as zinc [48] over stimulating nearby
neurons resulting in cell death. Previously it has been shown that following ischemic
stroke large influxes of labile zinc are present in the neuronal cells which may be the
central source of their demise [13]. It has been shown that while calcium levels increase
in parallel with zinc the increase in calcium appears to be a result of the zinc ions
increasing making zinc the more potent mediator [49, 50]. Studies have investigated
treating stroke victims by reducing zinc as a potential treatment to alleviate the damage
incurred following a stroke with mixed success [51]. Zinc plays a central role in proper
brain functioning, development, plasticity, and maintenance although there are other
5

secretory tissues that have unusual zinc requirements that set them apart from other cells
such as prostate, pancreas, and mammary gland tissues.
The pancreas is an organ with multiple roles within the body involving glucose
regulation and digestion. Zinc has a critical role in pancreatic cells assisting with
secretion and signaling of glucagon and insulin packaging [52]. Zinc serves a crucial role
in α-cells glucagon secretion [53]. ZIP-1, ZIP-10, and ZIP-14 channels are all expressed
on the plasma membrane of the α-cells serving as a mechanism to bring zinc into the
cytoplasm of the cell [54]. What can occur is zinc when imported into the cell via these
ZIP channels can then bind to the ATP-K+ channel activating the channel allowing the
efflux of zinc and potassium. The zinc blocks depolarization (hyperpolarizing the cell)
preventing voltage gated calcium channels from opening and releasing glucagon [54, 55].
The zinc can inhibit the release of glucagon consequently affecting glucose metabolism.
The zinc acts as a signaling molecule in this system being released from β-cells which
also are heavily dependent on zinc too. β-cells will import zinc through the ZIP-4 channel
on the plasma membrane and condense the zinc into vesicles containing insulin using the
ZnT8 zinc transporter [56]. Zinc is imported into the insulin vesicles because zinc is a
required structural component of insulin granules. Two zinc ions will bind to two insulin
dimers which will then be combined with an additional insulin dimer forming a
hexameric unit requiring zinc as a structural component [57]. Once these insulin
containing vesicles release the insulin hexamers in response to glucose the zinc can
dissociate from the insulin hexamer as the hexamer breaks apart into individual insulin
subunits allowing zinc to be imported into the α-cells preventing glucagon secretion [52].
Zinc has a fundamental role in pancreatic cells being required for the biogenesis of
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insulin as a structural component of insulin, in addition zinc is of paramount importance
as a signaling molecule in the regulation of blood glucose levels by monitoring glucagon
release (increasing blood glucose) and insulin formation (decreasing blood glucose).
While zinc is essential for maintenance of proper blood glucose the soft tissue with
the highest zinc concentration is the prostate tissue, containing more than 3 times higher
zinc than any other tissue [52, 58]. The prostate cells are unique unlike any other cells
where zinc is typically sequestered into compartments, prostate cells have over 35% of
their total zinc in the cytosol [52]. The zinc remains loosely bound to small molecules
mainly citrate leaving the zinc still biologically active (available to bind zinc sites) [58].
How the prostate cells accomplish maintaining high concentrations of cytosolic zinc is by
inhibiting the Krebs cycle enzyme m-aconitase responsible for the oxidation of citrate in
the Kreb’s cycle [59]. This promotes the accumulation of cytosolic citrate allowing
citrate to be available to coordinate free zinc ions. The justification for the prostate
containing high concentrations of zinc is to maintain sperm motility [60] and release [61],
and zincs antimicrobial ability [62]. Zincs importance in prostate cells is so pronounced
that lowered zinc concentrations lead to decreased fertility [63] and prostate cancer [52].
Zinc concentrations in the prostate tend to decrease with age which result in lower
fertility rates of men [63] a result of decreased sperm motility. The decreased zinc also
tends towards higher likelihood of prostate cancer [52]. The production of prostate cancer
results from the decreased zinc no longer inhibiting the aconitase enzyme boosting the
mitochondrial metabolism in these cells [42]. Increased mitochondrial function increases
reactive oxygen species contributing to oxidative stress damaging DNA which increases
the probability of a cancerous mutation [64, 65]. Zinc is the central component for
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functioning prostate cells, a tissue that is imperative for reproduction a process universal
to all living organisms.
While zinc is required for the male reproductive system, zinc is also required for
mammary gland function in the female reproductive system. Zinc is imperative for
mammary gland function and tissue remodeling during pregnancy and lactation. The
mammary gland is a dynamic secretory tissue that remodels both structurally and
functionally depending largely on zinc signals [52]. The mammary gland is comprised of
a network of branched structures terminating into acini. The cells lining the acini are
mammary epithelial cells (MEC) which are the cells responsible for the transfer of
nutrients into breast milk [52]. MEC can be argued to be the most important cells in
lactation and uncontested as the most dynamic cells in the mammary gland. The control
of MEC proliferation, differentiation, and function is essential for functional mammary
glands. The mammary gland utilizes transcription factor IIIA for proliferation of MEC’s,
transcription factor IIIA is a protein with a 9 repeat zinc finger domain responsible for all
cellular RNA transcription [66]. Transcription factor IIIA requires zinc bound to the zinc
fingers to properly regulate RNA transcription in the cell and can be regulated by changes
in zinc concentrations [67]. Additional proteins are dependent on zinc interaction for
proper proliferation of MEC’s such as Zfp289 [68], differentiation LIM-ONLY [69], and
GATA3 [70]. Expansion of the MEC is highly important in mammary glands during
lactation to accommodate the production of breast milk for the offspring. Expansion is
accomplished by the zinc dependent proteins metalloproteinases changing their
expression in response to lactation or cessation of lactation [71, 72]. All of these proteins
are sensitive to changes in MEC zinc concentrations where deficient zinc can lead to
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breast cancer [73] and dysfunctional mammary gland expansion/development or low
concentrations of zinc in breast milk [74]. As mentioned previously low zinc in youth can
affect their brain development as well as cause diarrhea and skin conditions [12].
Mammary gland tissue is another example of an extremely zinc sensitive tissue.
There are numerous examples of how zinc is emerging as an important regulator,
signaling molecule, or structural component for not only cellular processes but
physiological systems. All of these discoveries hinge on techniques to analyze zinc which
have improved dramatically over just the last decade. Throughout this manuscript we
show the importance of developing accurate and sensitive zinc sensors to solve questions
pertinent to zinc biology. Zinc biology similar to all science is constantly evolving
revealing the complex interlaced workings of the cell. In this work we discovered zinc
was not sequestered in the mitochondria if cytosolic zinc concentrations increase to
potentially deadly concentrations despite previous studies claiming the mitochondria to
be a sink for unbound zinc. This changes our view how zinc homeostasis is maintained
evolving our understanding of zinc biology. We furthered our understanding of zinc
biology upon discovering zinc biology also regulates microtubule-based trafficking a
mechanism previously thought to be independent of zinc. These discoveries in zinc
biology would not have been possible without the development of novel zinc sensors
designed in this work. All of these discoveries have added momentum to the importance
of zinc being a key component of cell biology. Further details of how zinc is regulated
and characteristics of biological zinc will be discussed for clarity while discussing zinc
throughout this work.
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1.2 ZINC HOMEOSTASIS IN MAMMALIAN CELLS
The importance of maintaining zinc homeostasis is vital for cell survival as is the case
with all nutrients, although labile zinc concentrations unlike many other biological metal
species are extremely small. Despite being the second most abundant heavy metal (after
iron) in the body, labile zinc concentrations are maintained in the pico molar to low nano
molar concentrations because the majority of zinc is bound and unavailable to the zinc
effectors within the cell. The “total zinc” or ZnTotal include both the bound and labile zinc.
The total zinc concentration has been determined using x-ray fluorescence spectroscopy
(XRF), atomic absorption spectroscopy (AAS), and inductively coupled plasma mass
spectroscopy (ICP-MS) to be between 50 and 730 µM [75] while unbound zinc is
typically ~100 pM in the cell [76-78]. The vast majority of zinc is coordinated to proteins
within the cell and therefore inaccessible within the cell. Despite the small concentrations
of unbound zinc, this active form of zinc is affecting a plethora of cellular processes vital
for life. Total zinc in the cell is estimated to range from 1-300 µM [75, 79, 80] while
serum concentrations of zinc range from 1-15 µM [81-83]. The concentration of total
zinc in the cell is approximately 10-100 times more concentrated than the zinc
concentration outside the cell. There are exceptions such as pancreatic, prostate, and
mammary gland cells which concentrate zinc into vesicles [52] regardless this shows all
cells require substantial amounts of zinc. Zinc is buffered to such low concentrations via
a variety of mechanisms requiring numerous channels, buffering proteins, and
compartments for the sequestration of zinc. Unbound zinc being at such low
concentrations was a major contributor to why zinc was originally interpreted to not be as
biologically significant as other ions i.e. calcium. Although this logic was only a
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consequence of lacking the techniques and tools necessary to accurately measure zinc
ions at such low concentrations. To drive the progression and understanding of zinc
biology sensitive and accurate tools are essential to monitor zinc at such low
concentrations, without these tools the field of zinc biology will be unable to advance.
Maintaining proper zinc concentrations in the cell is a complex endeavor with
numerous proteins responsible for the maintenance of zinc concentrations. Zinc in the
cytoplasm is present at very minute concentrations typically on the order of pico molar
(10-12 M) concentrations [76, 77, 84], although due to elaborate mechanisms the cells can
raise the concentration of zinc to the hundreds of micro molar (10-6) concentrations for
example in zinc vesicles at the synapses and when released into the synaptic cleft [85,
86]. These vast concentration differences in zinc are observable in different
compartments of the cell by FluoZin-3 AM staining showing punctate structures
containing high zinc for example in insulin secretory granules and hippocampal and
cortical neurons synaptic vesicles [87]. These reservoirs of zinc are also found in
organelles such as the lysosomes [88] reported as having significantly higher zinc
concentrations than cytosolic concentrations.
Besides the above mentioned transporters of zinc there are proteins that store zinc
called metallothionien proteins. There are four isoforms of metallothionien in the body
MT-I and MT-II are expressed in a multitude of tissues throughout the body, MT-III is
found exclusively in the brain [89], and MT-IV is found exclusively in stratified
squamous epithelium [90]. MT-III is specifically found in neurons that sequester zinc
into zinc vesicles. Metallothionien proteins bind up to seven zinc ions through sulfur
bonds from cysteine's [91] with a high affinity (kd = 1.4 x 10-13 M) [92]. Metallothioniens
11

act as reservoirs of zinc for the cells that can buffer zinc concentrations by releasing or
storing excess zinc. These proteins release zinc through oxidation of cysteines creating a
disulfide bridge which releases the coordinated zinc. Zinc is released by oxidation due to
the high affinity cysteine has for binding zinc ions. Oxidation is facilitated by glutathione
which can oxidize the metallothionien cysteines and release zinc [92]. The
metallothioniens perform the function of an intracellular zinc pool gathering up excess
zinc to prevent zinc neurotoxicity while also releasing zinc when necessary.
Metallothionien have been shown to regulate zinc concentrations through redox
environments. If exposed to an oxidizing environment the metallothionien will release
zinc and vice-versa if exposed to a reducing environment. Metallothioniens can
dramatically affect the concentration and thus the homeostasis of zinc within the cells.
While metallothionien proteins provide a buffering system for zinc another
mechanism the cell has to regulate zinc homeostasis is through sequestration of zinc. Zinc
is sequestered into compartments with high zinc for example lysosomes or vesicles to
expel zinc from the cell to the extracellular environment. Sequestration of zinc affords the
cell a mechanism to maintain zinc homeostasis when zinc concentrations exceed zinc
buffering capabilities. The major group of proteins responsible for zinc homeostasis in
the cells are zinc transporters split into two families solute carrier 30 (SLC30, ZnT, Zinc
Transporters) proteins and solute carrier 39A (SLC39A, ZIP, Zinc-Iron Permease)
proteins. There are other proteins that are believed to transport zinc however these
proteins are less studied and not well understood. ZnT and ZIP proteins are found in all
mammalian cells and have been found to be expressed or redistributed based on stimuli
(i.e. changes in zinc concentrations) to maintain zinc homeostasis.
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ZnT’s function is the efflux of zinc out of the cell cytoplasm to the extracellular
environment or into intracellular compartments (i.e. lysosomes, vesicles). There are 10
ZnT’s that are encoded in the human genome localizing on specific organelles. The ZnT's
have been found to be a zinc proton exchanger stabilizing the pH of the cells. The zinc
import proteins are coupled to proton or carbonate ion gradients contributing to both pH
and zinc homeostasis. Following excitotoxicity or increased levels of nitric oxide a
known second messenger to release zinc ZnT expression was increased, suggesting the
protein may be shuttling zinc away from the neuron to decrease cell injury [93]. The
structure of mammalian ZnT has been determined although the exact mechanism of zinc
transport is still not understood. Mammalian ZnT proteins typically have 6
transmembrane domains with the N and C termini on the cytosolic side of the membrane.
The loop in between the fourth and fifth transmembrane domain is rich in serine and
histidine residues and believed to be the location where zinc interacts and can be
transported through the channel. The C-terminal tail is also a potential zinc interaction
site where it also could potentially act as a site for dimerization. No mammalian ZnT
protein structures have been determined although an E. Coli Yiip protein was published
in 2007 clearly showing zinc interacts on the cytosolic interface and the transmembrane
domains [94].
ZIP proteins perform the opposite function of ZnT proteins by allowing the influx
zinc into the cytosol of the cell from the extracellular fluid or from vesicles [95]. There
are 14 ZIPs encoded in the human genome. These zinc transporters are found within the
cell membrane and throughout the organelles. These transport proteins are responsible for
the majority of the zinc buffering occurring within the cell by sequestering zinc or
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increasing the zinc concentrations. ZIP protein structures have been determined but again
the exact mechanism of how zinc is transported through the channel and the channel
regulation are still not known. ZIP proteins have 8 transmembrane domains with the N
and C termini on the non-cytosolic side of the channel. The loop between the
transmembrane domains 3 and 4 is rich in histidine residues and is believed to be the
interaction site for zinc. ZIPs function by a symport mechanism Zn2+-(HCO3)2 that is
independent of ATP and driven by the concentration gradients of the ions [96].
These two families of zinc transporters, ZIP’s and ZnT’s, are responsible for the
transport of zinc into or out of the cell to maintain zinc homeostasis if the zinc buffering
mechanisms are overloaded. Other channels contribute to zinc homeostasis although
these two families are the most extensively studied and show the most robust response to
maintain zinc homeostasis. There are many routes found for zinc to enter or exit the cells
to buffer the cellular concentration of zinc such as NMDA (N-methyl-D-aspartate) [97],
voltage gated calcium channels (VGCC) [54], GluR2-lacking AMPA(Alpha-amino-3hydroxy-5-methyl-4-isoxazole propionoic acid receptors (AMPARCa-Zn) channels [98],
and ZIP or zinc importing proteins, and Zinc transporters (ZnT's) [99]. NMDA, VGCC,
and AMPA receptors will be discussed in further detail in chapter 3. Zinc buffering
proteins such as metallothionien buffer intracellular unbound zinc by several orders of
magnitude compared to total zinc concentration. The cell utilizes a variety of proteins to
maintain labile zinc within a tight concentration range.
Aside from buffering zinc with metallothionien proteins and the sequestration of zinc
through the use of ZIP and ZnT channels the majority of cellular zinc is bound to
proteins. This bound zinc has been shown to be a structural component to thousands of
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proteins and a cofactor for hundreds of proteins. Zinc fingers are a common structure in
cells typically containing 20-40 amino acids stabilized by a zinc ion. These structures are
required for many sequence specific binding of transcription factors to DNA, proteinRNA, and protein-protein interactions. Our understanding of zinc required structures is
expanding rapidly but still not well understood and many of our presumptions about zinc
binding are based on previously known zinc binding sites perhaps eliminating novel zinc
binding sites. Many of these proteins can be present at high concentrations such as
carbonic anhydrase in red blood cells being in the micro molar range and requiring zinc
to act as a Lewis acid to catalyze the conversion of carbon dioxide to bicarbonate [100].
Zinc also binds other amino acids such as cysteines and glutathione as previously
mentioned which are present in mili molar concentrations in cells likely meaning almost
all zinc will be bound to protein. This provides adequate binding sites for all the zinc in
the cell to be bound, leading to changes in unbound zinc through changes in the
occupancy of bound zinc. Detecting these zinc dynamics in the cells is pivotal to the
advancement of zinc biology to understand how zinc is changing and coordinating
cellular functions. An in depth description of biological zinc is necessary to understand
the zinc biology discussed further in this work.
1.3 BIOLOGICAL INORGANIC CHEMISTRY OF LABILE ZINC
Understanding what exactly biological zinc is at a chemical level is key to understand
how zinc functions in biology. When we discuss unbound zinc this is misleading and not
necessarily true. Zinc in a biological environment will always be “bound” by ligands
even if not coordinated by proteins (i.e. water, hydroxide, chloride, etc.) although our
interpretation is if the zinc is free to interact with protein ligands the zinc is “unbound”.
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Semantics such as these will be teased out in further detail in this section. We will focus
on elucidating the chemistry of biological zinc.
Biological zinc can be coordinated with oxygen, nitrogen, or sulfur donors which are
the side chains of the amino acids cysteine, aspartate, glutamate, and histidine. Common
zinc binding domains include Cys4, Cys2His2 for zinc fingers [1] one of the most
common zinc binding domains. Figure 1A shows the zinc coordination site for ZAP1
transcription factor utilizing the Cys2His2 for zinc coordination (Figure 1C) [101]. Figure
1B shows another common coordination of zinc ions for zinc fingers, Cys4 (Figure 1D),
from a RNA regulator DksA zinc finger [102]. Many other examples exist although zinc
fingers are among the best studied zinc coordination sites and will serve a large role later
in this work. Any protein with these amino acids (Nitrogen, Sulfur, or Oxygen) has the
potential to coordinate zinc via 3-6 coordination sites on zinc. Although these amino
acids must be structurally close to be able to coordinate the zinc ion. In addition small
perturbations in the protein environment can alter the ability of amino acids such as
cysteine with a pKa close to physiological pH from coordinating zinc [103, 104]. When
cysteine’s thiol group is protonated the thiol group will not coordinate zinc although once
the pH exceeds pKa of the thiol group (~8) the sulfur loses the proton and the electrons
can then coordinate zinc. The large flexibility of coordination geometries (3-6
coordination sites) for zinc stabilization is due to the lack of ligand field stabilization for
Zn2+ [80].
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Figure 1: Zinc Finger Coordination of Zinc Ions. (A) ZAP1 transcription factor
coordination of zinc ions. Two zinc fingers coordinating two zinc ions using two
histidine’s and two cysteines. Structure derived from PDB 1ZW8 [101]. (B) Zinc finger
from RNA regulator DksA utilizing four cysteines to coordinate a zinc ion [102]. (C)
Cys2His2 zinc coordination site. (D) Cys4 zinc coordination site.
The lack of ligand field stabilization allows biological zinc to flexibly coordinate
using multiple geometries to permit zinc to coordinate a diverse range of coordination
sites [80]. The d-block of zinc in the 2+ oxidation state is completely full preventing
changes in the degenerate barycenter electrons (i.e. being more stable than other
degeneracies) produced when anion ligands coordinate with the d-orbitals. As a ligand
approaches the metal ion (Zn2+), the electrons from the ligand will be closer to some of
the d-orbitals and farther away from others, causing a loss of degeneracy. This can be
observed in Figure 2 where the free zinc ion energy state is the most stable and as the
ligands coordinate zinc the energy is increased to the “barycenter” higher energy state.
The electrons in the d-orbitals and those in the ligand repel each other due to repulsion
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between like charges. Thus the d-electrons closer to the ligands will have a higher energy
than those further away which results in the d-orbitals splitting in energy. Coordination of
ligands will change the degenerate electrons energy state depending on the most stable
coordination for the electrons. This is accomplished by placing the majority of the
electrons into lower energy states compared to the barycenter which will stabilize the
electrons when coordinated with ligands (i.e. t2g and t2 energy states, Figure 2). Although
in the case of zinc the full d shell is never stabilized further than the barycenter no matter
which coordination geometry (number) is used, see Figure 2 for example comparison
between octahedral and tetrahedral coordination states. The eg and t2g orbitals will always
cancel each other out regardless of the coordination number dissolving any stabilization
different coordination geometries may offer making the barycenter energy state the most
stable, see the crystal field stabilization energy equation in Figure 2 [105, 106]. This
increases the catalytic prowess of biological zinc for proteins due to the variety of
coordination geometries that can stabilize the zinc ion. Zinc-ligand bonds utilize the 4s
electron shell with the full d-orbital which causes the zinc ion to become sterochemically
inactive promoting flexibility in coordination number unlike other biological transition
metals. This combined with the fast kinetics for ligand exchange are characteristics that
make zinc well suited for signaling on biological time scales and to serve as a second
messenger in biological systems in response to external stimuli.
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Figure 2: Ligand Field Stabilization Energy. Two examples of ligand field
stabilization energy diagrams are shown for tetrahedral and octahedral geometry.
Although the same stabilization is observed for all geometries for zinc in the 2+ oxidation
state.
Another unique characteristic of biological zinc is that it remains in the 2+ oxidation
state for all biological redox potentials and pH changes unlike any other metal in the cell.
This can be viewed from a Pourbaix diagram of the speciation of zinc under biological
redox (-670-820 mV) and pH conditions (0-9) [80]. The inert nature of biological zinc
enables zinc to have a flexible coordination number by restricting zinc to the 2+ oxidation
state. Whenever referring to zinc it will be zinc in the 2+ oxidation state not Zn (s) with
no oxidation state as is the common jargon with chemists.
Although the O, N, or S atoms coordinate directly with the zinc ion and are
commonly considered the major zinc binding sites there are always secondary
coordination spheres created by hydrogen bonding of ligands such as water. Secondary
coordination spheres create pockets of variable dielectric constants which contribute to
zinc binding sometimes more than the atoms forming the first coordination sphere for
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example with zinc hooks where the zinc affinity is increased to femto molar affinity
[107]. Hydrogen bonds, electrostatic and hydrophobic interactions all contribute to the
exchange kinetics of bound zinc ions which has been documented in zinc fingers [108].
These secondary coordination spheres are not always obvious and many times they occur
from intra and inter molecular interactions causing changes in the zinc binding site
affinity. The biological coordination of zinc has been catalogued extensively although is
still not well explored.
Unbound zinc is what the focus of this dissertation will be. Unbound zinc is also
referred to as labile zinc or free zinc or mobile zinc or fast-exchange zinc, this form of
zinc is the zinc that can interact with macromolecules. Free zinc is an ion that is buffered
to low pico molar concentrations in the cell and available to interact. The different
mechanisms have been presented for buffering free zinc in the cell although how
precisely do these proteins buffer zinc? Zinc buffering is due to the zinc binding
sites/proteins having dissociation constants for zinc in the nano molar and pico molar
range which bind up any available zinc forcing the concentrations in the range of these
dissociation constants. The buffering system will prevent the zinc from increasing or
decreasing outside this range in the same fashion pH buffers perform this function on
hydronium and hydroxide ions. The Henderson-Hasselbalch equation can be used
analogously with the conjugate base and acid being replaced with the protein and zinc
bound protein respectively. Zinc coordinates to proteins better than any other divalent
cation with the exception of copper following the Irving-Williams series (Cu(I) > Zn(II)
> Ni(II) > Co(II) > Fe(II) > Mn(II) > Mg(II) > Ca(II)) [109]. This is due to lack of
specificity for metals at binding sites. The lack of metal specificity at binding sites would
20

cause copper and zinc to dominate all the metal binding sites outcompeting any other
metal, although this issue is overcome by buffering the different metals to different
concentrations [110]. For example total zinc concentrations are approximately 200 µM
while free zinc is around 100 pM. That is 6 orders of magnitude lower or only 0.00005%
of zinc is in the free form. The equilibrium of zinc ions and a zinc binding protein lies
almost entirely to the left with zinc bound to protein shown in equation 1 below.
ZnP

P + [Zn2+] (1)

The concentrations of the metals within the cell are opposite the binding affinity with
zinc having very low concentrations within the cell (10-12 M) and magnesium having
higher concentrations (10-3 M) allowing the magnesium to bind to “magnesium binding
sites” and zinc to bind to “zinc binding sites” [110]. This balance is phenomenal in that
all zinc enzymes must be bound to zinc while not allowing labile zinc concentrations to
exceed pico molar concentrations causing toxicity. Furthermore labile zinc is often
interpreted as a zinc ion with no ligands bound or all coordination’s are water forming an
aquo complex. Although zinc is not always bound to all water ligands there are numerous
light molecular weight (LMW) ligands both organic and inorganic anions present zinc is
bound to many different LMW ligands. These LMW ligands can be displaced by other
macromolecules that have higher binding affinities for zinc such as the amino acids
cysteine, glutamate, aspartate, and histidine [80]. When referring to free zinc this zinc ion
is actually bound to a variety of LMW ligands with multiple different coordination
geometries. These different zinc species become important when trying to understand the
zinc dynamics occurring in cells by designing zinc probes that are free zinc sensing and
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not being selective to some free zinc ions that contain or do not contain certain LMW
ligands.
Measurements of free zinc is at the heart of this work using reporters called
fluorescent sensors. Free zinc concentrations have been recorded since 1971 [111]
although many improvements have been made producing far more accurate zinc
measurements since then with the advent of acetoxymethyl (AM) esters being
incorporated into small molecule probes in 1981 [112] to the advancement of genetically
encoded zinc sensors taking off in the last decade. Fluorescent sensors can bind free zinc
offering a quantitative measurement of free zinc. Although many techniques can be
utilized to analyze free zinc, fluorescent probes and fluorescent microscopy is the most
heavily utilized method. Throughout the entirety of this work “zinc” will be referring to
the free/labile/exchangeable form of zinc ions in the 2+ oxidation state. Further work
needs to be done to create sensitive zinc sensors to reveal the hidden intricacies of zinc
biology.
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CHAPTER TWO: ZINC SENSOR DESIGN AND OPTIMIZATION
2.1 INTRODUCTION
Zinc biology is rapidly becoming an integral part of numerous cellular processes upon
each new discovery although each discovery requires the proper tools to study biological
zinc. The scientific communities’ recent desire to further elucidate the role of zinc in
these essential cellular functions has driven the development of fluorescent zinc sensors
in the past decade. Zinc sensors are still in their infancy especially when compared to
calcium sensors which have been developed for over 50 years. Small molecule probes
such as Quin2 developed by Roger Tsien [113] and genetically encoded sensors such as
GCaMP[114] and GGECO[115] sensors have been improved and optimized for decades.
Calcium has been a focal point of biological metal research for decades while zinc has
been dismissed mainly due to the extremely small physiological concentrations of zinc
relative to other biological metals. Low concentrations of zinc made zinc effectively
invisible to early researchers who focused on calcium. Labile zinc concentrations in the
cytosol of the cell are ~100 pM [84] compared to cytosolic calcium concentrations of 100
nM [116], a 1000 fold difference between the concentrations of these two ions. This
creates a challenge when designing a sensor to be sensitive enough to detect low
concentrations of zinc while also remaining specific for zinc. This opened the door to
focus on creating zinc sensors that are sensitive enough to pick up zinc dynamics
occurring at physiological concentrations both spatially and temporally.
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Two different approaches for metal sensor development have resulted in the
establishment of small molecule probes and genetically encoded sensors. While both
sensors have their distinct advantages, genetically expressed zinc sensors demonstrate
advantages in studying the physiological functions of zinc in living cells due to the ability
to control the spatial expression of sensors within specific cellular compartments using
various molecular tags. These molecular tags offer a plethora of ways to tag a fluorescent
protein to any location within a cell, refer to Figure 3 for examples of the multitude of
subcellular localizations possible. Genetically encoded sensors are composed of proteins
which the cell will assemble after receiving the DNA sequence via transfection. This
allows the cell to make the genetically encoded sensor and localize the sensor using the
same machinery the cell uses to localize any protein to a location within the cell. Small
molecule probes however cannot be localized to specific locations with nearly the
specificity or breadth of locations genetically encoded sensors are capable of. One
method small molecule probes rely on is utilizing organelles with a charge potential such
as the mitochondria and designing the probe to be oppositely charged creating an
electrostatic attraction localizing the majority of small molecule probes to this location
for example the mitochondrial probes tetramethyl rhodamine methyl ester (TMRM) [117]
and tetramethyl rhodamine ethyl ester (TMRE) [118] and the small molecule zinc probe
Rhodzin-3 [119]. Small molecule probes are limited in the mechanisms to localize them
to specific locations within a cell making it difficult to analyze specific locations within
cells. In addition small molecule probes that are designed to localize to a specific
subcellular location still suffer from high background noise due to non-localized small
molecule probes. Besides the issue of localizing small molecule probes these probes
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suffer from loading the small molecule probe into the cell causing the sensor to bind free
metal ions. This rapid chelation of metal ions alters the physiological concentrations of
metal ions believed to create artifacts when studying physiological metal dynamics [120,
121]. These two issues can be overcome by using a genetically encoded sensor.
Genetically encoded zinc sensors are designed using various metal sensing domains for
zinc including zinc finger 1 (ZF1) and zinc finger 2 (ZF2) from the Zap1 transcription
factor of S. cerevisiae for the ZapCY, ZapCmR and GZnP sensors [78, 122-124], Atox1
and the fourth domain of ATP7B (WD4) for the eCALWY sensors [125, 126], and
simple metal coordinating amino acids (Cysteine and Histidine) introduced at the
dimerization interface between the two chromophores in eZinCh sensors [127, 128]. One
characteristic that should always be considered when using genetically encoded sensors is
their susceptibility to pH changes. These sensors are extremely sensitive to pH changes
because the amino acids that compose the sensor are susceptible to pH changes. Changes
in pH can quickly quench or increase fluorescence signals which must be accounted for
to prevent misinterpretations of the sensor signal.
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Figure 3: Subcellular targeting of genetically encoded zinc sensors. (A) Nucleus
localization of NLS-ZapCY1 in HeLa cell. (B) ER localization of ER-ZapCY in HeLa
Cells. (C) Mitochondrial localization of mito-GZnP1 in HeLa Cells. (D) Cytosol
localization in NES-ZapCV2 in HeLa Cells. (E) Interior localization to plasma membrane
using lck-GZnP1 in HeLa Cells. (F) Exterior localization to plasma membrane using
pDisplayGZnP1 in Ins-1 Cells. (G) Post synaptic localization of PSD95-GZnP1 in
primary hippocampal neurons. (H) Pre synaptic localization of synaphysin-GZnP1
(unpublished) primary hippocampal neurons.
Two types of genetically encoded sensors have been developed using this concept of
metal sensing domains: FRET based (ratiometric) and single fluorescent protein based
(intensiometric) sensors. The FRET (Förster Resonance Energy Transfer) based sensor
relies on fluorescent resonance energy transfer between two different fluorescent proteins
(FP) to indicate if the sensor is bound or unbound to the metal ion. The two different FP
chromophores are both specific and unique to each other based on their emission and
excitation wavelengths. The donor will be excited then the donor emission fluorescence
needs to closely match the excitation wavelength of the acceptor chromophore. In
addition the acceptor will only be excited if the donor chromophore is close to each other
physically (1-10 nm) allowing the emission light to act as excitation light on the acceptor
chromophore. The zinc induced conformational changes in ZF1 and ZF2 can bring the
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donor and acceptor fluorescent proteins closer to each other, resulting in increased FRET
(Figure 4A). One pro to using FRET sensors is they do not depend on the sensor
concentration or thickness of the sample due to the spectral shift in wavelengths allowing
these sensors to be normalized for quantification of free metal ions. The total number of
FRET sensors will be known in the sample by measuring both the donor and acceptor
fluorescence. Some of the limitations to a FRET based sensor is the need for the
combination of two different excitation and emission filters for image acquisition,
spectral bleed through if using other sensors, and smaller dynamic ranges correlating to
lower sensitivity to the metal ion of interest. FRET sensors are typically better for the
quantification of metal ions due to their indifference of cell expression and thickness.

Figure 4: Sensor design for ratiometric and intensiometric sensors. (A) Schematic of a
FRET sensor design. The FRET/ratiometric sensor is composed of two separate
fluorescent proteins bound via ZF1and ZF2. Upon binding zinc, the conformation
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changes of ZF1 and ZF2 brought the donor and acceptor fluorescent protein close
together. (B) Schematic of a single fluorescent protein sensor design. The intensiometric
sensor is designed by attaching a pair of zinc fingers to circularly permuted GFP
(cpGFP). Zinc induced conformational change protects the cpGFP fluorophore from
solvent attack, resulting in increased fluorescence.
The following is the structural and mechanistic description of the Green Zinc Probe
(GZnP) [78], the sensor optimized and developed for the remainder of this chapter refer
to Figure 5. GZnP is a single fluorescent protein based zinc sensor that utilizes one
chromophore and detects changes in the metal ion concentrations based on changes in the
fluorescent sensor intensity (AKA an intensiometric sensor). This chapter focuses on the
optimization and design of genetically encoded zinc sensors designed using zinc fingers
derived from the Zap1 transcription factor of Saccharomyces Cerevisiae (Residues 575 to
643) [78] linked to the N and C termini of circularly permuted GFP. The first two zinc
fingers from transcription factor Zap1 (ZF1 and ZF2) have been shown to confer major
conformational changes in response to zinc. Prior to binding zinc, the ZF1 and ZF2
domains are un-structured linear strings of protein, after binding zinc there is a
conformation change in the zinc fingers, resulting in a finger-finger interaction complex
and the linear strings of amino acids form into structured alpha helices [129]. The ZAP1
transcription factor ZF1 & 2 was found to exhibit a robust response to zinc binding in
FRET sensors [122] which was perfectly suited for a similar role in the design of an
intensiometric zinc sensor. The zinc fingers are specific to zinc allowing the metal sensor
to be specific to zinc ions given the physiological concentrations of other metal ions.
Copper II for example is the only metal that could potentially compete with zinc for
binding of the zinc sensor [80, 109] although labile copper II in the cell is in femto molar
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concentrations ([Cu2+]= ~0) [130] therefore the sensor will show high selective response
to biological zinc.

Figure 5: Structure and Schematic Mechanism of GZnP Fluorescence. ZAP1 zinc
fingers derived structure derived from PDB 1ZW8 [101]. CpGFP structure derived from
PDB 3SG3 [131].
The circularly permuted GFP is constructed by linking the original GFP N and C
termini together using 6 amino acids translocating the new N and C termini to the middle
of the 7th β-strand of the 11-stranded β-barrel, exposing the side of the β-barrel bordering
the phenolate oxygen of the GFP chromophore [132]. We used enhanced GFP (eGFP) a
variant of GFP that was designed to enhance the original GFPs photophysical properties
i.e. increased brightness, lower photo bleaching, etc.[133]. Enhanced GFP is the most
commonly used variant of GFP for current research making the original GFP obsolete
due to these photophysical improvements. In addition the super folding GFP mutations
were incorporated to allow the GFP protein to properly fold to a mature protein and
prevent misfolding of the sensor when expressed in cells [134]. The GZnP sensors
display the turn on effect zinc has on the sensor either increasing or decreasing in sensor
brightness in relation to zinc concentrations (Figure 5). The change in fluorescence of the
zinc sensor results from a change in the protonation equilibrium of the chromophore
between an anionic and neutral state [132, 135, 136], changes in the chromophore pKa
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[137, 138], and structural changes in the zinc fingers that shield the exposed 7th β-strand
of the β-barrel protecting the chromophore from solvent interactions [131, 137, 138].
The above mentioned factors that affect the sensor fluorescence will cause a change
in both the quantum yield and the molar absorption coefficient of the sensor. The
extinction coefficient is the molar absorption coefficient of a single photon sensor. The
extinction coefficient is the efficiency of the sensor to absorb photons at the excitation
wavelength the higher the efficiency of the sensor to absorb photons the higher chance
the sensor has to release these bound photons as fluorescence [139]. The quantum yield is
the sensors ability to convert absorbed photons to fluorescence and not release the energy
non-radiatively. Both of these biophysical characteristics are either enhanced or
diminished depending on the changes occurring for the sensor.
The mechanism for the biophysical changes of the GZnP sensor can be interpreted
from studies performed on GCaMP sensors a calcium sensor using a similar mechanism
for sensing calcium. The difference between the GZnP sensor and the GCaMP sensors
are the GZnP sensor uses zinc fingers instead of the calmodulin and M13 domains used
for GCaMP sensors, although the same biophysical principals apply to both sensors. The
mechanism of the sensor is more complicated than simply a dim and bright state for the
sensor. The sensor can be in a metal-saturated or metal-free state and the chromophore
can be in a neutral or deprotonated (anionic) state. This offers four different states the
sensor can be in all of which change the excitation wavelength of the sensor [132]. All of
these different states have vastly different absorption (excitation) spectrums although the
reason for exciting at 488 nm is due to the state that absorbs at this wavelength has the
maximum fluorescence. The anionic state of the chromophore has the highest
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fluorescence and dominates the emission spectrum which is why this state is what we
target by exciting at the well-known 488 nm wavelength due to the anionic excited states
for zinc-free and zinc-saturated states are 504 nm and 497 nm respectively [132]. The red
shifted absorption of the original GFP chromophore (from ~400 nm to 488 nm) is due to
mutations in eGFP which alter the stabilization of the phenolate oxygen. The phenolate
oxygen is stabilized by two amino acids (T203 & H148) and a water molecule in eGFP
and in the cpeGFP the phenolate oxygen is coordinated by two water molecules which
result in a red shift of the chromophore emission [138, 140, 141]. The changes between
the zinc bound and zinc saturated sensor excitation peaks results from changes in the
local electric field surrounding the chromophore [140].
Two states of the chromophore exist the anionic and neutral states, both are excitable
at different excitation wavelengths. The reason for the majority of the emission
fluorescence occurring at ~515 nm is due to the anionic species of the chromophore being
the dominate emission state. The anionic chromophore will emit at 515 nm and any of the
neutral state chromophore that is excited will be converted to an anionic chromophore
although in an unrelaxed state (slightly different from the true anionic state) through
electron stabilization proton transfer (ESPT). The ESPT will occur rapidly following
excitation of the neutral state chromophore converting the chromophore to the anionic
state. ESPT occurs due to the tyrosyl group of the chromophore transferring a proton to a
nearby proton acceptor generating the deprotonated chromophore or the anionic state
[141]. The ESPT emission is the same as the anionic state emission although the
structures of the chromophores are slightly different with the ESPT state. The hydrogen
bonding network for the ESPT state is altered compared to the anionic state with phenolic
31

proton being released to form the anionic state but the phenolic oxygen is only stabilized
by one hydrogen bond. The anionic state has slightly altered geometries by rotations of
nearby key amino acids to form hydrogen bonds with the phenolic oxygen stabilizing the
deprotonated chromophore ~3.8 kJmol-1 compared to the ESPT state [142]. This is why
the ESPT anionic state is referred to as unrelaxed and the true anionic state is relaxed
although both when excited at 488 nm will fluoresce at 515 nm.
Another factor that changes the fluorescence of the zinc saturated and the zinc free
state of the sensor is the change in the protein pKa. The pKa of the sensor will decrease
upon binding zinc this decreased pKa will result in an increased brightness of the sensor
[132]. Why this is occurring is the sensor will increase in brightness as the pH is
increased due to the anionic state of the chromophore being more favorable (compared to
the neutral state) resulting in higher fluorescence. Once reaching a sufficiently high pH
~11.5 the protein will denature and the fluorescence will decrease [132] although up to
this inflection point the sensor brightness will continue to increase. If the sensor’s pKa is
decreased this means that the equilibrium of neutral to anionic chromophore will be
shifted in favor of the anionic form. Because more chromophores will be present in the
anionic state there will be increased fluorescence (brightness) of the sensor. When the
sensor binds zinc the pKa of the zinc sensor will decrease resulting in increased
brightness of the sensor when bound to zinc. The reason why the pKa changes when the
zinc is bound is most notably due to changes in the electrostatic potential energies of
interactions between the chromophore and the surrounding protein [143]. The zinc
fingers are not the only protein domains that change conformation upon binding zinc, the
GFP structure will have conformational changes, the most important being the polar
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amino acids surrounding the chromophore. When these charged amino acids change
position they change the charge potential of the chromophore which subsequently change
the pKa of the chromophore [132]. The altered pKa is one of the biggest contributing
factors to the changes in the observed brightness [132].
The last factor that influences the sensors dynamic brightness between the zincsaturated and zinc-free state is solvent interactions with the chromophore [137, 144].
These solvent interactions will dissipate energy when the chromophore is excited
allowing the excited electrons to non-radiatively decay to the ground state, diminishing
the fluorescent signal (Figure 4B). This would occur if the chasm in the 7th β-barrel is
exposed allowing solvent to interact with the chromophore. The opposite effect can also
occur if the chasm is “covered up” by the zinc fingers preventing solvent attack allowing
fluorescent radiative decay to become the primary source of energy release. The excited
electrons will relax back to the ground state no matter what although the mechanism of
how they relax is what we hope to control i.e. fluorescence. The solvent (mostly water)
will hydrogen bond with the chromophore especially the phenolate moiety and
significantly decrease the quantum yield [132].
All three of these biophysical interactions influence the biophysical characteristics of
the sensor (quantum yield and extinction coefficient) [139] which are the characteristics
we aimed to optimize in the GZnP sensor. Our zinc sensor development and optimization
utilizes many techniques previously used to improve calcium sensors such as GCaMPs
and GGECOs [114, 145]. Many of the techniques used to improve calcium sensors were
applied due to the zinc sensor having a very similar layout and the techniques used on
calcium sensors have been proven to work through decades of trial and error. This also
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illustrates why ZF1 & 2 from Zap1 transcription factor were used, a protein that has the
ability to significantly change conformation upon binding zinc is requisite to protect or
expose the chasm in the β barrel, change the sensors pKa, and favor the anionic state of
the chromophore.
The GZnP sensor design is an intensiometric sensor which have many advantages
over ratiometric sensors. An advantage of intensiometric sensors is the flexibility to use
multiple sensors simultaneously without spectral bleed through. Imaging is simplified by
requiring only one excitation and emission filter decreasing the complexity of imaging
compared to FRET sensor designs. Single fluorescent intensiometric sensors typically
have significantly higher dynamic ranges which directly correlates to more sensitive
measurements of the metal ions.
This zinc sensor exhibits all the benefits of an intensiometric genetically encoded
sensor with tremendous potential for photophysical improvement. The dynamic range,
kinetics, and brightness were all modified to produce an improved variants of GZnP. In
this chapter our goal was to improve the photophysical characteristics of the GZnP sensor
characteristics to design a sensor with a larger dynamic range (higher sensitivity to zinc),
increased kinetics (faster response to changes in zinc concentrations), and maintain a high
maximum fluorescence and specificity for zinc ions. Improvement of this sensor was
necessary due to zinc sensors that were available at the time lacked in their sensitivity to
changes in zinc concentrations. By improving the GZnP sensor we provided an additional
tool to study biological zinc. The development of new zinc sensors allows new insights
into how zinc is modulated within the cells and how zinc regulates processes within the
cell. Multiple examples are shown in later chapters utilizing the newly designed zinc
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sensors from this chapter. With the ability to more accurately and precisely measure zinc
concentrations at specific locations within the cell further progress can be made in
diseases where zinc could regulate their function.
2.2 METHOD
CELL CULTURE MAINTENANCE
HeLa cells were maintained in high glucose Dulbecco’s Modified Eagle Medium
(DMEM) with 10% fetal bovine serum (FBS). Cells were kept in a 37 degree Celsius
VWR incubator at 5% CO2. HeLa cells were passaged once a week until confluency was
~90% for 15 passages then a new flask of HeLa cells was thawed and used.
TRANSFECTION
PEI (polyethyleneimine) transfection reagent was used for the transfection in HeLa
cells (dissolved to 1 mg/ml in water at pH 7.2 with long-term storage at -20 ˚C, short
term storage at 4 ˚C). Transfection was performed when the cells were approximately 4050% confluent. For each transfection reaction in an imaging dish 3 µl of PEI transfection
reagent and 1.25 µg of DNA were mixed in 250 µl Opti-MEM. The mixture was
incubated for a minimum of 25 minutes at room temperature before direct addition to one
imaging dish containing the cells. The addition was to the surrounding media of the
imaging dish not to the center. The dish was rocked back and forth gently to thoroughly
mix the transfection reagents with the cells.
CHELEX WATER AND HHBSS BUFFER SOLUTION
HEPES-buffered Hanks Balanced Salt Solution (HHBSS) is a buffer solution used to
image all the cells. This solution is free of any metals except what is supplemented to the
buffer. There is no phosphate since phosphate species can chelate zinc precipitating this
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out of solution. Extensive measures must be taken to prevent zinc contamination to
imaging buffers due to physiological Zn2+ typically being in the pico molar range. Begin
by preparing Chelex water (4 g per liter). Add MilliQ water to the Chelex water container
(contains Chelex beads in the container). Stir the water with the Chelex beads for a
minimum of 8 hours. Once stirred the Chelex beads can extract all the metal ions from
the water. Let the solution sit without stirring for 10 minutes to have beads settle at
bottom of the container. Once settled filter the water using a 0.22 µm vacuum filtration
system to remove the beads from the water. The Chelex treated water can then be
transferred to a new container for storage. Use plastic containers because glass have large
amounts of metal ions embedded into the silica. Wash the plastic containers using the
following guidelines. The container must be washed with soap, sink water, and then
rinsed several times with milliQ water. Then the container must be washed 3 times with
Chelex treated water.
The HHBSS buffer solution was prepared in the plastic beaker with 800-900ml of
Chelex water. Add a washed stir bar. Add each of the following chemicals one at a time
until each one dissolves when moving to the next chemical. CaCl2 0.14 g or 1.26 ml 1M
CaCl2; KCl 0.4 g; MgCl2*6H2O make 1 M MgCl2 solution add 1.1 ml; NaCl 8 g; DGlucose 3 g; HEPES 7.144 g. Once each of the components have been added and
dissolved check the pH using the pH meter. Be sure that the pH meter is calibrated for
use. Clean the pH meter off by rinsing and submerging the pH meter in milliQ water.
Bring the pH up to 7.4. This will likely require at least 2 tablets of solid NaOH and add
drops of 1M NaOH after the two tablets have completely dissolved. If the pH is
accidently too basic then use HCl to bring the pH lower. Once the pH is adjusted pour the
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solution into the plastic graduated cylinder. At this point fill the graduated cylinder up to
1000 ml using Chelex water. Filter the HHBSS buffer using the 0.45 µM vacuum
filtration system. This will remove any potential bacteria within the imaging solution that
could cause the buffer to become contaminated. After filtered transfer to new containers
prewashed containers using chelex water to rinse them.
ZINC BUFFER SOLUTIONS
Below is the protocol to make the different zinc buffer solutions. The protocol was
adapted from a previous paper designed to create calcium buffers [113] and zinc buffers
(cite my PNAS paper, which I provide more details about the descriptions of the zinc
buffer) .
Zinc buffer Solutions, ~pH 7
A1: Zn2+/Ca2+/EGTA B1: Ca2+/EGTA
A2: Zn2+/Sr2+/EGTA B2: Sr2+/EGTA
A3: Zn2+/EGTA B4: EGTA
A4: Zn2+/ HEEDTA B4: HEEDTA
A0: Zn2+/EDTA B0: EDTA
Solution A1
Weigh out 1.958 g of 99% pure EGTA to equal the 0.1 M concentration in the final
50 ml solution. This takes into account the purity of the EGTA. This will be 5 mmol of
the EGTA. Because 5 mmol of EGTA is measured out to make the 0.1 M concentration
4.5 mmol of ZnCl2 will be measured out to be just below equal concentration to perform
the titration. 0.625 g of 99% pure zinc chloride was measured out. 0.35 M KOH was
measured out and the purity accounted for (1.225 g of 85% pure KOH). Mix the above
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measurements in a 50 ml centrifuge vial with 15 ml of chelex treated water. Heat the
solution to ~100 degrees Celsius to aid in the dissolving of the solutes. Needs to remain
between a pH of 6.5-8 for the solution to dissolve adjust the pH using 1 M KOH. Use
small amounts to change the pH ~20 µl. If water evaporates during dissolving the solutes
then add additional chelex treated water. Once dissolved the pH titration is performed at
room temperature. Prepare a 1 M ZnCl2 solution in chelex water (~1 ml) fresh to prevent
the formation of zinc oxide while dissolved in water.
At this point on the titration will occur. Record the starting pH of the solution. Add a
predesignated amount of Zinc to the solution (20 µl thus a known mmol amount) and
record the change in pH. Write a value of the change in pH over the change in zinc.
When the ΔpH/ΔZn is half what the initial change was the titration is complete.
Throughout the titration the pH needs to remain neutral (pH 7-8.5) maintain this via the 1
M KOH. Transfer the solution to a 50 ml conical vial and rinse the original container
with chelex to ensure the transfer of everything. Add 10 ml of 1 M CaCl2. Bring the
volume to 50 ml using chelex treated water.
Solution B2
Weigh out 1.958 g of 99% pure EGTA to equal the 0.1 M concentration in the final
50 ml solution. This takes into account the purity of the EGTA. This will be 5 mmol of
the EGTA. 0.35 M KOH was measured out and the purity accounted for (1.225g of 85%
pure KOH). 10 ml of 1 M CaCl2 was added to the solution. Mix the above measurements
in a 50 ml centrifuge vial with 15 ml of chelex treated water. Heat the solution to ~100
degrees Celsius to aid in the dissolving of the solutes. Needs to remain at a pH of 7 for
the solution to dissolve adjust the pH using 1 M KOH. Use small amounts to change the
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pH ~20 µl. If water evaporates during dissolving the solutes then add additional chelex
treated water. Transfer the solution to a 50 ml conical vial and rinse the original container
with chelex to ensure the transfer of everything. Bring the volume to 50 ml using chelex
treated water.
This protocol was to make the A1:B1 zinc buffered solutions. For the following
solutions the same protocol will be used but differing chelators will be used for the A and
B solutions.
A2:B2 or 0.1M EGTA/ 0.1M Zn2+/ 0.2M Sr2+ and a 0.1M EGTA/ 0.2M Sr2+
A3:B3 or 0.1M EGTA/ 0.1M Zn2+ and a 0.1M EGTA
A4:B4 or 0.1M HEEDTA/ 0.1M Zn2+ and a 0.1M HEEDTA
A0:B0 or 0.1M EDTA/ 0.1M Zn2+ and 0.1M EDTA
Table 1: Zinc Buffer Solutions Concentration at pH 7
A1

B1

1
2
3
4
5
6
7
8
9

9
8
7
6
5
4
3
2
1

Free
2+

Zn (pM)
2770253.6
6702864.6
12199407
19843103
30488942
45382081
66266116
95223766
134817605

A2

B2

1
2
3
4
5
6
7
8
9

9
8
7
6
5
4
3
2
1

Free
2+

Zn (pM)
9707.537
23826.27
44245.3
74111.49
119084.4
190466.9
314556.7
569710
1337450

A3

B3

1
2
3
4
5
6
7
8
9

9
8
7
6
5
4
3
2
1

Free
2+

Zn (pM)
117.3226
263.9759
452.5301
703.9357
1055.904
1583.855
2463.775
4223.614
9503.132

A4

B4

1
2
3
4
5
6
7
8
9

9
8
7
6
5
4
3
2
1

Free
2+

Zn (pM)
0.183613
0.413129
0.708221
1.101676
1.652515
2.478772
3.855868
6.610059
14.87263

A0

B0

1
2
3
4
5
6
7
8
9

9
8
7
6
5
4
3
2
1

Free
2+

Zn (pM)
0.003266
0.00735
0.012599
0.019599
0.029398
0.044097
0.068596
0.117593
0.264585

MUTAGENESIS PCR REACTION
Combine all the components shown in table 2 below to make a control and a mutant.
The control is used to ensure that the mutagenesis worked and it is not parent strand DNA
that transformed.
Table 2: Mutagenesis PCR Components
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Component
H2 O
10 × pfu buffer
10 mM dNTP
5µM Fwd primer
5µM Rev Primer

Mutagenesis (µl)

Template DNA (50 ng/µl)
Pfu Turbo/Ultra

Control (µl)
10.5
2.5
0.5
5
5

21
2.5
0.5
0
0

1

1

0.6

0

The temperature cycle for mutagenesis PCR is shown below in Table 3.
Table 3: Temperature Cycle for Mutagenesis PCR
Step
Denaturation
Denaturation
Annealing

Temperature
95 ˚C
95 ˚C
55 ˚C

Time
1 min
30 s
1 min

Elongation

68 ˚C

X min (2 min per kb)

Repeat

To 2

18 cycle

Remove the PCR tubes and cool down using ice for 2 minutes. This is to prevent
denaturation of the Dpn1 enzyme that will be added next. This enzyme will denature
DNA that has been methylated, all the PCR product DNA is not methylated meaning
only parent DNA will be denatured leaving the PCR product. 0.5 µl of Dpn1 is added for
2 hours at 37 degrees Celsius.
ELECTROPORATION
Gather 1 mm electroporation cuvette, ice and ice bucket, Top10 electroporation
competent cells. Keep the competent cells on the ice even for them to thaw. Add 100 µl
of the Top10 competent cells to the cuvette and 10 µl of the mutagenesis reaction to the
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cells. Pipette up and down to mix. Place back on ice. Electroporate the cells and within
one minute add 250 µl of LB to the cuvette. Keep the cuvette on ice. Incubate on the
shaker at 250 rpm and 37 degrees Celsius for one hour. Plate 100 µl on agar plate with
antibiotic and incubate overnight at 37 ˚C.
GZNP SENSOR DEVELOPMENT
The zinc sensor GZnP2 was created by cell lysate based screening from sensor
libraries derived from GZnP1 according to previously described methods for GCaMP and
GGEC01 sensor development, suggesting that previous work on calcium sensors can
serve as a model of how to optimize the GZnP sensor [145]. This method uses rational
design and saturation mutagenesis by picking locations on the sensor to mutate to any
amino acid and analyzing the sensors photophysical characteristics following the
mutation and compare to the parent variant. In optimization of GZnP the dynamic range,
brightness, and kinetics were analyzed.
To optimize GZnP1 and increase its dynamic range, we created sensor libraries with
saturation mutagenesis in the linker regions between the zinc binding motif and the
fluorescent protein (Linker 1 and Linker 2, Figure 6A) as well as the zinc binding
domains (ZF1 and ZF2). Two amino acids were mutated to any permutation of the 20
amino acids using primers with two codons mutated to any of the nucleotides and the last
nucleotide in each codon can only be a guanosine or thymine. A library size of 400 was
used and 800 colonies of Top10 Escherichia Coli bacterial colonies expressing sensor
variants were picked and grown in deep well plates. 800 colonies were chosen since there
were 400 possibilities (202). Colonies were grown in 1 ml of LB and 50 µg/ml of
ampicillin. The colonies were grown at 37 ˚C and 300 rpm until the OD600 reached 0.5.
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Sensor expression was induced by addition of 0.2% arabinose. After one to two days of
growing in the shaker at room temperature, the cells were centrifuged at 2250 g for 20
minutes then decanted and lysed with BPER buffer with protease inhibitor. After lysis,
the cells were centrifuged at 2250 g for 20 minutes. Lysates were collected from bacterial
cells expressing sensor variants and then were treated with 100 µM of the specific zinc
chelator N, N, N′, N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) and 130 µM
buffered zinc separately in 96-well plates. New TCEP was made and added at a working
concentration of 0.5 mM to each of the lysates to reduce the cysteine thiols allowing for
binding of zinc. The minimal fluorescence intensities of cell lysates with zinc chelation
(Fmin) and the maximal fluorescence with zinc saturation (Fmax) were read by a M1000
Tecan fluorescence plate reader (Ex: 488 nm, Ee: 515 nm, 5 nm emission bandwidth) and
normalized to the fluorescence before treatment (Figure 6A). Normalize data sets: FTPEN
= FTPEN treatment / FTPEN no treatment FZn2+ = FZn2+ treatment / FZn2+ no treatment. Calculate
dynamic range (DR): DR = Fmax / Fmin = F Zn2+ / FTPEN. The sensor variant with increased
dynamic range as measured by the ratio between maximal and minimal intensity
(Fmax/Fmin) or increased brightness as measured by Fmax were further examined by in situ
characterization and then selected for next round of screening (Figure 6B). A minimum
increase in the brightness or the dynamic range was set and sensors showing favorable
photophysical characteristics in the high throughput method were advanced to a medium
throughput method, in situ analysis. The high throughput method showed only a weak
correlation between increases in brightness or dynamic range so a medium throughput
method was implemented to confirm more accurately promising mutants of GZnP.
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The medium throughput method utilizes in situ analysis with HeLa cells. Sensor
constructs were transfected into cells and imaged 48-72 hours post-transfection. Imaging
experiments were performed on a Nikon/Solamere CSUX1 spinning disc microscope.
Images were collected with a 40× 1.3 NA oil objective and imaging data was acquired
using the MicroManager software. The acquisition times were 20 seconds, with exposure
times of 100 ms and a laser power of 10% by the 488 nm laser and exposure times of 50
ms and a laser power of 3% by the 561 nm laser. Cells were imaged in phosphate-free
HHBSS, pH = 7.4. For sensor calibration, cells were treated with 100 μM N,N,N′,N′tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) to give the minimum signal and
2.5 μM pyrithione and 20 μM ZnCl2 to establish the maximum signal. TPEN is a zinc
specific chelator that will bind zinc more efficiently than any sensor or known biological
binding location[146]. Pyrithione is a zinc ionophore which can effectively equilibrate
the extracellular zinc concentration with the intracellular zinc concentration.
Imaging analysis was performed by Fiji (Image J) [147]. Every image in an image
stack was aligned to account for drift using the Stackreg plugin and the Rigid Body
method in Fiji. For the quantitative analysis, images of the GZnP mutant were
background corrected by generating a region of interest (ROI) on a blank area of the
imaging dish and subtracting the fluorescence intensity, e.g. IGZnP (cell) – IGZnP
(background). The background corrected GZnP mutant images were used to calculate the
normalization intensity. The calibration of the sensors was plotted in the KaleidaGraph
program. The baseline GZnP mutant intensity, minimal intensity achieved with TPEN
(Imin), and maximal intensity achieved with zinc saturation (Imax) were recorded. All in
situ sensor calibrations were performed at room temperature (RT). The dynamic ranges
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and brightness were recorded for determination if the GZnP mutant was an improvement
over the previous mutation. If the mutation improved over the previous mutant this
mutation was kept and more cycles of high throughput and medium throughput saturation
mutagenesis was performed. Refer to Figure 6 below for the layout of sensor
optimization.

Figure 6: Engineering GZnP2 with a higher dynamic range compared to GZnP1. (A)
Optimize GZnP1 sensors by cell lysate based high throughput screening assays.
Mutations were introduced into the Zn2+ linker regions to generate several sensor libraries
by saturation mutagenesis. The sensor library was then screened using cell lysates, highthroughput assays based on sensor fluorescence read with Zn2+ and the chelator TPEN. A
cutoff was set shown as the red bar and sensors exceeding this cutoff were chosen for
medium throughput analysis (B) The in situ response (low throughput method) of the
selected sensor variant in HeLa cells. Sensor fluorescence was decreased when cells were
treated with 100 µM TPEN, and the fluorescence was increased with the addition of 5
µM Pyrithione and 100 µM ZnCl2.
CHARGING CHELATING SEPHAROSE WITH NICKEL SULFATE
(NISO4(6H2O))
The Nickel Sulfate columns were used for the purification of the proteins (zinc
sensors). These nickel sulfate columns use sepharose beads as a support structure. The
sepharose have nitrolotriacetic acid (NTA). These triacetate groups at the ends of the
sepharose beads are deprotonated allowing for the oxygens to coordinate the nickel ion
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through three coordination bonds and water can coordinate with the three other bonds
forming the octahedral coordinated nickel ion in the NTA sepharose column. This nickel
ion being positively charged will then bind to histidine when the pH is over 6 due to the
pKa of histidine being 6 for the loss of the proton on one of the nitrogen’s. This then
allows the electron pair on nitrogen to coordinate with the positively charged nickel much
better than the water molecules that were aiding in the stability of the nickel-NTA
complex. This design works for the purification of proteins with a histidine tag which
will effectively get stuck on the Ni-NTA column. The proteins are eluted out of the
column once bound using an imidazole solution which when reaching a critical
concentration will elute the histidine tagged protein. Imidazole competes for the same
location due to imidazole being the functional group on the histidine that is binding the
nickel. Below is the procedure for the charging of Ni-NTA columns.
Shake the sepharose bead bottle (GE Health Sciences Chelating Sepharose Fast Flow)
and add ~20 ml to a column and allow the solution to settle separating the sepharose
beads from the ethanol suspension solution. Elute the ethanol solution from the beads but
be sure throughout the use of the columns to not let them dry out as described above the
water coordinates the nickel to support the Ni-NTA coordination and without the water
the column will not have the nickel coordinated. Wash out the ethanol using double to
column height (40 ml) of miliQ water. Now the sepharose beads are ready for the
addition of the nickel, add the column height volume (10-15 ml) of 0.4 M NiSO4 to the
column and discard the flow through. The column will change color from white to blue.
Wash the beads with double column height of miliQ water and a solution of 0.02 M
sodium acetate, 1 M NaCl at pH 4. The addition of the low pH solution will elute loosely
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bound nickel in the column. The beads were then suspended in a 20% ethanol solution
that is the same volume as the beads and stored at 4 ˚C.
PURIFICATION OF TEV PROTEASE
Tobacco etch virus (TEV) Protease was homemade by using BL21(DE3)-RIL
Escherichia coli cells containing pRK793 according to previously described method
[148]. pRK793 will overexpress the catalytic domain of TEV protease in the form of a
maltose binding protein that will be cleaved in vivo to produce the catalytic domain of
TEV with histidine tags on the N-termini and arginine tags on the C-termini [149]. The
TEV protease was required to cut the histidine tags off the proteins that were purified
using the Ni-NTA columns. The histidine tag is not normally attached to the protein of
interest and thus could affect its properties and its removal is necessary using this
protease. The TEV protease we purify will also have a 6X histidine tag although this does
not impede the proteases function.
The BL21(DE3)-RIL Escherichia coli cells were inoculated to an ampicillin plate and
grown overnight at 37 ˚C then grown again at 37 ˚C in 50 ml of LB broth supplemented
with 100 µg/ml of ampicillin. The cells were then added to 2 L of LB broth and grown at
37 ˚C until the OD600 ~ 1.0. Once reaching the mid log phase of growth temperature is
reduced to 30 ˚C and Isopropyl β- d-1-thiogalactopyranoside (IPTG) (1 mM) is added to
induce the production of the TEV protein. After 6 hours of induction centrifuge the cells
at 5000 RPM, 4 ˚C and decant; store cells at -80 ˚C.
The following buffers were used to purify the TEV protease. Buffer A (50 mM
sodium phosphate , 200 mM NaCl, 10% glycerol) pH 8, 1M imidazole pH 8,
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Equilibration buffer (25 mM imidazole in buffer A), Elution buffer (250 mM imidazole
in buffer A).
The cell pellets were dissolved in equilibration buffer then lysed via sonification
(Branson Sonifier 450). Sonification was performed for 5 minutes in 1 minute intervals
on ice at 50% duty cycle and output 5. Cells were immediately centrifuged at 15000 g for
30 minutes to collect cell debris that is heavier than proteins. The supernatant was filtered
through 0.45 µm filter to remove aggregates.
One Ni-NTA column was equilibrated using the equilibration buffer. The low
concentration of imidazole has been shown to increase the purification of the protein of
interest. Low concentrations of imidazole prevent contaminating proteins from binding to
the column and ensure the 6X His tagged protein is the only protein binding to the NiNTA column. Add the TEV protein and elute through the column, elute 7 column
volumes of equilibration buffer to remove any proteins that did not bind the Ni-NTA
column. The histidine tagged TEV protease was eluted with a linear gradient to 100%
elution buffer over one column volume at each concentration of imidazole: 40mM, 80
mM, 100 mM, 200 mM, 250 mM. The increasing imidazole concentration increased the
competition between imidazole and the histidine’s bound to the nickel which eventually
the higher concentrations of imidazole out compete the histidine tagged protein eluting
the protein. The protein concentration was checked for each elution imidazole
concentration using UV-Vis absorption at 280 nm. Proteins absorb highly at this
wavelength due to the aromatic rings present in some of the proteins. The purity of the
protein was also analyzed by checking the absorption at 260 nm where nucleic acid bases
absorb. Through these the concentration of protein in each elution volume was recorded.
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The TEV protease is purified but in a high concentration of imidazole which can
interfere with protein-protein interactions that are polar due to the imidazole acting
similar to a salt. To remove/lower the imidazole concentration Amicon Ultra-15 10K
centrifugal filter devices were used to filter the protein out of the imidazole through
dilutions. The purified TEV protease in imidazole solution was added to the Amicon
Ultra-15 10K centrifugal filter devices and centrifuged at 5000 g for 45 minutes. The
imidazole solution beneath the filter was discarded and the protein solution diluted with
12 ml of buffer A. This process was repeated three times to bring the imidazole
concentration below 1 mM. Calculate concentration using UV-Vis 280 nm and store in 80 ˚C freezer.
6X HISTIDINE TAGGED SENSOR PROTEIN PURIFICATION VIA NI-NTA
AGAROSE
The sensor protein was expressed in the pBAD vector. The pBAD vector is optimal to
express recombinant proteins due to its tight regulation of protein expression through the
regulation of carbon sources. The regulation prevents any toxic effects the expressed
sensor could cause the cell resulting in plasmid instability. Using the pBAD vector to
express the sensor allows for optimal production of the sensor protein. The pBAD vector
contains the bidirectional araBAD promoter which allows the expression of the protein of
interest and the regulatory protein AraC. This promoter is what gives the regulatory
control over the sensor protein expression. Without L-arabinose, AraC will dimerize
forming a loop in the promoter region of the protein of interest preventing transcription.
Although with L-arabinose AraC will change conformation and bind to other sites in the
promoter allowing transcription to occur. This system allows for very tight regulation of
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the expression of the sensor protein, incorporation of L-arabinose increases the
production of the desired protein >1000 fold and is inexpensive allowing for large scale
production of the protein [150]. The pBAD vector has an ampicillin resistance gene to
ensure growth of cells with the pBAD plasmid.
Our sensor protein is added to the pBAD vector and expressed with a 6X histidine tag
that will be used in an analogous method to the TEV protease extraction to bind the NiNTA column then elute the sensor protein. The sensor plasmids were transformed into
Top10 Escherichia coli cells. The Top10 cells perform better with the pBAD vector due
to no arabinose catabolism which can cause disproportionate production of the sensor
protein over time after the induction of the protein with arabinose. After transformation a
colony was picked and grown overnight at 37 ˚C in 50 ml of LB broth supplemented with
ampicillin (100 µg/ml). The cells were then added to 2 L of LB and grown at 37 ˚C and
shaking at 250 RPM until the OD600 ~ 0.6. Once reaching the mid log phase of growth
temperature is reduced to room temperature (RT) and shaking to 200 RPM and 0.02%
arabinose is added to induce the production of the sensor protein for 24 hours. Centrifuge
the cells at 5000 g for 5 minutes and decant the solution.
Resuspend the cells in 25 ml of Bacterial Protein Extraction Reagent (BPER)
(Thermo Fisher Scientific) and 1 tablet of EDTA free protease inhibitor cocktail to lyse
the cells. This amount is sufficient to lyse up to 1 L of cells grown up to an OD600. The
BPER is a nonionic detergent that will solubilize proteins and disrupt the cell membranes
of cells. The EDTA free protease inhibitor cocktail allows ions such as calcium and
magnesium to be present and inhibit proteases that may otherwise break down the sensor
protein. The cells were shaken at 200 RPM for 1 hour then centrifuged at 14000 g at 4 ˚C
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for 15 minutes. Add supernatant to a charged Ni-NTA column and add imidazole to
working concentration of 20 mM.
To charge a Ni-NTA column the ethanol solution was removed from above the beads
and replaced with a TNS buffer (50 mM Tris, 300 mM NaCl, pH 8) and 20 mM
Imidazole). The column is rotated for 15 minutes then allowed to settle and the TNS-20
mM imidazole solution is removed. All the steps involving the Ni-NTA column are
performed at 4 ˚C to prevent degradation of the protein. Rotate the column with the
protein for one hour.
Elute one column volume of TNS buffer-20 mM imidazole to remove any proteins
that did not bind the Ni-NTA column. The histidine tagged sensor protein was eluted
with a linear gradient to 100% TNS buffer-100 mM imidazole over one column volume
at 40mM and 100 mM imidazole. The increasing imidazole concentration increased the
competition between imidazole and the histidine’s bound to the nickel which eventually
the higher concentrations of imidazole out compete the histidine tagged protein eluting
the protein. The protein concentration was checked for each elution imidazole
concentration using UV-Vis absorption at 280 nm. Proteins absorb highly at this
wavelength due to the aromatic rings present in some of the proteins. The purity of the
protein was also analyzed by checking the absorption at 260 nm where nucleic acid bases
absorb. Through these the concentration of protein in each elution volume was recorded.
The sensor protein was purified but in a high concentration of imidazole which can
interfere with protein-protein interactions that are polar due to the imidazole acting
similar to a salt. To remove/lower the imidazole concentration Amicon Ultra-15 10K
centrifugal filter devices were initially used to filter the protein out of the imidazole as
50

described above for the TEV protease extraction although the solution was too viscous.
For this we used an Amicon Stirred Cell which applied positive pressure to the protein in
the imidazole solution to a filter and performed the same task as the centrifugal filter
device. This process was repeated three times to bring the imidazole concentration below
1 mM using the 50 mM Tris buffer pH 8 for the buffer exchange. The concentration was
calculated using UV-Vis 280 nm.
The 6X histidine tag must be removed from the sensor. The tags must be removed
from the sensor to prevent dimerization of the histidine tagged proteins caused by the
affinity histidine tags have for zinc ions (at nanomolar concentrations) [151]. If dimers
were formed intermolecular FRET would interfere with future assays designed to
measure the affinity of the sensor for zinc, other ions, etc. Use a 1:10 ratio of TEV
protease to sensor protein and incubate the solution overnight at room temperature in a
dark place. The following day the protein needs to be separated from the histidine tags.
The same process as described above was performed once again with a charged Ni-NTA
column (TNS buffer-20 mM imidazole) the protein is added and rotated for one hour.
Then the solution is eluted through the column with no additional solutions. The elutant
has the sensor protein, the column now has all the histidine tags bound to it. Calculate the
protein concentration using UV-Vis 280 nm and store the protein protected from light at
4 ˚C. The sensor protein was only viable for up to a week from the day of purification.
IN VITRO BIOPHYSICAL CHARACTERIZATION OF GZNP SENSORS
ZINC BINDING CURVE
Zinc titrations were performed in HEPES buffer (150 mM Hepes, 100 mM NaCl, 0.5
mM TCEP and 10% glycerol, pH 7.4) with 2 μM sensor protein and Zn2+ buffering
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solutions with defined Zn2+ concentrations as described in the zinc buffer solutions
methods. All the possible zinc concentrations (A0:B0, A1:B1…) were used in the
construction of the zinc binding curve using the zinc buffers at a pH of 7.4. The reducing
agent TCEP was prepared just prior to running characterization and allowed to incubate
with the sensor for 10 minutes prior to performing analysis. TCEP was added to the
solution to ensure a reducing environment which allows the thiol groups on cysteines to
be reduced and not in an oxidized disulfide bridge state. If in an oxidized state the
cysteine thiol residues cannot bind zinc and therefore would not be a good indicator of
zinc without the ability to bind zinc ions. Purified sensor protein was titrated with Zn2+ to
determine the fluorescence intensity as a function of Zn2+ concentration. The sensor
responsiveness to Zn2+ was reported as an apparent dissociation constant (Kd’), which
reflects the Zn2+ concentration midway between the Fmin and Fmax and the proficiency of
the sensor to separate from the bound zinc ions. This zinc curve was fit using the binding
equation m1*m0^m3/(m2^m3+m0^m3)+m4; with limits set for each of the m values. M1
= maximum asymptote; m2= minimum asymptote; m3= Hill coefficient (slope at IC-50);
m4= kd (IC-50). The in vitro fluorescence measurements used for zinc binding curve
studies were made on a Tecan fluorescence plate reader using the following parameters:
Ex = 488 nm; Ee = 515 nm; emission bandwidth, 5 nm. Prior to all measurements the final
solutions were spun down at 2250 RPM for 5 minutes and incubated for 45 minutes in the
dark. 96-well polystyrene black bottom plates were used to measure the fluorescence for
the metal specificity and the zinc binding curve measurements.

52

METAL SPECIFICITY
Metal selectivity was measured across biologically relevant divalent metals calcium,
zinc, magnesium, copper, manganese, cobalt, and nickel. 2 mM stock solutions of these
various metals were made in 100 mM HEPES pH 6.8 and chelex water. The stock
solutions for zinc and copper need to be remade every time metal specificity tests are
performed due to the metal precipitating out of solution. For example with zinc, once
exceeding ~200 µM ZnCl2 at pH 7.4 in water the zinc and chloride ions will be
dissociated in solution with water. The water is dissociating between protonated and
deprotonated forms (H3O+ & OH- Respectively). The central zinc ion is coordinated with
water which eventually the oxygen will become polarized resulting in the dissociation of
a proton and the formation of an aquo-hydroxo complex [80]. This complex is favored
instead of the aqua complex once reaching a critical concentration dependent on the pH
of the solution then zinc hydroxide will be favored. This is an effect of Le Chatiers
principal. This same rule applies to the other metals although this critical concentration is
not reached at 2 mM with the metals used except for Cu2+ too.
38 µM of each metal and 15 µM of EDTA was added to each well with 0.5 mM
TCEP. The EDTA was added to chelate any contaminating metal in the solution besides
the one of interest and the divalent metal ion of interest is at a higher concentration than
the EDTA making this the only metal available to bind the sensor. These different metal
solutions were added to zinc titration buffer (150 mM Hepes, 100 mM NaCl, 0.5 mM
TCEP and 10% glycerol, pH 7.4) and 2 µM of sensor protein.
The in vitro fluorescence measurements used for metal specificity studies were made
on a Tecan fluorescence plate reader using the following parameters: Ex = 488 nm; Ee =
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515 nm; emission bandwidth, 5 nm. Prior to all measurements the final solutions were
spun down at 2250 RPM for 5 minutes and incubated for 45 minutes in the dark. 96-well
polystyrene black bottom plates were used to measure the fluorescence for the metal
specificity.
To make the EDTA solution need to keep the pH above 8 or else the EDTA will
precipitate out of the solution. This will require a lot of NaOH to raise the pH above 8
due to the EDTA being acidic and having many acidic protonated groups.
QUANTUM YIELD AND EXTINCTION COEFFICIENT
The quantum yield also referred to as the quantum efficiency was measured for each
sensor, the quantum yield is the ratio of the number of photons emitted via fluorescence
to the number of photons absorbed[152]. This is a good indicator if a sensor is suitable
for fluorescence imaging. If the quantum yield is low then the sensor will be difficult to
detect despite using the proper excitation wavelength with high laser power and high
exposure times. If the sensor does not have a high conversion of photons absorbed to emit
as fluorescence then the sensor will always be relatively dim.
The quantum yield was measured by diluting the purified sensor in a MOPS solution
(30 mM MOPS buffer, 100 mM KCl, 0.5 mM TCEP, at pH 7.4). The TCEP solution was
made and only used the same day. The sensor was compared using fluorescein as the
control for the calibration curve. Fluorescein was diluted in 0.1 M NaOH. The
absorbance of fluorescein was adjusted to 0.01-0.05 at 494 nm to maintain a linear
function. Absorbance’s outside of 0.01-0.05 become non-linear, this will prevent using
the control as a calibration curve for our sensor. 6-10 absorbance’s were measured at
dilutions within the 0.01-0.05 range using a Varian Cary 100 Bio UV-Vis
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spectrophotometer. The same protocol as the fluorescein was used for the purified sensor
with the solvent being the MOPS solution with either 15 µM TPEN or 10 µM ZnCl2 to
determine the maximum and minimum fluorescence of the sensor. The same dilutions
made above for the absorbance’s for each sample are then run through a Cary Eclipse
Fluorescence Spectrophotometer fluorimeter with excitation at 488 nm and emission
from 500 nm to 600 nm using 1 nm slits, 1 second integration time and 1 nm steps. The
total fluorescence intensities were obtained by integrating the emission spectrum of each
sample. These points were then plotted against the absorbance reading at the maximum
wavelength (494 nm) for the sensor with and without zinc (TPEN) and the controls. The
quantum yield was obtained from the slopes of each line using the equation ΦSensor =
ΦStandard × (Slope of Sensor/Slope of Standard). See Figure 7 below of the quantum yield

Integrated Emission (A.U.)

of GZnP3 after the above measurements and calculations are made.
25000
20000
Control

y = 309899x - 1816.9
15000

TPA

y = 152992x - 1121.4

10000

Zn
Linear (Control)

5000

y = 12584x + 385.42

Linear (TPA)
Linear (Zn)

0
0

0.02
0.04
0.06
Absorbance (A.U.)

0.08

Figure 7: Quantum Yield Plot for GZnP3. The control is fluorescein with a quantum
yield of 92.5%.
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The extinction coefficient is a measurement of how well a sensor absorbs photons of
the proper wavelength to excite the fluorophore. If the absorbance is low then there is a
lower number of potential conversion of absorbed photons to fluorescently emitted
photons. The higher the extinction coefficient of a sensor the higher the likelihood to
have higher fluorescent emission from a sensor.
For the extinction coefficient determine a set concentration of purified sensor and use
this concentration for all measurements. The concentration does not need to fall in a
specific range as in the quantum yield measurements. The sensor was diluted in a MOPS
solution (30 mM MOPS buffer, 100 mM KCl, 0.5 mM TCEP, at pH 7.4). and the
absorption spectrum of the sensor was measured in Zinc-free buffer (30 mM MOPS, 100
mM KCl and 15 µM TPEN, 0.5 mM TCEP, at pH 7.4) and Zn2+-buffer (30 mM MOPS,
100 mM KCl and 10 µM Zn, 0.5 mM TCEP at pH 7.4). The highest absorbance value for
the respective wavelength was recorded. The same amount of protein was denatured by
diluting in 0.1 M NaOH for 3 minutes and the sensor absorption at 446 nm was recorded.
To calculate the extinction coefficient we used the Beer-Lamperts law of A=εcl
(A=Absorption, ɛ=Epsilon or extinction coefficient, c= Concentration, l= Path length of
the light). Given the same sensor protein concentrations and the same path length, we
determined the extinction coefficient using the equation Ɛ sensor / 44000 = Asensor / Asensor
in NaOH.
PH NORMALIZATION OF GZNP3 SENSOR
As mentioned in the introduction one of the downsides to using genetically encoded
sensors is their amino acid composition is extremely susceptible to perturbations in pH
which will affect the proteins secondary, tertiary, and quaternary structure. This
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perturbation will affect the characterization of the sensor (kd, quantum yield, extinction
coefficient, metal specificity, etc.). To avoid these perturbations on GZnP3 we developed
a method to circumvent the pH effect on the genetically encoded sensor. We
accomplished this by normalizing the GZnP3 signal to correct for zinc-independent, pHdependent changes therefore measuring only the changes in signal resulting from zinc.
We calculated the changes in sensor intensity across a physiological relevant range of
pH’s (5.1 to 9) in HeLa cells. Tagging either GZnP3 or the red fluorescent protein-based
pH sensor, pHuji, with the pDisplay tag we performed in situ pH normalization. The
pDisplay vector targets our GZnP3 sensor to the surface of mammalian cells. The GZnP3
sensor is targeted and anchored to the cell surface using the pDisplay N-terminal
secretion signal and the C-terminal transmembrane anchoring domain, platelet-derived
growth factor receptor (PDGFR) effectively displaying the protein on the extracellular
surface of the mammalian cell.
Buffers were made at pH 5.1, 5.5, 6, 6.5, 7, 7.4, 8, 8.5 and 8.9, using phosphate free
HHBSS imaging buffer with identical compositions except the chelator changed
depending on the desired pH (MES for pH 5.1, 5.5, and 6; MOPS for pH 6.5; HEPES for
pH 7, 7.4, and 8; Tris for pH 8.5 and 8.9). pDisplay-pHuji and pDisplay-GZnP3 plasmids
were co-transfected into cells and imaged 48-72 hours post-transfection. Images were
acquired every 20 seconds, using 100 ms exposure at 10 mW laser power for the 488 nm
laser and 50 ms and 5 mW for the 561 nm laser. Cells were imaged for 5 minutes in each
pH buffer, then washed with the next sequential pH buffer, beginning with pH 5.1 and
ending at pH 8.9. Averages of each pH’s sensor intensity for both the pDisplay-GZnP3
and pDisplay-pHuji sensor were taken to plot the intensity of the GZnP3 sensor as a
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function of pH. These intensities were normalized to physiological pH (7.4) and standard
curves were generated for each sensor (Figure 8A & 8B). Sigmoidal functions were fit to
the curves. The normalized values for each sensor were plotted against each other to
estimate the change in GZnP3 intensity as a function of change in pHuji intensity (pH)
creating the standard curve seen in Figure 8C. An exponential curve was fit to this data.
This then allowed us to normalize the GZnP3 signal despite intracellular pH changes
using equations 3 and 4.
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Figure 8: pH effect and pHuji normalization of GZnP3 sensor. (A) The change in
fluorescent intensity of pDisplay-GZnP3 was plotted against pH. The sensor intensity
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was normalized to physiological pH (7.4). Green line shows fitted sigmoidal curve, R =
0.99927, see Equation 1. (B) The change in fluorescent intensity of pDisplay-pHuji was
plotted against pH. The sensor intensity was normalized to physiological pH (7.4). Red
line shows fitted exponential curve, R = 0.99658, see Equation 2. (C) pH effect on
GZnP3 intensity. The y-axis values from the graphs in (A) and (B) were plotted against
each other to display the change in GZnP3 signal as a function of detected change in the
pHuji signal. Blue line shows fitted exponential rise curve, R = 0.99596, see Equation 3.
This allows for direct normalization of intracellular GZnP3 signal by removing pHdependent changes in brightness detected by pHuji, see Equation 4.
By simultaneously measuring the pH and zinc concentration in cells co-expressing
GZnP3 and pHuji we can factor in the pH change and not have this signal interfere with
the quantification of the zinc signal.
Equation 1: GZnP3 intensity (y) as a function of pH (x).
y=0.54322+(-1.4458)/(1+(x/7.2184)^20.347 )
Equation 2: pHuji intensity (y) as a function of pH (x).
y=11.201+(-12.13061)/(1+(x/10.409)^7.6328 )
Equation 3: GZnP3 intensity (y) as a function of pHuji intensity (x).
y=0.65638(1- e^(-1.0696x) )
Equation 4: pH Normalized GZnP3 intensity (y) as a function of GZnP3 (z) and pHuji
intensity (x).
y=z-0.65638(1- e^(-1.0696x) )
PLASMID CONSTRUCTION
PDISPLAY-PHUJI
For mammalian expression, the sensor was constructed in the mammalian vector
pcDNA3.1 by PCR cloning. The pDisplay vector must be placed on the C-terminal end of
the sensor. The pDisplay-GZnP1 was cut with XmaI (N-terminal) and SacII (C-terminal)
excising GZnP1. Made primers and used PCR to add both restriction sites to the
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respective locations onto PHuji. The PHuji PCR product with the XmaI and SacII
restriction sites was restriction digested then ligated into the pDisplay vector in
pcDNA3.1 already cut with SacII and XmaI.
PDISPLAY-GZNP3
For mammalian expression, the sensor was constructed in the mammalian vector
pcDNA3.1 by PCR cloning. The pDisplay vector must be placed on the C-terminal end of
the sensor. The pDisplay-GZnP1 was cut with XmaI (N-terminal) and SacII (C-terminal)
excising GZnP1. Made primers and used PCR to add both restriction sites to the
respective locations onto GZnP3. The GZnP3 PCR product with the XmaI and SacII
restriction sites was restriction digested then ligated into the pDisplay vector in
pcDNA3.1 already cut with SacII and XmaI.
2.3 RESULTS/DISCUSSION
Our starting platform for sensor optimization was the probe GZnP1 designed by Yan
Qin [78]. We used site-directed saturation mutagenesis described above in the methods
section for GZnP sensor development. This process allowed for all possibilities (amino
acid mutations) to be analyzed via the high throughput cell lysate assay allowing further
in situ analysis of promising variants. This method allows us to analyze the majority if
not all possible mutations narrowing the possibility of missing mutations that may cause
a favorable change in the characteristics of interest for the sensor. The process worked
exceptionally well to increase multiple characteristics of the GZnP sensor (Fmax, DR, &
Kinetics) with a ~5 fold increase in the dynamic range between GZnP1 to GZnP3 while
maintaining the fluorescence intensity, refer to Table 4 below.
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Sensors were named as the favorable mutations were produced and characterized.
GZnP2 improved on GZnP1’s DR by incorporating a mutation to the zinc finger binding
domain 1 (F to M) and a mutation in the linker 2 domain (T33P). This increased the DR
of GZnP1 ~2 fold to ~4.5 fold for GZnP2. These mutations allowed for over 100%
increase in the DR and the brightness remained unaffected at baseline. This baseline
fluorescence was important as will be observed with the GZnP3 being difficult to detect
at baseline. Other mutations showed favorable mutations when developing GZnP2,
GZnP1.1-1.7. Some of these variants were used for future GZnP sensors (GZnP1.3)
although we used the most favorable of these sensors for further mutation.
An interesting observation was the only mutation that produced favorable
characteristics outside the linker regions of the GZnP variants was to the zinc binding
domain of the zinc fingers for GZnP1.1 (to ZF1 F299M). This mutation was incorporated
into all future variants of GZnP due to the favorable increase in the dynamic range. Many
of the mutations made directly to the zinc fingers potentially affect the metal specificity
of the sensor for zinc possibly decreasing or abolishing the sensors affinity for zinc
altogether. We still risked zinc affinity of the sensor by modifying this region in hopes to
produce favorable characteristics. We accomplished this although many other mutations
to this region completely impeded the sensor to perform the function of a zinc specific
sensor. This mutation is the likely reason the binding affinity of all the future sensors are
lower than its predecessor GZnP1, see Table 4 & 6. Although changing the binding
affinity of the sensors was also a goal of sensor development too. The sensors are
typically only sensitive an order of magnitude higher or lower than the calculated
dissociation constant. With different zinc concentrations throughout the cell we ideally
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want a distribution of zinc sensitivity for our zinc sensors ranging from low picomolar to
high nanomolar concentrations of zinc.
In the design of GZnP3 the DR was dramatically increased through a mutation to the
first two residues in the linker 2 region of the zinc fingers (TH278/279IL) creating
GZnP1.3. GZnP1.4 also had a high DR although the DR was slightly lower than the
GZnP1.3 variant therefore GZnP1.3 was retained for further development, Table 4 & 5.
The baseline fluorescence for this sensor was substantially decreased compared to GZnP1
& 2 baseline fluorescence although the FMax remained almost unchanged (Table 5). The
baseline fluorescence of GZnP3 is barely observable over background fluorescence. This
characteristic made observing the sensor without zinc perturbation difficult although even
small increases in zinc resulted in dramatic increases in brightness as shown in the large
DR of 15.5, Table 5. Part of the decreased baseline fluorescence is a result of lower
affinity of the GZnP3 sensor for zinc compared to GZnP2, kd = 1.3 nM and 0.352 nM
respectively. Refer to table 4 for the mutations made to all the variants discussed in this
chapter. Another mutation was made to the ZF1 binding domain of GZnP1.3 (F299M)
ultimately yielding our final product GZnP3. This mutation slightly increased the DR and
had no effect on the Fmax. The more dramatic increase in DR from the linker region
mutations likely results from the greater flexibility provided to the zinc fingers. Increased
flexibility allowing the zinc fingers to both better protect and expose the GFP
chromophore to solvent attack. This will allow for a larger range of fluorescence from the
sensor.
As mentioned previously we mutated the zinc binding domains (ZF1 & 2) although
we must account for potential loss of zinc specificity or binding when mutating these
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domains. Another region we considered during our site-directed saturation mutagenesis
was the eGFP structure many of the mutations resulted in severe fluorescence quenching.
This lead to our focus for site directed mutagenesis on the zinc finger linkers and the
amino acids nearby the linker regions. The linker region is essential to allow the zinc
fingers to change the conformation of the protein and therefore move to either open the
GFP chromophore for solvent attack or prevent solvent attack. The eGFP structure
provides the mechanism for fluorescence so when mutations were incorporated to the
eGFP structure we observed decreased sensor brightness most likely due to reducing the
capacity for the β-barrel to hold the chromophore rigid, preventing the excited state
proton transfer (ESPT) and/or formation of the anionic state, and/or changing critical
amino acid residues surrounding the chromophore to prevent decreased pKa of the
phenolate oxygen. The sensor fluorescence was considerably quenched steering our
mutagenesis away from the GFP structure of the sensor. Modification to the zinc binding
domains could affect the sensors ability to coordinate the zinc ions causing the ZF
conformational change, therefore we avoided these regions too. We directed our attention
to the linker regions and nearby areas for site directed saturation mutagenesis to optimize
the GZnP sensors.
While the mutations described above increased the DR which increases the sensors
sensitivity to zinc perturbations the sensor kinetics are also of high importance. Zinc like
all metals within a cell is highly regulated and buffered to specific concentrations as
mentioned in chapter 1.2. Therefore perturbations in the zinc concentrations will be
quickly buffered back to physiological levels therefore providing a kinetically fast sensor
is pivotal to respond to fast fluctuations in zinc concentrations. During our site directed
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saturation mutagenesis we revealed mutations to the linker 1 region specifically
PW278/279LP amino acids resulted in an increased kinetic response from the sensors.
We monitored kinetics by observing how long after zinc and pyrithione addition it took
the sensor to plateau. The GZnP1.3 mutant took ~ 5 minutes longer for the signal to
plateau after zinc and pyrithione addition when compared to the GZnP1.3 LP variant.
Mutating the amino acids in the linker 1 region PW to LP we observed dramatically
increased kinetics when compared to other variants. We hypothesize the mutation from
PW to LP in linker 1 increases kinetics likely by reducing strain on the linker region
allowing faster rotation of the ZF into and out of position to cover the exposed
chromophore of eGFP and positioning of charged amino acids surrounding the
chromophore to quickly reduce the pKa of the chromophore. We found that mutations to
the PW amino acids in the linker 1 region resulted in increased kinetics in more than just
GZnP1.3 to GZnP3. This mutation increased the kinetics between GZnP1.1 vs GZnP1.2
and GZnP2 vs GZnP2.1 (a mutant of GZnP2 with the mutation PW to LP in linker 1).
These results show the linker regions have a profound effect on the Fmax, DR, and kinetics
of the sensor. The linker 1 region appears to have a more pronounced effect on the
kinetics of the sensor while the linker 2 region has a more pronounced effect on the
DR/Fmax of the sensor. To explain this linker 2 may not move as much as linker 1
resulting in linker 1 modifying the kinetics while the relatively immobile linker 2 may
dictate the overall fluorescence of the sensor. Linker 2 may alter the likelihood of the
chromophore to be in an anionic state and reduce the pKa while linker 1 may situate the
chromophore to enter these states faster. One way could be the mutation to linker 2
provides the correct geometries for amino acids to stabilize the anionic chromophore state
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and lower the pKa of the sensor but mutations to linker 1 place these key conformational
changes close to their zinc saturated geometry increasing the kinetics between the zincsaturated and zinc-free sensor states. Refer to Table 4 & 5 below for the location and
identification of the mutations and the results of those mutations on the DR, Fmax, and the
kinetics.
The LP mutation was shown to increase the sensor kinetics although it was found that
it can under some circumstances decrease the stability of the sensor when saturated with
zinc. This same observation was found in the original design and development of the
GZnP sensor [78]. One example is shown in GZnP2.1 with the LP mutation after addition
of zinc and pyrithione the signal becomes unstable and the fluorescence is quenched
compared to GZnP2 without the mutation to linker 1. This is interesting since the
GZnP1.3 to GZnP3 does not show this instability when saturated with zinc. The only
difference between GZnP2.1 and GZnP3 is in linker 2 a PH33/34 to IL33/34 respectively.
Potentially the proline prevents movement of the zinc finger or the flexibility present
with other amino acids causing this instability observed in the GZnP2.1 sensor. We
hypothesize this instability could result from a similar mechanism to why the histidine
tags must be removed due to dimerization and FRET occurring when high concentrations
of zinc are present. The zinc could interact with the ZF’s causing dimerization and
diminish the GZnP signal. Another potential is the conformation the two zinc fingers are
placed in the zinc saturated state does not fully protect the chasm in the 7th β-barrel
allowing zinc to interact with the phenolate oxygen when reaching a sufficiently high
concentration stabilizing the neutral state of the chromophore and preventing ESPT from
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occurring at the chromophore. Either of these scenarios would cause a decrease in the
fluorescence once zinc saturated the sensor.
Table 4: Mutations to Optimize GZnP Sensor. The mutated residues from the
previous sensor (except GZnP2.1, which is based on GZnP2, and GZnP3, which is based
on GZnP1.3) are denoted in red.
Sensor
Variants

Zn2+-Binding
Domain

Linker 1

Linker 2

GZnP1
GZnP1.1
GZnP1.2
GZnP1.3
GZnP1.4
GZnP1.5
GZnP1.6
GZnP2
GZnP2.1
GZnP3

SSLFD
SSLMD
SSLMD
SSLMD
SSLMD
SSLMD
SSLMD
SSLMD
SSLMD
SSLMD

LPKNN
LPKNN
PWKNN
PWKNN
PWKNN
PWKNN
PWKNN
PWKNN
LPKNN
LPKNN

THLENV
THLENV
THLENV
ILLENV
IILENV
ITLENV
VHLENV
PHLENV
PHLENV
ILLENV

Table 5: Results from Site-Directed Saturation Mutagenesis for optimized variants
with improved DR, Fmax, and/or kinetics. Treatments for both the dynamic range and FMax
included 100 µM TPEN for FMin and 20 µM Zinc Chloride & 2.5 µM Pyrithione for FMax.
GZnP1
GZnP1.1
GZnP1.2
GZnP1.3
GZnP1.4
GZnP1.6
GZnP2
GZnP3

Dynamic Range
2.2
2.2
4.3
15.5
15.0
5.5
4.5
11.0

FMax (A.U.)
7500
1800
1500
8000
NA
10000
6500
6000

Biophysical characterization of the most promising sensors made was performed to
determine the specificity of the sensor for zinc, the dissociation constant, and the
quantum yield & Extinction coefficients. The biophysical characterization was performed
in vitro on purified sensor derived from Top10 Escherichia coli cells expressing the
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sensor variant. The sensors were purified and analyzed for metal specificity comparing
the sensors response to other common biological cations such as calcium, magnesium,
nickel, copper, cobalt, manganese, potassium, mercury, chromium, and aluminum, refer
to Figure 9. Some of the sensors were tested against more metals upon request by
reviewers for publications. All the metals showed no response except for cadmium II and
copper II. This follows the Irving-Williams affinity for coordination of amino acids. This
is unavoidable and acceptable due to biological labile copper and cadmium
concentrations being zero [130]. None of our mutations affected the specificity of the
optimized probes. GZnP1.1 and GZnP1.5 were excluded due to lower DR’s and unstable
FMax. There is a significant increase in the sensor fluorescence at 515 nm between the
zinc-free and zinc-saturated states as shown in Figure 10 below for two sensor variants
(GZnP2 & GZnP3).

Figure 9: Metal Specificity of Optimized GZnP Sensors. All the sensors remain
specific to zinc. AA is ascorbic acid and was used to reduce the iron III to iron II.
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Figure 10: Emission Curve of GZnP2 & GZnP3. There is a substantial increase in
fluorescence at 515 nm when the sensor is saturated with zinc compared to the zinc-free
state (TPEN treatment) for both sensors.
A zinc binding curve was made for the optimized GZnP sensors using the method
described in the methods section and shown in Figure 11. The zinc binding curves were
performed at pH 7.4, although the derived constants (hill coefficients and dissociation
constants) will change at different pH’s for the reasons explained in the introduction for
genetically encoded sensors. There is variation in the binding affinities of each sensor due
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to the mutations performed on the zinc linker regions. The biggest change in the binding
affinity results from the initial change to the zinc finger between GZnP1 & GZnP1.1.

Figure 11: Zinc Binding Curves for Optimized Variants of GZnP Sensor. The
dissociation constant is shown for each optimized GZnP variant.
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At higher pH’s the dissociation constant and hill coefficient will decrease (Higher
affinity) for example GZnP2 has a kd of 352 pM and a hill coefficient of 0.49 at pH 7.4
while the kd drops to 112 pM and the hill coefficient drops to 0.264 at pH 8, (Table 6 &
Figure 12). Changes in pH as mentioned in the introduction will dramatically affect the
brightness of the sensor by altering the pKa of the chromophore which will shift the
equilibrium of the anionic and neutral state of the chromophore. This can be observed in
Figure 13 with the higher pH lowering the chromophore pKa enhancing the brightness of
the sensor by favoring the anionic state of the chromophore. Once dropping down to ~6.5
pH the sensor brightness dropped off completely likely due to the pH denaturing the
protein and the chromophore no longer being held rigid and protected diminishing all

Intensity (A.U.)

fluorescence.
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Figure 12: Zinc binding curve for GZnP2 at cytosolic pH 7.4 and the Mitochondrial
Matrix pH 8. The zinc binding curve for the GZnP2 sensor is shown at pH 7.4 & 8.
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Figure 13: Effects of pH on GZnP2 Sensor. The pH will quench the signal at lower
pH eventually denaturing the protein and will enhance the signal at higher pH due to
decreasing the chromophore pKa and shifting the chromophore anionic state to be more
favorable. There is a **** (p<0.0001) between each pH between all the A, B, & C bars
respectively, n=3 calculated using a one way ANOVA post hoc Tukey.
Table 6: Dissociation Constants and Hill Coefficients of GZnP Sensors

GZnP1
GZnP1.3
GZnP1.4
GZnP1.6
GZnP2
GZnP3

Apparent
dissociation
constant (Kd’,
pH 7.4)
34 pM
483 pM
855 pM
552 pM
352 pM
1.3 nM

Apparent
dissociation
constant (Kd’,
pH 8)
NA
NA
NA
NA
112 pM
NA
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Hill coefficient
(n, pH 7.4)

Hill coefficient
(n, pH 8)

0.6
0.42
0.5
0.29
0.49
0.34

NA
NA
NA
NA
0.264
NA

The quantum yield (QY) and extinction coefficients were found for the optimized
GZnP sensors. As observed in Table 7 the quantum yield for the GZnP1.3 and GZnP1.4
sensor in the zinc-free state there is almost no fluorescence. This is the reason the sensor
is difficult to visualize at baseline with low concentrations of zinc but also the reason for
the large DR of the two sensors compared to the other variants. With the lower limit set
lower than other variants but with relatively high QY in the zinc-saturated state the
sensors can increase their brightness substantially more than other sensors with a higher
QY in the zinc-free state. Interestingly when comparing GZnP1.3 and the LP variant
(GZnP3) the DR’s are close although the mechanism of increasing the DR is dissimilar.
The GZnP1.3 sensor relies on a large change in the QY between the zinc-free and zincsaturated state while GZnP3 relies on a more significant change in the extinction
coefficient with a modest increase in the QY. These different mechanisms still
accomplish the end result of a more sensitive sensor just through different mechanisms.
The ultimate goal would be a sensor with a large change in both the QY and the
extinction coefficient leading to a massive DR. All the optimized sensors show an
increase in the DR due to an increased extinction coefficient or QY in the zinc-saturated
state or a combination of the two biophysical characteristics, refer to Table 7.
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Table 7: Quantum Yield and Extinction Coefficients of Optimized GZnP Sensors

Quantum yield
(QY, Apo)

Quantum yield
(QY, Zn2+bound)

Extinction
coefficient
(Apo)

Extinction
coefficient
(Zn2+-bound)

0.42

0.57

NA

NA

0.03

0.39

12600

29500

0.03

0.41

28800

36000

0.41

0.84

2600

30100

GZnP2

0.21

0.64

10000

34000

GZnP3

0.112

0.462

4000

23400

GZnP1
GZnP1.3
GZnP1.4
GZnP1.6

The optimization of the GZnP1 sensor produced promising sensor variants with
improvements in the sensitivity of the sensors for zinc (DR), the kinetics, and sensors
with a variety of binding affinities for zinc. This offers a spectrum of zinc sensors to
expand the current toolbox of zinc sensors available for imaging. This sets the stage for
the next chapter where we required zinc sensitive sensors to monitor mitochondrial zinc
dynamics. Below is a comparison of all the current mitochondrial zinc probes including
GZnP1 & 2 discussed in this work shown in Table 8. What can be noticed is our
mitochondrial zinc probes are the only intensiometric mitochondrial zinc probes available
offering the benefits of intensiometric sensors over ratiometric sensors.
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Table 8: Comparison of Currently Available Genetically Encoded Mitochondrial Zinc
Sensors. The dissociation constants were measured at pH 8.
Sensor
type
FRET
FRET
FRET
FRET
FRET
FRET
FRET
Single
FP
Single
FP
Single
FP

Zn2+ Sensor

Apparent dissociation
constant (Kd)

In situ
Dynamic range
(Smax/Smin)

1.6 pM

3.22

NA

1.3

NA

1.13

NA

1.14

1.7 µM

1.17

Ref

mitoZAPCY1
mitoZAPCY2
mitoZAPCY4
mitoZAPCY5
mito-ZifCY1
mitoeCALWY-4
mito-eZincCh

60 pM

1.4

[126]

10.0 pM

1.7

[128]

mito-GZnP1

NA

2.2

[153]

mito-GZnP2

112 pM

4.5

[154]

mito-GZnP3

NA

11

[88]

[123]

2.4 CONCLUSIONS
The goal of this chapter was to design improved zinc sensors expanding the toolbox
of available zinc sensors to analyze a wide variety of physiological situations. This goal
was accomplished through the improvement and optimization of the GZnP1 a sensor
originally developed by Yan Qin [78]. GZnP1 was a great starting point resembling
GCaMP2 & GCaMP3 in respect to the quantum yield (0.57 compared to 0.53 & 0.65
respectively) but lacked in the DR of such calcium genetically encoded sensors [131].
The DR enables sensors to become more sensitive to the ions the sensors are designed to
detect. In the case of zinc the concentrations are already very small in the picomolar to
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nanomolar range, to design a sensor with a large DR is necessary to detect dynamics in
small concentrations of zinc. The GZnP1 sensor has a DR of 2.3-2.6 [78] which is a great
starting point but needs to be improved to match current calcium sensors with DR’s of 5
as in GCAMP2 [153] to 111 with GEM-GECO1 [115]. Commonly used calcium probes
have a DR that falls between 5 and 20 which is sensitive enough to pick up miniscule
changes in calcium concentrations. Our objective at the onset of this project was to
design zinc sensors with DR’s between 5-20 to match current calcium sensors. The
development of GZnP3 and GZnP2 with in situ DR’s of 11 and 4.5 respectively we have
accomplished that goal to develop more sensitive zinc sensors that will respond strongly
to slight changes in the zinc concentration.
In addition to designing the sensors with a higher DR the sensors dissociation
constant was modified to create a spectrum of sensors that can detect changes in low zinc
(0.3 pM, GZnP1) to high concentrations of zinc (13 nM, GZnP3). This enables us to pick
up zinc dynamics occurring at all known physiological concentrations of zinc, from
almost no zinc as in the mitochondria[84] to high nanomolar concentrations found
released from lysosomes[88]. The wide variety of developed zinc sensors has improved
the currently available genetically encoded intensiometric, ratiometric, or small molecule
zinc probes available. With these improved zinc sensors zinc biology has the tools
necessary for investigation.
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CHAPTER THREE: MITOCHONDRIAL ZINC HOMEOSTASIS
3.1 INTRODUCTION
Emerging studies have shown that zinc affects certain cellular processes such as
enzymatic reactions[2], mitochondrial function[3-5], cell division [6] and apoptosis[6].
The ambition to explore and elucidate the roles of zinc in these essential cellular
processes has propelled the development of fluorescent zinc sensors within the past
decade. Both quantitative and qualitative measurements of total zinc and labile zinc have
been characterized using fluorescent zinc sensors. The ability to measure labile zinc
specifically and accurately in various subcellular locations is paramount to understanding
how zinc modulates various functions within a cell. Although the labile zinc
concentration is tightly regulated in the cell, it is also highly dynamic both spatially and
temporally. There are zinc fluxes from different subcellular compartments, exchanges
between coordinated zinc binding proteins, or communications occurring between the
extracellular environment and the cell releasing or eliminating zinc. For this reason the
development of a zinc sensor that can be reliably subcellularly targeted in the cell can
offer a wealth of information on the zinc dynamics occurring within the cell.
We established in chapter 2 the importance of developing novel sensitive zinc probes,
while in this chapter we focus on utilizing and developing these novel zinc probes further
to understand zinc dynamics occurring in the mitochondria. Both small molecule sensors
and genetically encoded sensors have been utilized to monitor and measure zinc
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dynamics and concentrations in the mitochondria including RhodZin-3 and DA-ZP1-TPP
[154, 155], mito-ZapCY1 [123], mito-eCALWY4 [126] and mito-eZinCh [128]. These
sensors have opened the door to how zinc is involved in a multitude of processes due to
mitochondrial zinc fluctuations causing significant interactions with dramatic outcomes.
Localizing these sensors has become essential in understanding the principal of how zinc
interacts in the cell. Many zinc interactions involve a complex spatiotemporal mechanism
where zinc responsive fluorescent probes are perfectly suited for the task. For these
reasons a probe that can be reliably localized to specific regions of a cell can offer insight
into how zinc is being trafficked in cells and how this trafficking can alter cellular
function. For example, DA-ZP1-TPP, a mitochondrial small molecule zinc probe that
localizes to the mitochondria via electrostatics found that zinc uptake into mitochondria is
inhibited in tumorigenic prostate epithelial cells compared with non-cancerous cells
[155]. Inside the mitochondrial matrix, zinc inhibit the aconitase and other energy
production enzymes [3-5, 44, 45, 156], hence reduced mitochondrial zinc uptake could
potentially release the suppression of zinc on mitochondrial enzymatic activity, aiding in
the explosive growth rates of cancer cells. With another mitochondrial targeted zinc
sensor, Mito-CA-DSRed2, studies found that zinc accumulates in the matrix of the
mitochondria of neurons during ischemia/reperfusion events depolarizing and destroying
mitochondrial function [157]. This accumulation of labile zinc is believed to contribute or
cause neuronal death following an ischemic event. There are many more examples of
important discoveries derived from the use of mitochondrial targeted zinc probes
although many of them need improved zinc probes to substantiate their claims. One

78

biological certainty is zinc accumulation in the mitochondria will cause mitochondrial
dysfunction.
Due to excess zinc the mitochondrial membrane potential will decrease thereby
decreasing the ATP production without a strong proton gradient present to produce the
ATP via the electron transport chain. This causes mitochondrial fragmentation, increased
ROS production [44], depolarization of the mitochondria [3], and enzymes such as αketoglutarate dehydrogenase, aconitase, all four complexes of the electron transport chain
but with high affinity for NADH dehydrogenase (complex I), and cytochrome bc1
complex (complex III) [42, 156, 158] involved in respiratory metabolism to be inhibited
by zinc. The rise in mitochondrial zinc causes the formation and opening of the
mitochondrial permeability transition pore (MPTP) which can then release apoptotic
factors such as cytochrome c, DIABLO/SMAC, and apoptosis-inducing factor (AIF)
which lead to cell apoptosis [4]. This mitochondrial apoptosis pathway has been
described for numerous pathologies such as a type of Parkinson’s disease where the
patients lack the PARK9 gene which encodes for the ATP13A2 protein [40, 41, 159].
The ATP13A2 protein is an ATPase that functions in cells to regulate zinc homeostasis
by sequestering zinc into lysosomes [41]. When this ATPase is not present zinc cannot be
sequestered in the lysosomes and accumulates in the mitochondrial matrix quickly
overwhelming the mitochondria causing apoptosis as described above [41]. Zinc
overcoming the mitochondria has been documented in ischemia, head trauma, and
Parkinson’s disease [41, 42, 155, 160]. Zinc dynamics depend on many factors requiring
probes that not only have a high specificity and sensitivity to zinc but also importantly
have the ability to localize to specific locations within the cells to observe zinc micro79

environments. In the above examples zinc concentrations in the mitochondria are
dynamic in response to many different stimuli, in order to monitor and observe these zinc
dynamics in live cells sensors targeted to specific locations in the cell are necessary.
Knowledge that arose from experiments utilizing zinc sensors targeted to specific
locations offers novel pathways for treatments of pathologies associated with zinc
dyshomeostasis.
The focus of this chapter surrounds the mitochondria and what zinc dynamics are
occurring within and around the mitochondria. Labile zinc can dramatically alter
mitochondrial function which places a high importance on the study of zinc dynamics in
relation to mitochondrial function. Mitochondrial function has expanded from the initial
view as only a bioenergetic source of ATP to an integral part in cell signaling events,
multiple diseases, cell proliferation, and cell death [161]. A biological question that this
chapter addressed is if the mitochondrial matrix will store excess zinc in the cell to
muffle the labile zinc concentration. As stated previously zinc will cause mitochondrial
dysfunction which would indicate the mitochondria would not be a location to store labile
zinc although indirect evidence has suggested that the mitochondria may act as a source
or supply of labile zinc [162, 163]. Various studies have shown that the total zinc
concentrations in the mitochondria are high in several cell types such as the mammary
gland cells[162], prostate cells[42], and neurons[154, 164] suggesting that the labile zinc
could potentially be high in these cells as well. In addition, labile zinc may be released
from the mitochondria to the cytosol due to increased cytosolic zinc concentrations when
the mitochondria were depolarized in cultured neurons [154]. Large concentration of
labile zinc have been recorded in the mitochondria using the FloZin-3 small molecule
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probe. This probe is not specific to the mitochondria although studies have shown
through colocalization of a mitochondrial marker that high zinc is present in the
mitochondria following lysosome permeabilization [165] or induced ischemic events
[154, 157]. Although, direct quantitative measurements have reported the labile zinc
concentration in the mitochondrial matrix is very low if not zero using several probes
such as mito-eZinCh-2 (3.3 pM)[128], Mito-CA-DSRed2 (0.2 pM)[166] and mitoZapCY1 (0.14 pM)[123] in HeLa and PC12 cells. The uncertainty if the mitochondria is a
storage site for zinc needed further attention with a higher sensitivity zinc probe and by
investigating a variety of cell types.
Another question related to mitochondrial zinc this chapter addresses pertains to the
intermembrane space (IMS). This region of the mitochondria is between the inner
membrane and the outer membrane of the mitochondria. The allure of this region lies in
the mystery involving the zinc dynamics that occur there. It was still unclear if the zinc
dynamics in the IMS are a separate moiety from the cytosol. The reason for the belief the
IMS may be continuous with the cytosol is the integral membrane protein, Voltage
Dependent Anion Channel (VDAC) or porin, present on the outer membrane of the
mitochondria. This integral protein is permeable to molecules 3000 Daltons in size or
less[167]. These channels are water filled and thought to be non-selective allowing
hydrophilic solutes to pass through them via simple diffusion. It has been inferred that
zinc ions can diffuse freely across the mitochondrial outer-membrane meaning that the
zinc concentrations in the IMS are synonymous with the cytosolic zinc concentration
[168, 169]. However, conflicting studies have shown that the VDAC channel is selective
and only allows certain solutes through the pore [170]. In fact immunohistochemical,
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biochemical, and electrophysiological methods have shown that the VDAC channel is not
isolated in the outer membrane of the mitochondria but also located in other regions such
as the plasma membrane of B lymphocytes[171] and the sarcoplasmic reticulum of
skeletal muscle[170, 172]. These locations do not allow simple diffusion to occur with
molecules below 3000 Daltons. The VDAC channel does have some degree of specificity
of what can pass through, although the mechanism of how this specificity occurs is
currently unknown. VDAC does remain permeable to Ca2+ ions meaning there is the
potential zinc could pass through the channel via simple diffusion [170, 173]. Currently
the view for zinc is that the VDAC channel is permeable to zinc similar to calcium
thereby allowing the simple diffusion of zinc from the cytosol to the IMS or vice-versa.
Although no studies have shown this to be valid there are other grounds for why zinc
concentrations in the IMS may be vastly different from the cytosol.
The IMS is a critical site for oxidative phosphorylation reactions which create free
radicals such as superoxide and hydrogen peroxide which are neutralized in iron-sulfur
clusters and metallothionien proteins [174]. The metallothionien proteins are major zinc
buffering proteins that can covalently bind up to seven zinc ions. Studies have shown that
oxidation can liberate zinc from metallothionien [91, 175]. Due to the high amount of
oxidation-reduction reactions taking place within the IMS of the mitochondria the free
zinc concentration could potentially be much higher than the cytosolic concentration of
free zinc through the release of zinc from the metallothioniens. In addition due to the
proton gradient from the electron transport chain the pH could potentially drop as well
also resulting in reduction of the cysteines causing release of zinc from the
metallothioniens [158]. It is also believed that metallothionien from the cytosol may
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translocate to the mitochondrial IMS which can also result in the release of zinc when
entering the redox and/or lower pH environment [158]. In order to address this debate, we
created a zinc sensor specifically targeted to IMS of the mitochondria which has never
before been performed. This allowed for direct analysis of the zinc dynamics occurring in
this region.
There are two proposed transport mechanisms for labile zinc uptake into the
mitochondrial matrix; the mitochondrial calcium uniporter (MCU) and the MCU
independent mechanisms such as ZnT2 protein [176-179]. The mechanism of the export
of zinc from the mitochondria remains unknown. The MCU is believed to be permeable
to zinc because of two studies performed using isolated mitochondria [177, 178]. The
MCU is activated with elevated cytosolic calcium concentrations [180] . Using a
subcellular targeting sensor to the cells in situ calculations of the calcium uniporter
channel were tested. The INS-1 β cells were either depolarized or not depolarized in the
presence of the inhibitor and compared to when the inhibitor was not present.
Depolarization conditions found no difference in the zinc uptake to the mitochondrial
matrix, although no depolarization found zinc levels increased faster in cells treated with
the inhibitor which could be a result of ancillary inhibition of channels other than the
calcium uniporter changing other factors in the cell to increase mitochondrial matrix zinc.
The RU360 has been shown to affect a variety of other channels besides the MCU [181].
This work filled the gap in our current understanding about mitochondrial zinc
dynamics occurring in the IMS as well as illuminating the zinc concentration in the IMS
relative to the cytosol. This offers direct concrete evidence that the cytosolic zinc
concentration is contiguous with the IMS zinc concentration. The ability to accurately
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monitor zinc in different subcellular compartments with a sensitive sensor will provide
insight into zinc dynamics and homeostasis within the cell. This can be taken further
when examining disease models and monitoring zinc dynamics for ways to mitigate or
reverse the damaging effects zinc may be causing in various diseases.
3.2 METHODS
MITOCHONDRIAL SENSOR PLASMID CONSTRUCTIONS
For mito-mCherry-GZnP2 construction, three repeats of the coding sequence for the
first 29 amino acids of the human cytochrome c oxidase subunit 8a (mitochondrial
precursor; accession number NP_004065) was utilized for mitochondrial matrix targeting
and incorporated into pcDNA3.1 vector using HindIII. The mCherry fragment was
inserted between the BamHI and EcoRI restriction sites and the GZnP2 fragment was
inserted between the EcoRI and XhoI restriction sites. Making a mitochondrial
ratiometric zinc sensor.
The fragment mCherry-GZnP2 was amplified from the template mito-mCherryGZnP2 and cloned into pcDNA3.1 vector using BamHI and XhoI restriction enzymes.
This made the zinc sensor a ratiometric cytosolic sensor.
To construct the SMAC-mCherry-GZnP2, the IMS targeting sequence was amplified
using the template PCMV1-SMAC-HA-eGFP and cloned into pcDNA3.1 with BamHI
and KpnI, then the fragment mCherry-GZnP2 was inserted between BamHI and XhoI
restriction sites. pCMV1-SMAC-HA-eGFP was a gift from Richard Kahn (Addgene
plasmid # 67487). This was a ratiometric zinc sensor targeted to the IMS of the
mitochondria.
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MICROSCOPE PARAMETERS
This microscope was the most utilized instrument in the experiments performed. A
confocal microscope built by Solamere Technology Group and contains a Nikon Tieclipse inverted fluorescence microscope with a Yokogawa CSUX1 spinning disk
confocal system. Features of the confocal microscope include: Nikon Ti-E Perfect Focus
System (PFS) for maintenance of sample focus, motorized XY stage with piezo Z-Drive
insert for rapid multidimensional (XYZ) imaging, environmental chamber (LiveCell)
with temperature, carbon dioxide, and humidity regulation, 4 Objectives: 10X (NA 0.45),
20X (NA 0.75), 40X (NA 1.30), 60X (NA 1.4) and a 1.5X optivar, 6 Laser lines: 405 nm,
445 nm, 488 nm, 514 nm, 561 nm, and 640 nm, Hamamatsu X2 EMCCD camera, LED
light for Wide field illumination, and the capacity to operate in simultaneous imaging,
photo activation, and FRAP modes.
The microscope parameters are shown below in Table 9. These parameters were used
for any image analysis performed using the spinning disk confocal fluorescence
microscope.
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Table 9: Spinning Disk Confocal Fluorescence Microscope Parameters
Objecti
ve

OptiVa
r
Setting

Effective
Magnificati
on

1.0x

10x

1.5x

15x

1.0x

20x

1.5x

30x

10x

20x

1.0x

40x

Pixel
Size
0.8473
µm
0.5632
µm
0.4254
µm
0.2830
µm

0.2146
µm

40x

1.5x

1.0x

60x

0.1425
µm

60x

0.1412
µm

90x

0.0940
µm

60x

1.5x
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FWH
M
(pixel
s)

1st 𝜎 of Point
Spread Function
(PSF)

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

488n
m–
2.5767
561n
m – 2.411
Avg =
2.494
488n
m–
2.9007
561n
m–
2.8329
Avg =
2.867
488n
m–
2.5767
561n
m – 2.75
Avg =
2.663
488n
m–
4.0308
561n
m–
3.4356
Avg =
3.733

488nm –
234.8215 nm
561nm –
219.7161 nm

488nm –
175.5326 nm
561nm –
171.4292 nm

488nm –
154.5051 nm
561nm –
164.8958 nm

488nm –
160.9029 nm
561nm –
137.1434 nm

MAKING IMAGING DISHES
Punch holes in the center of the Corning 10 mm x 35 mm imaging dishes (corning
430165) using the hole punch. Use sand paper to extensively score the plastic around the
punched hole. Make the glue mixture using a 9:1 ratio of Silicon Elastomer base & f
Silicon Elastomer curing agent respectively. Use the P1000 pipette to distribute the glue
evenly around the hole. Apply a glass cover slip on top of the glue being sure to not
adhere multiple cover slips. Reapply glue around the perimeter of the cover slips after
being attached to the imaging dishes to ensure a tight seal. Leave the dishes at room
temperature overnight. 24 hours later leak test the dishes by adding 2 ml of MiliQ H2O to
each dish. If a dish leaks discard the dish. Wash dishes with MiliQ H2O three times to
remove any residual glue. Dry then sterilize the imaging dishes using UV light for 1 hour.
CELL CULTURE
HeLa cells, HEK293 cells, and Cos-7 cells were maintained in high glucose
Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS). INS1 cells were cultured in RPMI 1640 media with 10% FBS, 1% sodium pyruvate (100
mM), 1% HEPES (1 M) and 0.1% 2-mercaptoethanol (2mM). All cell lines were
incubated at 37 ˚C and 5% CO2. When placing INS-1 and Cos-7 cells in imaging dishes,
the imaging dishes were precoated with 1 mg/ml of Poly-D-Lysine (PDL) to adhere the
cells to the dishes. Dishes were incubated with PDL for 24 hours prior to being washed
3x with DPBS to remove excess PDL. All cell lines were passaged once the cells reached
~90% confluency for a maximum passage number of 15 passages. All cell lines were
split by plating 50,000 cells into a cell culture flask. All cell lines except HEK293 cells
were split 7 days later, HEK293 cells were split every 3 days due to their fast growth rate.
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TRANSFECTION
PEI (Polyethyleneimine) transfection reagent (dissolved to 1 mg/ml in water at pH
7.2 and stored at -20 ˚C for long-term >1 month and 4 ˚C for short term <1 month) was
used for the transfection in HeLa and HEK293 cells. Lipofectamine 3000 transfection
reagent and lipofectamine buffer solution (P3000) was used as the transfection reagent
for INS-1 and Cos-7 cells due to the difficulty in transfecting these cell lines.
Transfection was performed when the cells were approximately 40-50% confluent. For
each transfection reaction in HeLa or HEK293 cells, 2 µl of PEI transfection reagent and
1.25 µg of the sensor DNA were mixed in 250 µl OPTI-MEM. The mixture was
incubated for a minimum of 25 minutes at room temperature before direct addition to one
imaging dish containing the cells. Transfection of INS-1 or Cos-7 cells was similar to the
method used to transfect HeLa and HEK293 cells with slight modification. The following
reagents: 500 µl of OPTI-MEM, 3.75 µl of Lipofectamine 3000 transfection reagent, 1.25
µl Lipofectamine P3000 and 1.25 µg of the sensor DNA were mixed together. The
reaction mixture was incubated for a minimum of 25 minutes at room temperature and
then added the cultured INS-1 or Cos-7 cells. Sensor can be expressed as little as 12
hours post-transfection. Imaging was performed 48-72 hours post transfection. The ideal
method for transfection using any method of transfection was found to be transfecting the
cells 48 hours after splitting the cells at normal seeding concentrations for the imaging
dishes (10 mm Corning). The cells were allowed to uptake and express the transfected
plasmid for 48 hours then imaged. This produced the best results with high transfection
efficiency ~50-70% and healthy cells.
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TRANSFORMATION PROTOCOLS
HEAT SHOCK
Homemade competent Top10 cells are thawed on ice for 10 minutes. Once thawed 5
µl of plasmid is added to the cells and left on ice for 30 minutes to allow the plasmid to
accumulate around the cells. Heat shock was performed at 42 ˚C for 60 seconds to allow
the insertion of the plasmid surrounding the cells. 250 µl of LB is then added and placed
back on ice for 2 minutes to allow the phospholipids of the membrane to seal in the
plasmid. This is then transferred to a 2 ml micro-centrifuge tube and shakes at 37 ˚C for
45 minutes. The cells were then plated and incubated overnight on agar plates with the
correct antibiotic. This method provides a medium level of transfection efficiency ideal
for most situations unless it is more time effective to use a simple mix and go
transformation or if this is not efficient enough electroporation would be the optimal
choice.
ELECTROPORATION
The homemade electrocompetent cells are removed from the -80 ˚C freezer and left
on ice to thaw for 10 minutes. Homemade electrocompetent cells were made by lab
mates. The pellet is very dense in cells and needs to be diluted using 425 µl of GYT
(glycerol, yeast extract, tryptone) buffer. Add 100 µl of the diluted competent cells to the
1 mm cuvette and the plasmid. Pipette up and down to mix thoroughly. Place back on ice.
For the electroporation instrument select Bacteria, 1 mm, pulse the cells. Within one
minute add 250 µl of LB to the cuvette. Keep the cuvette on ice. Incubate on the shaker at
250 rpm and 37 ˚C for one hour. Remove and plate the solution using the correct
antibiotic. This method is used for extremely difficult transformations such as
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mutagenesis where the plasmid concentration is extremely low and we need a high
transformation efficiency.
CLONING PROTOCOLS
PCR, restriction digest, and ligation were all used to perform cloning procedures
throughout this work.
QUANTIFICATION OF ZINC CONCENTRATION IN THE CYTOSOL, IMS,
AND MATRIX
Sensor constructs were transfected into cells and imaged 48-72 hours posttransfection. Imaging experiments were performed on a Nikon/Solamere CSUX1
spinning disc confocal microscope. Images were collected with a 40× 1.3 NA oil
objective and imaging data was acquired using the MicroManager software. The settings
used for the 488 nm laser were an exposure time of 100 ms and laser power of 10% and
for the 561 nm laser an exposure time of 50 ms and laser power of 3%, 20 second
acquisition times were used for all image stacks. Cells were imaged in phosphate-free
HHBSS, pH = 7.4. For sensor calibration, cells were treated with 100 μM TPEN for the
minimum signal (Imin) and 1.25-5 μM pyrithione and 20 μM ZnCl2 to establish the
maximum signal (Imax). The pyrithione concentration had to be manipulated based on the
response of some of the sensors. Pyrithione can decrease the stability of the zinc
concentration by chelating zinc when pyrithione concentrations are too high and this is
detected by cytosolic sensors. Because unhealthy cells could demonstrate compromised
sensor response, we only chose the cells with dynamic ranges from 3-4.5 for
mitochondrial matrix quantification and dynamic ranges 4-6 for cytosolic measurement.
This eliminated artifacts imposed by unhealthy cells.
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Refer to Appendix A for details on the image analysis performed to quantify the zinc
concentration.
MONITOR CELLULAR ZINC DYNAMICS IN THE MITOCHONDRIAL
MATRIX, IMS AND CYTOSOL
To monitor zinc uptake when cells are loaded with high zinc, sensor constructs were
transfected into INS-1 pancreatic β-cells and imaged 48-72 hours post-transfection.
Imaging experiments were performed using the same methods described above for the
microscope and microscope settings. Cells were imaged in the phosphate-free HHBSS
buffer, pH = 7.4 with or without extracellular CaCl2. To record the cellular zinc transport
as close to physiological conditions as possible, cells were maintained in an
environmental chamber at 37 ˚C, 5% CO2 and 50-70% humidity. Cell depolarization was
induced using a high KCl HHBSS buffer (100 mM KCl, 1.1 mM MgCl2, 16.8 mM DGlucose, 20 mM HEPES, and 41.14 mM NaCl, at pH 7.4). The HHBSS buffers used for
depolarization were also supplemented with 100 µM ZnCl2 if adding extracellular zinc to
the media was used for the experiments. All imaging buffers used for the imaging were
preincubated in a bead bath at 37 ˚C until the buffers reached 37 ˚C. This prevented
thermal drift from occurring while imaging and after drug treatments of cells as well as
maintaining a physiological temperature throughout the experiments. When using the
inhibitor RU360 a concentration of 10 µM was used in each imaging dish. The cells were
incubated in the RU360 for 30 minutes prior to imaging experiments and maintained at
10 µM throughout all the imaging buffer changes.
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3.3 RESULTS/DISCUSSION
The GZnP2 sensor was used for the zinc quantification of cytosolic, mitochondrial
matrix, and mitochondrial intermembrane space. The GZnP2 sensor described in chapter
2 was further modified to account for z-axis drift and expression level variation. Since the
sensor relies on intensity changes to report the labile zinc concentration changes in either
the expression level or z-axis can lead to artificially low or high zinc concentrations.
Changes in the z-axis can result from thermal drift, drug additions, or movement of the
cell which need to be accounted for due to the changes in the GZnP2 signal. Expression
levels will change due to the highly dynamic nature of mitochondria undergoing
morphology changes through frequent fission and fusion as well as variations across cells
expression of the sensor. Another dynamic factor is the mitochondria move continuously
through cellular trafficking quickly changing the brightness of a sensor. For these reasons
we attached GZnP2 with a stable red fluorescent protein mCherry which is insensitive to
zinc for normalization. The excitation and emission peaks do not bleed through to the
GZnP2 signal offering a great strategy to convert our intensiometric sensor into a
ratiometric sensor with the benefits of both types of sensors and none of the drawbacks.
This strategy has been performed before for labile calcium quantification and shown to
provide better quantitative analysis of labile metal concentrations [182]. Using this
strategy, we created three sensors mCherry-GZnP2 for the cytosol, mito-mCherry-GZnP2
for the mitochondrial matrix and SMAC-mCherry-GZnP2 for the IMS see Figure 14A.
The cytochrome c subunit 8, which is a frequently utilized tag for mitochondrial matrix
localization [123], was used to construct mito-mCherry-GZnP2 see Figure 14A & B. The
second mitochondria derived activator of caspases (SMAC) was used to target SMAC92

mCherry-GZnP2 to the mitochondrial IMS see Figure. 14A & C as this SMAC signal
peptide has been reported previously as an IMS target [183]. The sensor with no
subcellular tag, mCherry-GZnP2 resides in the cytosol and nucleus see Figure 14A & D.

Figure14: Compare Zinc Measurements in the Mitochondrial Matrix, IMS, and
Cytosol. (A) Diagram showing the subcellular locations of GZnP2 in the mitochondrial
matrix, IMS, and cytosol. The mito-mCherry-GZnP2 is targeted to the mitochondrial
matrix using the cytochrome c oxidase subunit 8a, the SMAC-mCherry-GZnP2 sensor
localizes to the IMS using the SMAC/DIABLO protein, while the mCherry-GZnP2
sensor with no targeting sequence resides in the cytosol. (B-D) Representative images of
the sensors in HeLa cells at baseline for mito-mCherry-GZnP2 (B), SMAC-mCherryGZnP2 (C), and mCherry-GZnP2 (D). (E-G) Representative calibration curves showing
the percent saturation of the sensor in the mitochondrial matrix (E), IMS (F), and cytosol
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(G) in HeLa cells. The specific Zn2+ chelator TPEN (100 µM) was used to yield 0%
saturation, while 5 µM pyrithione and 20 µM ZnCl2 was used to yield 100% saturation.

Figure15: Representation of the mCherry-GZnP2 Sensor in Apo and Bound State.
Subcellular locations where the mCherry-GZnP2 sensor was localized.
Each sensor was calibrated in the three different subcellular compartments
(mitochondrial matrix, IMS, and cytosol) to compare zinc concentrations in each
compartment of HeLa cells, see Figure 14E-G. Cellular zinc was chelated using 100 µM
TPEN for 5 minutes reducing the sensor signal to the minimal saturation (0% zinc), while
treatment with 5 µM Pyrithione and 20 µM ZnCl2 yields 100% sensor saturation (bound
to zinc).
The resting baseline % saturation of mito-mCherry-GZnP2 (matrix zinc) was close to
0% saturation, while both SMAC-mCherry-GZnP2 and mCherry-GZnP2 were
approximately 20% saturated by zinc in the resting baseline state see Figure 14E-G.
Although both mito-mCherry-GZnP2 and SMAC-mCherry-GZnP2 presented the same
pattern of mitochondrial localization shown in Figure 14B & C, their calibrations
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baseline plots were vastly different as shown in Figure 14E & F. This confirms that these
two sensors were targeted to the two distinct regions within mitochondria (IMS and
matrix). The results of the calibration suggest that labile zinc in the mitochondrial matrix
is substantially lower than cytosolic and IMS labile zinc concentrations, while labile zinc
concentrations in the IMS and the cytosol are the same. The GZnP2 sensor fluorescence
was not affected by hydrogen peroxide suggesting that the mild redox environment of the
mitochondria will not affect the GZnP2 signal (Figure 16). Both the SMAC-GZnP2 and
mito-GZnP2 showed high Colocalization (Pearson Coefficient >0.85) refer to Figure 17.

Figure 16: Effects of H2O2 on the GZnP2 Sensor. The effect of H2O2 on the sensor
was evaluated in vitro in a reducing environment (0.5 mM TCEP) and in a natural
environment (without TCEP). There was no statistically significant difference for the
sensor fluorescence treated with hydrogen peroxide (0-1mM). Statistical significance was
calculated using one way ANOVA post hoc Tukey.
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Figure 17: Colocalization of SMAC-GZnP2 and mito-GZnP2 with known
mitochondrial markers. HeLa cells expressing mito-GZnP2 (A) were stained with
MitoTracker red (B). (C) The merged picture of a and b exhibited high colocolizaiton.
The Pearson coefficient for mito-GZnP2 and Mitotracker red was 0.92 ± 0.009 (A-C).
HeLa cells expressing SMAC-GZnP2 (D) were stained with TMRM (E). The merged
picture of d and e exhibited reasonable colocaliztion. The Pearson coefficient for SMACGZnP2 and TMRM was 0.85 ± 0.02 (D-F). A minimum of three different replicates were
performed, n=50.
This work was expanded to four cell types to quantify the zinc concentrations in the
mitochondrial matrix and IMS, and the cytosol and determine if the pattern found using
HeLa cells remained consistent. In situ calibrations were carried out using HeLa cells,
African green monkey kidney fibroblast (Cos-7) cells, human embryonic kidney 293
(HEK 293) cells, and rat pancreatic insulin secreting β (INS-1) cells. The GZnP2 sensor
fluorescence intensity was normalized to the mCherry intensity, the normalized signal
was then used to calculate the labile zinc concentrations in each subcellular compartment
(mitochondrial matrix and IMS). In all four cell types evaluated the mitochondrial matrix
labile zinc concentration was estimated to be less than 1 pM as shown in Figure 18A,
Figure 19 & Table 10. These results support the mitochondrial matrix does not store zinc
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and contains minimal labile zinc, at substantially lower concentrations than the cytosol.
Provided that many mitochondrial matrix enzymes such as glutamate dehydrogenase, αketoglutarate dehydrogenase, and aconitase can be inhibited by labile zinc, low zinc
concentrations in the mitochondria will prevent these important enzymes from being
deactivated and ensure efficient energy production required for proper mitochondrial
function[42, 156, 158] [45, 184] [185]. High zinc concentrations in the mitochondria
would be deleterious to cells by decreasing or halting production of ATP [44] further
supporting the low concentrations of zinc observed in the matrix of the mitochondria. It
appears that zinc does not infiltrate the mitochondrial matrix to decrease the
mitochondrial function potentially leading to cell apoptosis.

Figure 18: Comparison of Labile Zinc Concentrations among Four Cell Types within
the Mitochondrial Matrix, IMS and Cytosol. (a) In the mitochondrial matrix, the highest
zinc concentrations were in HEK293 cells and the lowest zinc concentrations were in
Cos-7 cells. All were less than 1 pM. (b)The labile zinc concentrations in IMS were
calculated to be between 60-100 pM. The only difference observed for IMS zinc
concentrations were between INS-1 cells having higher IMS zinc than Cos-7 cells.
(c)There was no difference among different cell types for cytosolic concentration of
labile zinc. The error bars indicate SEM (standard error of the mean). * indicates a p <
0.05 and ** indicates p < 0.01, p values were determined using the t-test with unpaired
data and unequal variance. Error bars are standard error of mean.
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Figure 19: Representative Calibration Curve for Mitochondrial Matrix of Four Cell
Types. HEK293 (a) cells showed response to TPEN while the other cell three types Cos-7
(b), HeLa (c), and INS-1 (d) cells showed no response to TPEN.
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Table 10: Measurement of Zinc Concentrations in the Mitochondrial Matrix, IMS and
Cytosol Among Various Cell Lines. The mean and standard error of mean were reported.
Different letters indicate significant differences across data sets as determined using the ttest.
Concentration (pM)
Cell Type

Matrix

IMS

Cytosol

a

Cos-7

0.0010 ± 0.00055 (n =
5)
65 ± 4.3d (n = 7)

HEK

0.50 ± 0.21c (n = 21)

100 ± 16de (n = 11) 120 ± 28de (n = 11)

HeLa

0.0070 ± 0.0025b (n = 7)

89 ± 12de (n = 11)

76 ± 9.6de (n = 16)

INS-1

0.0040 ± 0.0029b (n = 8)

99 ± 15e (n = 21)

94 ± 16de (n = 26)

79 ± 8.1de (n = 12)

The zinc concentration in the IMS and the cytosol were the same across all four cell
types tested. The zinc concentration in the cytosol was between 75-115 pM and the zinc
concentration in the IMS was between 65-100 pM see Figure 18B & C and Table 10. The
homogeneity between the IMS and the cytosol of all four cell types suggests the outer
mitochondrial membrane is permeable to zinc allowing passive diffusion of zinc between
the IMS and cytosol likely through the VDAC protein.
We then compared the zinc concentration in the mitochondrial matrix between the
four cell types analyzed. Interestingly a high heterogeneity was found in the zinc
concentration in the mitochondrial matrix with the highest zinc concentration being in
HEK293 cells (0.5 pM) and the lowest in the Cos-7 cells (0.001 pM) also refer to Table
10 and Figure 18A. There was almost no heterogeneity between the IMS and cytosol zinc
concentration of all the four cell types tested see Figure 18B & C & Table 10. The lack of
heterogeneity is possibly due to the cytosol and IMS containing high capacity zinc
buffering proteins such as metallothionien and glutathione[110, 174, 186, 187], which
maintain static zinc concentrations in both compartments (IMS & matrix) while the
mitochondrial matrix lacks any evidence of containing such zinc buffering proteins. This
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lack of zinc buffering proteins may also be the reason for the cell variability in
mitochondrial matrix zinc concentrations. The mitochondria may lack these zinc
buffering proteins since zinc is prevented from entering the mitochondrial matrix
therefore there would be no need to have such zinc buffering proteins. All zinc
concentrations were calculated using an adjusted pH for the mitochondrial matrix which
is typically around 8 instead of pH 7.4 for the cytosol and the IMS.
To address the other question proposed at the beginning of this chapter whether the
mitochondria is a sink for labile zinc we analyzed zinc transport in the matrix, IMS, and
cytosol of INS-1 pancreatic β cells. The mitochondria has been reported to be a location
for zinc sequestration within cells under stress [154, 163]. One example is the
mitochondria have been reported to uptake labile zinc following ischemia/reperfusion in
neurons [154, 157]. We will evaluate this further to see if the mitochondria can perform
the function of a sink to sequester excess labile zinc and lower cytosolic labile zinc
concentrations. INS-1 pancreatic β cells will be used to observe the zinc dynamics after a
large influx of zinc. Previous studies have shown that high labile zinc can flux into
pancreatic β cells through voltage dependent calcium channels when the cells are
depolarized [54, 188]. Utilizing this method we induced zinc influx into pancreatic β cells
and observed the zinc uptake into the cytosol, IMS, and the mitochondrial matrix. INS-1
pancreatic β cells were depolarized using high concentrations of KCl (100 mM) in the
presence of high extracellular zinc (100 µM), while control cells were only treated with
high extracellular zinc, both were performed in calcium free containing buffer see Figure
20A-B. In the presence of extracellular calcium 100 µM zinc and 100 mM KCl quickly
induced cell death, therefore the concentration of zinc was reduced to 50 µM to prevent
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cell death see Figure 20E. Depolarized zinc influx into the cytosol and mitochondrial
IMS were faster and ended with a higher intracellular zinc concentration when compared
to controls not using depolarization see Figure 20B & C and was similar between the two
subcellular compartments Figure 20F. This further supports that labile zinc can passively
diffuse between the cytosol and the IMS. Although depolarization did not cause more
zinc uptake into the mitochondrial matrix which was independent of extracellular calcium
(Figure 20A & E, & 21). These results show that higher cytosolic zinc did not induce
higher zinc flux into the mitochondrial matrix only into the IMS (Figure 20B & C).
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Figure 20: Observing Zinc Uptake in the Mitochondrial Matrix, IMS, and Cytosol of
INS-1 Cells with and without Depolarization. 100 mM KCl was used to induce
depolarization. (A-C) The zinc uptake in the mitochondrial matrix (A), IMS (B) and
cytosol (C) in INS-1 cells treated with 100 µM ZnCl2 with or without 100 mM KCl in the
absence of extracellular calcium. Higher zinc was taken into the cytosol and IMS when
depolarized, but not the matrix. (D) The calcium uptake in the cytosol and mitochondrial
matrix recorded using GGECO1 and mito-RGECO1 in INS-1 cells treated with 100 mM
KCl. The mitochondria rapidly sequestered a substantial amount of calcium while the
cytosolic calcium increased and dropped back to baseline quickly. (E) The zinc uptake in
the mitochondrial matrix of INS-1 cells treated with 50 µM ZnCl2 with or without 100
mM KCl in the presence of extracellular calcium. Extracellular calcium did not induce
more zinc uptake into mitochondrial matrix when cells were depolarized. (F) A
comparison of the maximal zinc concentrations in the mitochondrial matrix, IMS, and
cytosol of INS-1 cells incubated with 50 or 100 µM ZnCl2 with or without depolarization.
There is a significant difference between the control and depolarized cells for zinc
concentrations in the cytosol and IMS, but no statistically significant difference was
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recorded in the mitochondrial matrix between the control and the depolarized cells with
and without extracellular calcium. (G) and (H) show that there is no difference between
addition of RU360 the active inhibitory component of ruthenium red on the uptake of
zinc into the mitochondria. *** signifies p < 0.001.

Figure 21: Zinc uptake in the mitochondrial matrix and IMS after depolarization.
INS-1 β-cells were depolarized using a high potassium solution (100 mM) in
combination with 100 µM ZnCl2 to allow the influx of zinc ions into the cells. (A &
B)The zinc concentrations in the mitochondrial matrix were monitored by the sensor
mito-mCherry-GZnP2 before (A) and after (B) depolarizaiton with 100 µM ZnCl2 . (C &
D) The zinc concentrations in the mitochondrial IMS were monitored by the sensor
SMAC-mCherry-GZnP2 before (C) and after (D) depolarizaiton with 100 µM ZnCl2. The
experiments were performed in HHBSS buffer without phosphate or calcium at pH = 7.4.
When INS-1 cells are depolarized, calcium will influx into the cytosol of the cells
activating the MCU with a high calcium concentration causing the cytosolic calcium to
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then flux into the mitochondrial matrix via the MCU [180]. Consistent with previous
studies the cytosolic calcium initially increased dramatically following depolarization
although the calcium concentration rapidly dropped off shortly after, while the
mitochondrial matrix calcium increased rapidly then plateaued at a high concentration
(Figure 20D). This confirms that the mitochondria muffles the excess calcium by acting
as a storage site to sequester excess calcium when the cytosolic calcium concentrations
are increased too high. Unlike calcium, zinc was not sequestered into the mitochondrial
matrix after depolarization and the cytosolic zinc concentration was not buffered
immediately after being increased (Figure 20A-C). This was true in the presence of
calcium which should activate the MCU allowing zinc to be taken into the mitochondria
(Figure 20E). This conflicts with previous studies results claiming the MCU can mediate
mitochondrial zinc uptake. We believe the difference in the results was a result of
previous studies being performed on isolated mitochondria while these studies were
performed using native mitochondria. To further support this finding we observed the
zinc uptake into the mitochondrial matrix under high zinc conditions with and without the
MCU inhibitor RU360. In the presence of RU360 we observed a slightly faster uptake of
zinc into the mitochondria contrary to what was expected using an inhibitor of the MCU,
Figure 20G. Although under depolarization conditions there was no change in the zinc
uptake into the mitochondrial matrix. Given that all previous evidence supporting the
permeability of MCU to zinc were collected from isolated mitochondria [177, 178], the
metal selectivity of MCU can differ from an in situ environment. The data supports
another mechanism for zinc transport to the mitochondrial matrix other than the MCU.
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Further testing needs to be performed to clarify the roles of the MCU in regulating
mitochondrial zinc in living cells.
Both the low mitochondrial zinc under resting conditions and the finding of zinc not
being stored in the mitochondria supports our logic before performing the experiments.
Logically the cell would store zinc in a location where the zinc would not disturb any
cellular process hence performing the function of a cellular buffer. If the zinc was stored
in a compartment such as the mitochondria then it would defeat the purpose of a storage
site for excess zinc. This is what led to our investigation into the question if the
mitochondria was performing the function of a zinc sink since the mitochondria is highly
affected in a negative manner by zinc that has the potential to ultimately cause cell
apoptosis is this really a storage site for excess zinc? Our results show the mitochondria
is not a storage site for excess zinc which coincides with our logic dictating that the
mitochondria should not be a sink of zinc due to mitochondrial enzymes being inhibited
decreasing the energetic output of the cell while also releasing apoptotic factors into the
cell. This makes the mitochondria one of the last places the cell would want to store
excess zinc in, if there is a scenario where high zinc permeates the cell.
One other aspect tested during this chapter was the effect of mild redox stress
inducing cellular zinc dynamics. After we measured the zinc distributions in the
mitochondrial matrix, IMS, and cytosol in cells at resting state, we then investigated zinc
oscillation in these compartments when cells were exposed to redox stress. A few studies
have shown that mitochondrial matrix zinc was increased by redox stress either induced
by high glucose or incorporation of 50 µM hydrogen peroxide [165, 189]. Here we
introduced mild oxidative stress in HeLa cells using low concentrations of hydrogen
105

peroxide (100 µM). Hydrogen peroxide is a natural by product from oxidative
phosphorylation occurring within the mitochondria. Using a hydrogen peroxide
fluorescent sensor (Hyper-Red), we showed that 100 µM hydrogen peroxide simulates
oxidative stress within the cell (Figure 22C). The hydrogen peroxide concentration in the
cell can reach the milimolar range as estimated from the Km of catalase ~1.2 mM [190]
and ~45 µM for peroxidases indicating that 100 µM is within physiological conditions. In
addition, we found that 100 µM hydrogen peroxide did not alter mitochondrial membrane
potential by measuring mitochondria membrane potential using the mitochondrial dye
TMRE (Figure 22D), further confirming that mitochondria membrane potential was not
dissipated with brief exposure to mild redox. Because the cysteine residues in the zinc
binding motif of GZnP2 sensor could be oxidized by hydrogen peroxide, we examined
how sensor fluorescence was affected by different concentrations of hydrogen peroxide
(Figure 16). No significant difference in sensor fluorescence was detected in purified
GZnP2 protein exposed to 0-2 mM hydrogen peroxide concentrations (Figure 16),
suggesting that GZnP2 was not affected by low concentrations of hydrogen peroxide.
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Figure 22: Hydrogen Peroxide Zinc Increase Detected Using Other FP & Hydrogen
Peroxide Permeates Cell. (A) Mito-ZAPCY1 a mitochondrial matrix zinc FRET sensor
detects there is an increase in labile zinc upon addition of 100 µM H2O2. (B) MitoZAPCV5 is another mitochondrial zinc FRET sensor also detects an increase in
mitochondrial matrix labile zinc upon addition of 100 µM H2O2. (C) The hydrogen
peroxide sensor PC1-Hyper-Red detected an increase in the cytosolic hydrogen peroxide
when 100 µM hydrogen peroxide was added to the extracellular milieu. (D)
Mitochondrial membrane potential after hydrogen peroxide addition. After dying the
cells with TMRM results show no change in the mitochondrial membrane potential after
the addition of the 100 µM hydrogen peroxide. The different colors correspond to
different cells imaged in the same imaging experiment
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Figure 23: Mild redox by hydrogen peroxide induced zinc dynamics in the
mitochondrial matrix, IMS, and cytosol. The changes in zinc after HeLa cells were
treated with 100 µM hydrogen peroxide in different subcellular locations: (A) the
mitochondrial matrix using mito-mCherry-GZnP2 (B) the IMS using SMAC-mCherryGZnP2 and (C) the cytosol using mCherry-GZnp2.
We recorded zinc dynamics in HeLa cells treated with 100 µM hydrogen peroxide.
Consistent with previous studies using high concentrations of hydrogen peroxide, we
found that mild redox also increased the labile zinc in the mitochondrial matrix (Figure
23A). The same results were found using the FRET based mitochondrial zinc sensors
mito-ZAPCV5 & mito-ZapCY1 (Figure 22A & B). Surprisingly, we found that labile
zinc within the IMS and the cytosol were reduced with treatment of low hydrogen
peroxide (Figure 23B & C), suggesting that zinc might be transported from the cytosol
and IMS into mitochondrial matrix under mild redox. The transporter or channel proteins
localized in mitochondrial inner-membrane might mediate such zinc communications.
For example, studies have shown the TRPM2 channels can be activated by hydrogen
peroxide and induce more zinc uptake into the mitochondrial matrix [165]. The increased
mitochondrial zinc under mild redox might modify the activities of mitochondrial
enzymes as mentioned above through enzyme inhibition and hence alter mitochondrial
function. The GZnP sensor fluorescence can be perturbed by changes in pH as mentioned
in chapter 1 because of the chromophore protonation at low pH [78]. With 100 µM
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hydrogen peroxide, the cellular pH was altered (Figure 24), confirming that any GZnP2
signals induced by hydrogen peroxide were likely a result of pH changes.
What we learned while investigating the redox stress relationship with zinc was to
check all possible artifacts prior to continuing with an investigation. We had solid logic
for what we thought were observed changes in zinc concentrations although these
changes were artifacts of the pH changing altering the binding affinity of our GZnP
sensor. When the pH increased after the addition of hydrogen peroxide the sensors
binding affinity for zinc increases as observed in the difference of dissociation constants
between pH 7.4 & 8 for the cytosol and mitochondrial matrix increasing the brightness of
the sensor. This increase in the binding affinity (decrease in dissociation constant) makes
the sensor bind better to zinc making the sensor brighter despite there not being any more
zinc present in the environment. From this we learned that obvious pitfalls of experiments
such as pH with genetically encoded sensors must be evaluated prior to performing so
many experiments.
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Figure 24: PH Changes in the Mitochondrial Matrix Following H2O2 Addition. The
sensor mito-PHuji was transfected into HeLa cells and then treated with hydrogen
peroxide. The hydrogen peroxide caused an increase in the pH of the mitochondrial
matrix.
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3.4 CONCLUSION
In this chapter we constructed three probes for recording zinc concentrations and
dynamics within the mitochondrial matrix, IMS, and cytosol. We developed the first zinc
sensor targeted to the mitochondrial IMS, providing the first direct evidence of zinc
concentrations & dynamics in this location. By constructing the different subcellularly
targeted sensors from the same sensor we avoided variations in the biophysical features if
different sensors were used providing a better platform to compare zinc concentrations
among the different subcellular compartments.
We were able to quantify the labile zinc concentrations occurring in the mitochondrial
matrix, IMS, and cytosol of the cells at resting conditions as well as observe the zinc
dynamics when the cells were exposed to excess zinc. First we found that the zinc
concentration in the cytosol and the mitochondrial IMS are the same across all four cell
types tested. This same finding was confirmed when depolarizing INS-1 pancreatic β
cells with extracellular zinc, the zinc influx was the same between the cytosol and the
mitochondrial IMS. We believe the non-selective VDAC channels located on the outer
membrane of the mitochondrial membrane facilitate the diffusion of zinc between the
cytosol and the IMS. Second we found the mitochondrial matrix zinc concentrations are
heterogeneous between the four different cell types tested. Despite this heterogeneity the
zinc concentration in the mitochondrial matrix remains well below 1 pM in all cell types.
A 1 pM concentration when taking into account the volume of mitochondria equates to 01 free zinc ions being present in the mitochondrial matrix. This difference in the zinc
concentrations may be a result of the mitochondrial matrix lacking zinc buffering proteins
that are present in the cytosol and the IMS of the cell. These proteins are not present in
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the matrix of the mitochondria likely because no zinc is brought into the mitochondria.
Lastly we determined that zinc does not sequester into the mitochondrial matrix faster or
in higher concentrations when the cytosolic zinc is increased. This data suggests that the
mitochondrial IMS not the matrix may sequester excess zinc. Although these experiments
were performed over 30 minutes meaning over longer periods of time the mitochondrial
matrix could act as a potential site for the sequestration of excess zinc. Finally we found
that hydrogen peroxide may cause zinc dynamics to be altered but due to the hydrogen
peroxide causing the pH of the cell to change our genetically encoded sensors could not
reliably confirm if there was a change in the labile zinc concentrations. For potential
future experiments calibration of the mCherry-GZnP2 sensors could be performed for pH
changes as done for GZnP3 in chapter 2.
In conclusion we developed new sensors that can monitor zinc distributions in the
mitochondrial matrix, IMS, and cytosol, providing the first direct measurement of zinc
concentrations in the mitochondrial IMS showing the benefits of these new probes for
recording zinc concentrations and dynamics. Importantly we established the
mitochondrial matrix and IMS perform different roles in regulating cellular zinc
homeostasis. These new zinc sensors will provide scientists with tools to evaluate zinc
concentrations in these two distinct regions of the mitochondria despite the resolution
limit of light microscopy being unable to distinguish between the two subcellular
locations.
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CHAPTER FOUR: ZINC’S AFFECT ON MICROTUBULE-BASED
CELLULAR TRAFFICKING
4.1 INTRODUCTION
All cells are surrounded by a lipid membrane that separates the interior of the cell
from the environment the cell survives in. Eukaryotic cells expanded on this concept to
create lipid membranes and subcellular compartments within the cell. This idea allowed
for the expansion from single celled organisms to vast multicellular organisms arguably
one of the most advantageous evolutions of a cell. One requirement for a
multicompartmental cell is the cell must have the ability to communicate between the
different compartments of the cell. One of the main methods for communication is
through vesicular transport, endocytic, and exocytic transport all of which rely on the
cytoskeletal network. These pathways govern protein transport, protein modification,
disposal of waste, distribution of necessary biological materials, communication with the
cell environment, etc. [191]. All of these processes have intricate relationships with each
other for example the endocytic and exocytic pathways must regulate each other to
maintain compartmental sizes after fusion events. These relationships rely on
sophisticated machinery and communication between different compartments of the cell.
The cytoskeletal network is the key player in communication and transport within the
cell. The cytoskeletal network relies on three separate components for tracks within the
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cell; microtubules, intermediate filaments, and actin (microfilaments). Microtubules rely
on the motor proteins from the kinesin and dynein family to transport cargo such as
organelles long distances within the cell [192]. The intermediate filaments are not known
to transport cargo within the cell rather they perform the function of structural support for
the cell [193]. Actin is responsible for cellular trafficking small distances, structural
support, and cell movement with the motor proteins in the myosin class utilizing these
filaments [194]. The entirety of these processes is not well understood offering
opportunities to discoveries of how the cell regulates cellular transport. The long distance
cellular trafficking is the focus of this chapter.
One piece of technology that has advanced the progress of cellular trafficking
immensely is live cell microscopy. This instrument above all others has advanced our
knowledge of trafficking because of the inherent nature of trafficking involving
movement and live cell imaging being able to track this movement using time lapse
videos. Although live cell samples can be converted to non-living samples to
accommodate static measurements the more the sample digresses from its native state the
higher chance of introducing artifacts. One of the principal questions pertaining to
cellular trafficking is how the cell coordinates the movement of all intracellular cargos.
One impressive example of the importance of cellular transport is the construction
and maintenance of a complex functioning neurons. Neurons contain active synapses
requiring basic building materials such as lipids, proteins, carbohydrates, mitochondria,
synaptic vesicles, etc. that must be sorted to locations sometimes spanning meters in
length [195, 196]. It is common knowledge that intracellular transport in neurons is
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performed by motor proteins that either travel along microtubules or actin filaments.
Actin filaments are responsible for short range movement of cargo carried by motor
proteins from the myosin family [197, 198]. Microtubules are commonly used for long
range trafficking to axon terminals or from terminals to the soma of the neurons.
Microtubules rely on two classes of motor proteins, kinesin motors traveling in the
anterograde or “plus” direction of the microtubule and the cytoplasmic dynein motor
protein which travels in the retrograde or “minus” direction of the microtubules [199201]. Both the kinesin and dynein proteins are ATPase proteins require the hydrolysis of
ATP for binding to and directed movement on microtubules.
Human kinesin is a superfamily of 45 motor proteins broken down into 14
subfamilies (named kinesin1-14) based on structure [199]. The structure of kinesin is a
dimer of kinesin heavy chain (KHC) subunits and a dimer of kinesin light chain (KLC)
subunits[202]. This structure can vary across the 14 subfamilies of kinesin although this
is the prototypical structure of kinesin-1. The KHC subunits are the motors and
microtubule binding domain for the protein which are conserved across all the
subfamilies of kinesin proteins. The microtubule binding domain (MTBD) and the ATP
binding domain both are on KHC and completely conserved for all the kinesin motor
proteins. The KLC bind cargos for transport. KHC is typically ~60 kDa and KLC is ~32
kDa. The kinesin motor proteins affinity for microtubules is highest when bound to ATP.
Almost the entirety of kinesin walk in the anterograde direction (+) although a select few
can also walk in the retrograde direction (-), for this work we will monitor only kinesin
that travel in the anterograde direction.
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The dynein motor proteins are responsible for retrograde movement along
microtubules typically originating at the microtubule organizing center at the center (near
the nucleus) of the cell. When scientists discovered dynein is a member of the AAA+
protein superfamily [203] it was surprising since AAA+ proteins typically function by
unfolding proteins not behaving as a molecular motor. Another surprise was dynein’s
structure and function were both expected to be similar to kinesin although both are
completely different, kinesin retains more similarity to myosin motor proteins despite
moving on different tracks (actin vs microtubules) [204]. Dynein’s structure contains six
AAA+ rings forming a bound hexameric ring structure referred to as dynein heavy chain
because of its size ~500 kDa. This heavy chain is the motor of the protein and is linked to
dynein intermediate light chain, dynein intermediate chain, dynein light chain which help
the motor bind cargo. On the other end of the heavy chain is the stalk with the
microtubule binding domain. Cytoplasmic dynein is a colossal 1.5 MDa dimer of dimers
making this motor not only significantly larger than kinesin but so large it is only half the
size of the largest protein ever found titin (~3 MDa) [205]. Cytoplasmic dynein is
responsible for almost all retrograde transport in neurons and most cells. Cytoplasmic
dynein has a high affinity for microtubules when unbound to ATP [206] opposite
kinesins binding affinity. Cytoplasmic dynein is the only form of dynein actively
performing retrograde movement in the cell which varies dramatically from the 45
different kinesin proteins responsible for anterograde movement.
From the brief description of the two microtubule-based motor proteins it is obvious
how vastly different these two classes of proteins are both in their structure and function
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despite employing the same microtubule tracks. Both of these proteins have different
origins that coincided to form motor proteins using the same tracks for traveling,
microtubules.
Microtubules are hollow tubes approximately 25 nm in diameter with the walls of the
tube formed from αβ tubulin dimers stacked head to tail to form 13 protofilaments
running parallel along the wall of the microtubule giving polarity to the tube [207, 208].
This polarity is coined the plus end where β tubulin terminates and minus end where α
tubulin initiates the microtubule. Microtubules originate from microtubule organizing
centers (MTOC) and extend outward to the periphery of the cell leading with the plus end
of the microtubule and the minus end remaining at the MTOC. The α and β tubulins are
strongly conserved proteins across all eukaryotic cells maintaining 60% sequence
conservation [207]. These α and β tubulin monomers are relatively small ~55 kDa in size.
Both monomers of tubulin can bind guanosine triphosphate (GTP) although the β tubulin
is also a GTPase with the capacity to hydrolyze GTP to GDP. The hydrolysis of GTP to
GDP will create subtle conformational changes in the tubulin that will destabilize the
microtubule if hydrolysis occurs at the plus end of the microtubule. To stabilize a
microtubule the plus end (β tubulin) needs to remain bound to GTP while the β tubulin
monomers following the cap are mostly GDP bound [209]. Microtubules have a
conserved binding site for both kinesin motor proteins and cytoplasmic dynein along the
H11-12 C-terminal loop of α tubulin (AA 409-424) [210]. This region is rich in
negatively charged amino acids at physiological pH (aspartate and glutamate) which
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electrostatically attract the positive amino acids of the MTBD on the motor proteins
[211].
Although there are a plethora of motor proteins available for the cells to use for
transport of cargo the diversity of motor proteins alone cannot explain the precise timing,
specificity, and directionality of cargo delivery. Regulation of microtubule-based
transport has been shown through processes such as activation and deactivation of motor
proteins, microtubule associated proteins (MAP), and microtubule post translational
modifications (MPTM) [212-214]. All of these processes still do not account for the
precise spatiotemporal control cells maintain over microtubule-based transport. Further
investigation into how microtubule-based transport is regulated spatially and temporally
provides an exciting emerging field for scientists.
Proper cellular trafficking is especially important in neurons where there are extreme
lengths the cell must maintain sometimes as long as a meter in length. Neurons are
particularly susceptible to defects in cellular trafficking which result in neurodegenerative
or neurological disorders [215]. Examples include axonal pathologies that impede
cellular trafficking such as Huntington’s, Parkinson’s & Alzheimer’s Disease ultimately
leading to neuronal death [216]. It is unknown if the accumulations that impede cellular
trafficking in these pathologies are caused by issues with cellular trafficking or if the
cellular trafficking defects are a result of the accumulation in these diseases. In either
scenario cellular trafficking is vitally important to maintain a functional cell. Mutations
have been found in some of these diseases to the α-β tubulin dimers which may impact
cellular trafficking of neurons contributing or causing the eventual cell death [217-219].
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Deciphering the methods a cell utilizes to control microtubule-based trafficking in cells
could potentially offer a variety of therapies for pathologies affecting cellular trafficking.
In this work we used a variety of methods and techniques to show that increased
labile zinc inhibits microtubule-based motility. The movements of a variety of organelles
within cells were shown to be inhibited by increased zinc. We narrowed down the
location of the inhibition by learning both anterograde and retrograde transports are
inhibited when labile zinc was increased in primary rat hippocampal neurons. Finally the
location where zinc inhibits cellular trafficking was established on microtubules. Zinc
interacts with the alpha tubulin monomer by coordinating with two amino acid residues
H192 and H283. H192 and H283 were found to be imperative for the coordination of zinc
at this site [220]. The coordination of zinc using these two amino acids is believed to alter
the conformation of the alpha tubulin acting as an allosteric inhibitor of motor protein
landing and walking on microtubules.
4.2 METHODS
SENSOR PLASMID CONSTRUCTIONS
To construct mito-mCherry, four repeats of the coding sequence for the first 29 amino
acids of the human cytochrome c oxidase subunit 8a (mitochondrial precursor; accession
number NP_004065) was utilized for mitochondrial matrix targeting and incorporated
into pcDNA3.1 vector using HindIII. The mCherry fragment was inserted between
BamHI and EcoRI sites.
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To construct the LAMP1-mCherry, mCherry was subcloned into LAMP1-GZnP3
using BamH1 for the forward restriction site and Xho1for the reverse restriction site.
GZnP3 was cut out of the LAMP1-GZnP3 and mCherry was inserted into the vector.
pWBC was a gift from Ron Vale (Addgene plasmid # 15239). The pWBC C terminus
stop codon was removed through PCR. mCherry was cut out of TRPML1-mCherry with
EcoR1 forward and Xho1 reverse restriction sites and ligated into pcDNA3.1. The
mCherry-pcDNA3.1 and the pWBC plasmids were digested with EcoR1 and BamH1,
then the KIF5A plasmid was ligated into the mCherry in pcDNA3.1.
EGFP-IC2-FL was a gift from Trina Schroer (Addgene plasmid # 51409). The
mCherry was cloned with an AgeI forward restriction site and a BghlII reverse restriction
site. The mCherry product and the eGFP-IC2-FL were digested with AgeI and BghlII
then the mCherry was ligated into the IC2-Fl plasmid.
TRANSFECTION NON-NEURONAL CELLS
HeLa cell transfection was performed when the cells were approximately 40-50%
confluent. For each transfection reaction in HeLa cells, 3 µl of PEI transfection reagent
and 1.25 µg of the sensor DNA were mixed in 250 µl OPTI-MEM. The mixture was
incubated for a minimum of 25 minutes at room temperature before direct addition to one
imaging dish containing the cells. Sensor can be expressed as little as 12 hours posttransfection. Imaging was performed 48-72 hours post transfection.

120

PRIMARY RAT HIPPOCAMPAL NEURON CULTURE AND
TRANSFECTION
Primary hippocampal neurons were prepared from rat embryos at embryonic day 18
(E18) by graduate students Chen Zhang and Taylor Minckley. Neurons were transfected
between DIV 6-13, using the Lipofectamine 3000 transfection kit (Thermofisher) in 500
µL Opti-MEM. When transfected too early the neurons do not have synapses and after
DIV13 the transfection efficiency is too low. The reagent-DNA mixture was incubated
for a minimum of 25 minutes at room temperature before direct addition to the neuron
imaging dishes. Before adding reagent-DNA, 1 mL media was removed from each
imaging dish and syringe filtered (0.22 µm) with an equal volume of fresh neuron culture
media (50:50 media). After incubation at 37 ˚C for 4 hours, neurons were washed three
times with 1 mL prewarmed neuron culture media. Then, 2 mL of the 50:50 media was
added to the neuron imaging dishes and they were incubated at 37 ˚C until imaging.
LIVE CELL MICROSCOPY
Cells were imaged 48 hours post-transfection, and cells were washed three times with
the indicated imaging buffer immediately before imaging. All imaging was performed on
an inverted Nikon/Solamere CSUX1 spinning disc confocal microscope with a 40x (for
time-lapse) or 60x (for colocalization) 1.4 NA oil immersion objective. Data was
collected using MicroManager software and analyzed with Fiji (ImageJ).
All experiments were performed at 37 ˚C except for the microtubule motility
experiments. We used a Live cell chamber by Pathology Devices. Imaging for HeLa cells
(VAMP2, LAMP1, Rab7, and mito tagged organelles) was performed using 20 second
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acquisitions. 10 second image acquisitions were performed for the microtubule motility
imaging experiments. The microscope settings for 488 nm were 100 ms exposure times &
10% laser power; 561 nm were 50 ms exposure times & 5% laser power. All drug
additions were performed manually by pipetting in the drugs and mixing the imaging
solution by pipetting up and down three times. All the buffers were incubated in a 37 ˚C
bead bath prior to additions to the imaging chamber. The only buffer used was HHBSS
pH 7.4, with or without calcium and magnesium.
Imaging for zinc and pyrithione treatment on HeLa cells motility experiments were
performed with a 5 minute baseline then a 5 minute treatment with 2.5 µM pyrithione and
20 µM ZnCl2 followed by a wash out and treatment with 100 µM TPEN for 10 minutes.
High extracellular zinc incubation (100 or 200 µM ZnCl2) were performed with a 5
minute baseline then a 30 minute incubation with high zinc then a wash out and addition
of 100 µM TPEN. Controls for HeLa cells using pyrithione were treated for 5 minutes
with 2.5 µM pyrithione and 10 minutes with 100 µM TPEN.
Imaging for neurons was performed at 37 ˚C for all experiments presented. The
microscope settings for 561 nm were 100 ms exposure times & 5% laser power. Motility
experiments performed on mitochondria, endosomes, VAMP2 vesicles, and lysosomes
had acquisition times of 2.5 seconds and increased to 1.5 seconds for kinesin and dynein
experiments. Motility experiments followed the same time lengths used for HeLa cells
with 10 minute incubations with 100 µM TPEN, 5 minute incubations with 2.5 µM
pyrithione and 20 µM ZnCl2, 30 minute incubations with high extracellular zinc or
depolarization with high zinc (high K+), and 10 minute baselines were used. One
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difference was using glutamate and glycine to activate channels permeable to zinc only 5
minute incubation was used. When looking for neurons only healthy neurons were
chosen where there were minimal or no clusters of fluorophores on the axon and there
was high motility at baseline. If little to no motility was present on the axon we found the
cell was not healthy and not a good representation of the cellular motility. The cell soma
was observed prior to imaging any of the axons to ensure the cell looked healthy.
IMAGING DATA ANALYSIS
Neurons motility: Refer to Appendix B for image analysis for motility using the
ImageJ plugin “Kymolyzer”.
HeLa cells mitochondrial motility: Refer to Appendix A for image analysis for
motility using the ImageJ plugin “Total_Motility”.
HeLa cells lysosome, endosome, and VAMP2 motility: Refer to Appendix A for image
analysis for motility using the ImageJ plugin “Particle Tracker 2D/3D”.
COMPONENT DETERMINATION OF MITOCHONDRIAL SPEEDS
The data set was analyzed using the program Kymolyzer described in Appendix B.
Once the speeds were determined for each treatment (baseline, MLSA-1, and TPA) the
files were run through the R Version 3.6.3. Refer to Appendix C for analysis using the
computer software R.
DETERMINE THE DOSE-RESPONSE OF INHIBITION OF ZINC ON
ORGANELLAR MOTILITY
HeLa cells were cotransfected with GZnP2, previously developed in the Qin lab[84],
and one of the following plasmids mCherry-Rab7, VAMP2-mCherry, or mito-mCherry.
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The HeLa cells were imaged with 10 second acquisition times with the following
microscope conditions: 488 nm laser 10 mW power, 100 ms exposure time; 561 nm laser
5 mW power, 50 ms exposure time. The cells were imaged in phosphate free HHBSS pH
7.4 with calcium and magnesium for a 600 second baseline, 500 second treatment with
100 µM TPEN, washed out, 1000 second treatment of 20 µM zinc chloride and 2.5 µM
pyrithione. Imaging analysis was performed by Fiji (Image J). The image stacks of
GZnP2 and the mCherry tagged sensor were split. Every image in an image stack was
aligned to account for drift using the Stackreg plugin in Fiji with the Rigid Body
transformation. The zinc concentrations were determined using the equation as
previously described[84]. For the quantitative analysis of zinc, images of both GZnP2
were background corrected by generating a region of interest (ROI) on a blank area of the
coverslip and subtracting the fluorescence intensity of each channel, e.g. IGZnP2(cell) –
IGZnP2(background). The background corrected GZnP2 images are used to calculate the
normalization intensity. The calibration of the sensors was plotted in the KaleidaGraph
program. The baseline GZnP2 intensity (I), minimal intensity achieved with TPEN (Imin),
and maximal intensity (Imax) obtained with zinc saturation were used for cytosolic zinc
quantification using the equation [Zn2+] = Kd [(R – Rmin) / (Rmax – R)]1/n (Kd & n were
characterized previously[84]). All in situ sensor calibration were performed at 37 ˚C.
Particle motility for all measurements came from the Total_Motility program described
under Data Analysis HeLa cells mitochondrial motility. The zinc concentrations were
plotted against the reduction in motility normalized to baseline motility with the
respective zinc concentrations. The zinc concentrations varied from less than 0.1
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picomolar to more than 8 micromolar. The IC-50 was determined from the curve using
the binding curve equation (m1*m0m3)/(m2^m3+m0^m3)+m4 [78, 84].
ATP END POINT IN VITRO ASSAY
The Cytoskeleton Inc. Kinesin ATPase End-Point Biochem kit was used for the
analysis of kinesin function. The kinesin function was measured indirectly through the
hydrolysis of ATP to ADP and Pi measuring the amount of Pi produced. This design was
based off the malachite and ammonia molybdate forming a complex when bound to Pi
and absorbing at 640 nm compared to 446 nm when in the apo state, a procedure
originally described by Hess[221, 222] and further improved by Lanzetta [223].
Cytoskeleton Inc. designed a kit using the improved method designed by Lanzetta to
detect the inorganic phosphate.
The first step in the procedure is to create a standard curve to be able to calculate the
phosphate produced through motor protein functioning by only measuring the
absorbance. A known amount of phosphate is added to wells (0-2 nM) and reacted under
the same conditions described for the motor protein function and the absorbance
measured at 650 nm. These absorbance values will correlate to a known phosphate
concentration creating a linear relationship allowing any concentration within these
values to be determined.
Kinesin buffer (100 mM PIPES, 2 mM MgCl2, pH 6.8) is supplemented with 20 µM
Taxol to stabilize microtubules. Add stabilized microtubules to kinesin buffer
supplemented with taxol to a concentration of 0.2 mg/ml. The microtubules are stable at
room temperature but will disassemble if placed on ice, keep at room temperature for up
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to a day. KIF5A kinesin motor protein is diluted in kinesin reaction buffer to a
concentration of 0.08 µg/µl. Experiments can be set up using these solutions using half
area 96-well plates with a total volume of 30 µl. The working concentration of
microtubules is 0.067 mg/ml, kinesin is 0.007 µg/µl. Once all the testing conditions are
set the experiment is started by the addition of ATP (0.3 mM), perform this using a
multichannel pipette. The reaction is allowed to proceed for 5 minutes then stopped
through the addition of 70 µl of Cytophos reagent. The Cytophos reagent is the malachite
green with the ammonia molybdate which if inorganic phosphate is present will absorb at
650 nm. This is allowed to react for 10 minutes then the absorbance is measured at 650
nm.
4.3 RESULTS/DISCUSSION
What initially led our research to focus on the work in this chapter was the
observation that increased zinc inhibited mitochondrial motility in HeLa cells without
distorting the morphology of the mitochondria. We determined this observation was
separate from calcium dependent inhibition of mitochondrial motility for two reasons.
One is calcium induced mitochondrial inhibition changes the morphology of
mitochondria [224], two increased zinc decreased the motility of organelles other than
mitochondria while calcium is specific for mitochondria (Figure 25). Other organelle
motility is not regulated by calcium, calcium dependent microtubule-based motility is
specific to mitochondria. Upon determining our observation was separate from a known
and established calcium dependent regulation of cellular trafficking we drove to
understand zincs role in cellular trafficking.
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Figure 25: Inhibition of Organellar Motility in HeLa Cells. The motility of all the
mitochondria, lysosomes, Endosomes, and VAMP2 vesicles in HeLa cells were analyzed
at baseline, after treatment with 2.5 µm PTO & 20 µm ZnCl2, and after washout and
treatment with 100 µm TPEN. The motility was normalized to baseline (100%) showing
a significant reduction in motility after treatment with zinc and restoration back to
baseline or slightly above baseline motility. The mitochondria were analyzed using an
ImageJ plugin designed to evaluate % change in motion between frames which works
well for oblong shapes. The lysosomes, endosomes, and VAMP2 vesicles were analyzed
using a particle tracker ImageJ plugin which is ideal for circular shaped objects.
Statistical significance was performed using two-way T-Test, * represents p < 0.05; **
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. n=3 for
mitochondria; n=5 for lysosomes; n=6 for endosomes; n=6 for VAMP2 vesicles.
Intracellular zinc was revealed to be both dose and time dependent with respect to
inhibition of organelle motility (Figure 26 & 27 respectively). Higher concentrations of
zinc (zinc and pyrithione) would have a more pronounced inhibition of motility compared
to lower concentrations of zinc (incubating with high zinc alone). A time dependence was
established when discerning zinc inhibition is reversible upon removal of zinc via the
chelator TPEN. This further supports that zinc is the only cation responsible for this
inhibition due to the exceptionally exclusive and high binding affinity of TPEN (kd=6.4 x
10-16) for zinc [225, 226]. We believe the time dependent nature to reverse the zinc
inhibition is a result of the zin ions altering the structure of the α and β tubulin subunits of
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microtubules. Previous studies suggest that zinc binding to the α and β subunits will alter
the quaternary structure of the microtubules more dramatically the longer they are
incubated with the proteins possibly leading to irreversible changes in the protein
structure [227-229]. Therefore the longer the zinc ions are coordinated with the
microtubule the more difficult the changes in protein structure are to revert back to the
native conformation. This happens often during protein folding where a conformation
other than the native conformation for the protein is more stable than the proper native
conformation.

Figure 26: Mitochondria Motility Controls and Other Conditions Tested. The changes
in mitochondrial motility are documented in HeLa cells under various conditions of
showing a dose dependent decrease in mitochondrial motility: Zn-PTO n=3, 200 µM
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ZnCl2 n=3, 100 µM ZnCl2 n=6, 100 µM TPEN n=3, and 2.5 µM PTO n=3. Statistical
significance was performed using ANOVA post hoc Tukey, * represents p < 0.05; **
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001.
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Figure 27: Time-Dependence of Zinc Restoration. The zinc inhibition can be
reversible under high zinc concentrations (micromolar) only under 5 minutes once
incubated with zinc beyond this timeframe the inhibition becomes more permanent.
We confirmed that zinc induced inhibition of organelle motility was not an artifact of
the drugs being used to change the zinc concentrations within the cells (Figure 26). We
observed that the zinc inhibition is separate from calcium induced inhibition of
mitochondria motility although we needed to confirm that another biologically relevant
cation was not responsible for the inhibition of organelle motility.
We expanded our search to determine if another cation could be responsible for the
zinc induced inhibition of cellular trafficking. Magnesium and calcium are both prevalent
free divalent cations in the cell and are at significantly higher concentrations than free
zinc, 10,000 & 1,000 fold higher concentrations respectively [230]. A previous study
reported magnesium in addition to zinc was essential to influence kinesin motility [231].
We performed zinc inhibition experiments using HeLa cells and compared the degree of
inhibition observed in buffers either containing or not magnesium and calcium. We
observed no change in the degree of inhibition for mitochondria, lysosomes, &
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endosomes although we did see a change in the inhibition for VAMP2 vesicles (Figure
28A). VAMP2 is a target for synaptic vesicles and since there are no synaptic vesicles in
HeLa cells it is unknown what the VAMP2 tag localizes to in HeLa cells. This could
explain the discrepancy with this tag. Further testing was performed on kinesin in rat
hippocampal neurons to determine if increased calcium affected their movement. No
observable change was observed in kinesin motility after incubating with ionomycin in
calcium containing imaging buffer (Figure 28B & C). We then evaluated the effect
calcium has on dynein in vitro as opposed to in vivo due to the dynein imaging being
notoriously obscured by background fluorescence.
Additional experiments were performed by permeabilizing the cell membrane using
10 µM digitonin for 3 minutes then washout then addition of 1 µM ZnCl2. During these
experiments we included different concentrations of magnesium in the extracellular
buffer to determine if magnesium was needed to inhibit cellular trafficking with zinc as
was cited by Bohm [232]. Most times the cell became unhealthy following treatment with
the zinc and various concentrations of the magnesium although every time the inhibition
was still observed from zero magnesium to 15 mM magnesium. These were always
performed in zero calcium buffer to avoid cell death. In addition we performed
experiments using a magnesium ionophore 4-bromo-A23187 to load or deplete
magnesium from the cells [233]. To load the cells with magnesium we would incubate
the cells with 2 µM of the ionophore and 10 mM magnesium for 5 minutes then treat with
pyrithione and zinc. To deplete the cells the cells were treated with 2 µM of the
magnesium ionophore and zero magnesium with 50 µM EDTA, this solution was washed
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out after 5 minutes and zinc and pyrithione were added. The cells using the ionophore
became unhealthy regardless of the incubation time frame unless the magnesium
concentration was close to physiological (+/- 1 mM). This prevented analysis although
the motility was completely stopped under all these conditions. The changes in
magnesium concentration appear to be fatal to the cell. With these experiments we were
sure that zinc was the key ion responsible for inducing inhibition of cellular trafficking.

Figure 28: Effects of Other Biologically Relevant Divalent Cations on Cellular
Trafficking. (A) The bar graph shows the decrease in the motility of mitochondria,
lysosomes, endosomes, and VAMP2 vesicles after treatment with high zinc and
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pyrithione either in a buffer with or without calcium and magnesium. The graph was
normalized to baseline motility (100%). The mitochondria were analyzed using an
ImageJ plugin designed to evaluate % change in motion between frames which works
well for oblong shapes. The lysosomes, endosomes, and VAMP2 vesicles were analyzed
using a particle tracker ImageJ plugin which is ideal for circular shaped objects, n=3-7
depending on the organelle. (B) Representative kymograph of kinesin (KIF5A) motility
in primary rat hippocampal neurons at baseline and after treatment with ionomycin
(calcium ionophore), and TPEN. (C) Quantification of the kinesin kymograph in (B) n=4.
Statistical significance was performed using two-way T-Test, * represents p < 0.05; **
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001.
After establishing zinc inhibits cellular trafficking in HeLa cells we wanted to expand
our research to focus on neurons which show large physiological increases in zinc. HeLa
cells will not experience large changes in zinc concentrations hence why we adjusted our
research focus to a cell type that will see large fluctuations in zinc dynamics.
Glutamatergic neurons are the specific type of neuron used for this work because they
have zinc containing vesicles and release these vesicles into the synaptic cleft allowing
large influxes of zinc to nearby neurons [234]. There are many channels that are
permeable to zinc on neurons when activated or opened depending on the method
allowing extracellular zinc to flood into neurons (Figure 29). Voltage gated calcium
channels (VGCC) and GluR2-lacking AMPA (Alpha-amino-3-hydroxy-5-methyl-4isoxazole propionoic acid receptors (AMPARCa-Zn) are the two major channels for zinc to
enter into cells and thus establish a zinc concentration gradient between the extracellular
matrix and the cytosolic gradient of zinc. These two channels along with the N-methyl-Daspartate (NMDA) receptors are prevalent at post-synaptic terminals of neurons. The
reason being is when the glutamate and zinc from the gluzinergic neurons (neurons that
release both zinc and glutamate) releases these two neurotransmitters the zinc is picked
up by the subsequent neuron via one of these three channels. When the zinc contacts the
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AMPAR or VGCC zinc is transported into the cell, although when zinc contacts the
NMDAR's it will inhibit the channel from being a receptor of glutamate while retaining
the permeability of the ion channel to zinc. The channel primarily responsible for zinc
import into the post synaptic neuron is the AMPARCa-Zn channel. Both NMDA and
AMPA receptors can be activated through glutamate and glycine addition while the
VGCC’s can be activated by high potassium. High potassium depolarizes the cell by
decreasing the flux of potassium into the cell while the sodium channels remain
unaffected and continue the rapid influx of sodium into the cell. This causes the cell to
depolarize activating the voltage gated sodium channels allowing more sodium ions into
the cell depolarizing the negatively polarized state creating a chain reaction for the
voltage gated sodium channels. VGCC’s are also activated which are permeable to zinc
allowing zinc to influx into the neuron if present extracellularly. These methods activate
the zinc permeable channels on the neuron allowing us to mimic the excitability inherent
to neurons while observing the effects of the zinc influx.
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Figure 29: Zinc Influx in Rat Hippocampal Neurons. Primary rat hippocampal
neurons were depolarized using either a high potassium or addition of glutamate and
glycine. This depolarization will open channels on the surface of the neurons that are
permeable to zinc. With high extracellular labile zinc opening the channels causes a large
influx of zinc into the neurons.
Due to the ease of activating zinc channels on the neuron under physiological
conditions we focused our research on how neurons manage changes in labile zinc in
relation to cellular trafficking. This presents a physiological model to analyze zinc
induced inhibition of cellular trafficking with minimal perturbations from physiological
conditions preventing introduction of artifacts. We began by increasing zinc in primary
hippocampal rat neurons where we were able to confirm that both mitochondrial and
lysosomal motility was inhibited significantly upon incubation for 5 minutes with 20 µM
zinc chloride and 2.5 µM pyrithione and motility was restored with 100 µM TPEN zinc
chelation (Figure 30A-D) consistent to the work performed on HeLa cells. Depolarization
of the neuron and the subsequent activation of zinc permeable channels were analyzed for
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organelle motility inhibition while using high extracellular zinc which when depolarized
caused a large influx of zinc into the rat hippocampal neurons and inhibition of motility
(Figure 30C & D). We found that the addition of zinc inhibited cellular trafficking in
primary rat hippocampal neurons, HeLa cells, and in vitro experiments performed with
yeast dynein and kinesin showing this inhibitory mechanism appears to be universal
across many organisms and cell types.
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Figure 30: Zinc Influx Arrests Mitochondrial and Lysosomal Trafficking in Neurons.
(A & B) Representative kymograph of mitochondria and lysosomes in primary rat
hippocampal neurons baseline speeds, speed after depolarizing the neuron using high
potassium and 100 µM zinc, speed following wash out and treatment with TPEN, and
speed after treatment with 20 µM zinc and 2.5 µM pyrithione. (C & D) The average
speed of mitochondria and lysosomes in primary rat hippocampal neurons at baseline,
after depolarizing using high potassium and 100 µM zinc, wash out and treatment with
100 µM TPEN, and washout and treatment with 20 µM zinc and 2.5 µM pyrithione. All
statistical significance was performed using ANOVA post hoc Tukey, * represents p <
0.05; ** represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. n=13
& n=8 for mitochondria and lysosome respectively. (E, F, G, & H) Representative trace
of mitochondria, lysosomes, endosomes, and VAMP2 vesicles reduction in motility
plotted against the concentration of zinc in pico moles. The inset value is the IC-50 value
for mitochondria, n=6, n=5, n=4, n=5 for mitochondria, lysosome, endosome, and
VAMP2 vesicles respectively.
After establishing zinc is responsible for the inhibition of cellular trafficking across
multiple cell types we then concentrated on determining the threshold concentration of
zinc that inhibits cellular trafficking. Thus far zinc induced inhibition of cellular
trafficking was only evaluated under high zinc conditions. The zinc concentrations
assessed thus far have been in the micro-molar range while more common physiological
concentrations typically rest in the pico-molar to nano-molar range [78, 84, 122, 128,
163] with synaptic concentrations reaching micro-molar concentrations [86]. Due to the
disparity in the concentrations evaluated from physiological ranges we sought to
ascertain the IC-50 concentration of zinc induced inhibition of cellular trafficking. HeLa
cells were used to monitor both the labile zinc concentration and the motility of
lysosomes and mitochondria. Cytosolic GZnP2, a green zinc probe designed to accurately
and specifically measure zinc concentrations [84], was co-transfected in combination
with an mCherry fluorophore tagged with a localization sequence for either the
mitochondria or the lysosome (cytochrome c oxidase target or lysosome associated
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membrane protein 1, respectively) (Figure 31A-B). This allows both the zinc
concentration and the motility of the respective organelle to be quantified simultaneously.
Once co-transfected these cells were treated with 100 µM TPEN for 10 minutes then with
20 µM ZnCl2 and 2.5 µM pyrithione for 5 minutes. By monitoring both the mCherry
tagged mitochondria or lysosome motility and the GZnP2 fluorescence we were able to
connect the motility associated with a specific concentration of zinc (Figure 31C). The
zinc concentration can be quantified by evaluating the GZnP2 fluorescence at any given
point and plugging this fluorescence into the equation in Figure 31D as the variable “I”.
The hill coefficient and kd were previously characterized [84] and the Imin and Imax are
determined during the experiment by depleting the sensor using TPEN and saturating the
GZnP2 sensor with zinc and pyrithione respectively. The motility of the organelles was
calculated using the ImageJ plugin called “Total_Motility” designed by Kurt Vos Et. Al
[235]. The motility can then be paired with the respective zinc concentration at the same
time point to construct a sinusoidal curve with the zinc concentration on the x-axis and
the motility of the organelle on the y-axis. The paired concentration of labile zinc and
motility for the respective organelle can then be plotted together to create a graph as
shown in Figure 31E-H, & 32E. Using this plot the kd of labile zinc (IC-50) could be
determined for the inhibition of lysosomes, mitochondria, endosomes, and VAMP2
vesicles (17 nM, 26 nM, 1.6 nM, & 7 nM respectively). The calculated inhibitory labile
zinc concentrations are within the more common physiological concentrations labile zinc
observed. This indicates that zinc acting as a cellular trafficking inhibitor may be
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common to all cells where small concentrations of zinc can be released to regulate the
movement of cellular cargo.

Figure 31: Method for Calculating Threshold Concentration of Zinc Induced
Inhibition In Vivo. (A) Subcellular targeting of fluorophores in this example to the
mitochondrial matrix specifically the cytochrome c oxidase enzyme on the electron
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transport chain. This fluorophore is not sensitive to changes in zinc or other factors and
will just mark the location of the subcellular target. The other fluorophore which will
have no tag and thus go to the cytosol of the cell is GZnP2 (Green zinc probe 2) one of
our labs novel intensiometric zinc probes. The zinc probe is sensitive to changes in labile
zinc concentrations. (B) Both the subcellularly targeted fluorophore and the zinc probe
will be cotransfected into HeLa cells as shown in the representative images. (C) The Hela
cells will be treated with TPEN then zinc and pyrithione to determine the minimum zinc
probe intensity and maximum zinc probe intensity as well as the motility of mitochondria
in this example for each respective concentration in zinc. The mitochondrial motility can
be correlated with each respective zinc concentration. (D) The maximum and minimum
intensity of the zinc probe are necessary to calculate the concentration of zinc throughout
testing. This equation requires the maximum and minimum intensity for the cells, the hill
coefficient (n) and the kd are both determined a priori through sensor characterization in
vitro. These concentrations were calculated through the full range of zinc concentrations
from the minimum to the maximum zinc concentration. (E) Once calculating the zinc
concentration at every step from the minimum ([Zn2+] = 0 to the maximum ~micromolar
range) and the respective motility at each step both were combined to form the axis of a
graph and the threshold concentration for zinc was determined through the IC-50 value.
Once zinc was found to be inhibiting cellular trafficking in a physiological range
pertinent to most cell types and not solely neurons we pursued the location of where zinc
ions interact to inhibiting cellular trafficking. This work found increased labile zinc
inhibited the motility of a variety of organelles therefore the zinc was not interacting
directly with the organelles. Although the zinc could be inhibiting the motor proteins
dynein and kinesin which then prevent microtubule-based motility. We constructed two
mCherry tagged constructs one to kinesin heavy chain isoform 5A (KIF5A) and another
to dynein intermediate chain 2C (IC-2C). The motility was monitored in rat hippocampal
neurons due to the signal being saturated by background fluorescence in HeLa cells. The
motor protein motility after zinc addition was inhibited for both motor proteins in both
the retrograde and anterograde direction (Figure 32A & B). All the organelle motility in
both the anterograde and retrograde direction were inhibited by zinc too. An observation
that the two motor proteins moved in both directions (anterograde & retrograde) which is
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due to the opposite motor protein trafficking the motor to the opposite side of the
microtubule. There is still debate how motor proteins get back to their respective start
positions although an accepted principal is the motor proteins rely on the opposite motor
to transport them back to the opposite end of the microtubule. This is why the motor
proteins appear to be moving both anterograde and retrograde. The Fiji plugin Kymolyzer
previously developed was used to performed quantitative analysis of motor protein
speeds in either the anterograde or retrograde direction [224]. TPEN once again was able
to restore both retrograde and anterograde motility for both motor proteins. KIF5A
(Figure32C & E) and IC-2 (Figure 32D & F) in rat hippocampal neurites is significantly
inhibited by zinc and pyrithione and restored through chelation of zinc using TPEN. Both
of the motor proteins were inhibited by zinc which aligns with our previous finding that
both retrograde and anterograde motility of the organelles was inhibited by zinc because
the organelles rely on motor proteins for microtubule-based cellular trafficking. Controls
were performed using the rat hippocampal neurons to ensure that the methods used to
increase or decrease zinc concentrations were not artifacts on the cellular trafficking.
Figure 33 shows the controls performed to ensure no artifacts were present to cause
misinterpretation of the results.

141

Figure 32: Zinc inhibits both anterograde and retrograde axonal transport. (A) The bar
graph indicates the speed of the kinesin and dynein (B) in primary hippocampal neurons
at baseline, after treatment with high zinc and pyrithione, wash out and treatment with
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TPEN in the anterograde and retrograde direction, n=9 & 8 for kinesin and dynein
respectively. (C) Representative kymograph of kinesin (KIF5A) and dynein (Dynein
intermediate chain 2C or IC2C) (D) in primary hippocampal neurons in primary
hippocampal neurons at baseline, treatment with high extracellular zinc and pyrithione,
washout and treatment with TPEN. Shows the speed of the kinesin (E) & dynein (F) in
primary hippocampal neurons at baseline, after treatment with high zinc and pyrithione,
and wash out and treatment with TPEN. There was significant reduction in motility of
kinesin by increasing the zinc concentration and significant restoration of motility of
kinesin by removal of zinc with TPEN indicating zinc inhibits kinesin motility. Statistical
significance was performed using ANOVA post hoc Tukey, * represents p < 0.05; **
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. n=9 & 8 for
kinesin and dynein respectively.
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Figure 33: Controls and Other Conditions Evaluated on Motor Proteins and
Mitochondria. All of the controls shown were performed in primary rat hippocampal
neurons. (A) Kinesin (KIF5A) & Dynein (IC2) (I) & mitochondria (K) after treatment
with glutamate, glycine, and high extracellular zinc, wash out and treatment with TPEN,
and washout and treatment with high zinc and pyrithione, n=4,3, & 3 respectively. (B)
Shows the speed of kinesin (KIF5A) & mitochondria (L) are unaffected by high K+
alone, n=3. (C) Kinesin & mitochondria (M) speed with pyrithione alone, n=3. (D)
Shows the kinesin after treatment with zinc pyrithione in zero calcium imaging, n=9. (E)
Kinesin & dynein (J) & mitochondria (O) speed after treatment with high extracellular
zinc (100 µM) in calcium containing buffer, n=3 and in zero calcium buffer (F), n=3. (G)
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Kinesin & dynein (H) speed after high K+ and 100 µM ZnCl2, n=3 & 8 respectively. (N)
Shows the speed of mitochondria after treatment with TPEN alone, n=3. Statistical
significance was performed using a two-way T-Test, n=3. Statistical significance was
performed using ANOVA post hoc Tukey, * represents p < 0.05; ** represents p < 0.01;
*** represents p < 0.001; **** represents p < 0.0001.
At this point we established the motor proteins are being inhibited which defaults to
inhibiting organelle microtubule-based cellular trafficking. Although the motor proteins
still do not appear to be a strong site for zinc interaction since there are numerous kinesin
proteins and the structures are completely different from dynein. When encountering this
it made more sense the zinc was interacting at one location which then caused the
downstream observation of inhibition of cellular trafficking. We needed to eliminate
many of the potential routes zinc could be interacting with to cause the inhibition
observed. One way to eliminate many of the conceivable zinc interaction sites was to
perform an in vitro assay on kinesin motility where we can begin with the basic
necessities for motility then titrate in anything into the experiment to learn what zinc is
interacting with. Our starting evaluation began with minimum Mg-ATP, microtubules,
and kinesin, and we found kinesin motility was inhibited. This narrowed down our
potential zinc interaction sites considerably. Our in vitro assay evaluated the hydrolysis
of ATP to ADP + inorganic phosphate (Pi). We purchased the Kinesin ATPase End-point
Biochem Kit (Cytoskeleton Inc.) to determine if kinesin is functioning. The kit works by
indirectly measuring kinesin activity via hydrolysis of ATP to ADP + Pi. The free
phosphate will bind ammonia molybdate forming a complex. This ammonia molybdate
phosphate complex binds malachite green which absorbs strongly at 640 nm when bound
versus malachite green absorbing at 446 nm in the apo state (Figure 34A). UV-Vis
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absorbance of the ammonia molybdate-malachite green complex allows for very precise
and accurate measurements down to 100 pM of inorganic phosphate. When adding only
microtubules, ATP, magnesium, and kinesin, the kinesin motor protein was inhibited
narrowing down the zinc interaction site to one of these components. The motor proteins
are likely not the interaction site due to the zinc needing to inhibit two completely
separate proteins despite them performing similar roles. We then looked into ATP being a
possible candidate since zinc outcompetes magnesium to form an ATP complex (ATP-Zn
kd=7.7x10-6; ATP-Mg kd=3.5x10-5) [80]. ATP is only biologically available once
coordinated with magnesium due to the magnesium stressing the gamma phosphate bond
allowing hydrolysis of this last phosphate from ATP. It has been shown that ATP
coordinated with other metals either decreases or stops enzyme function [232, 236]
leading ATP coordinated to zinc to be a possible interaction site.
Our rationale for the ATP not being the target for zinc interaction is the ATP
concentrations in the cell are in the low milimolar range similar to magnesium, while zinc
concentrations are typically in the hundreds of picomolar range with some locations
reaching the micro molar range for example at the synapse. This means that if all the
labile zinc in the cell were to bind the ATP there would be essentially no change to the
biologically available ATP-Mg concentration. Zinc interacting with ATP is an unlikely
site for interaction given the information. The in vitro kinesin ATPase end point assay did
show that the threshold concentration for zinc inhibition on the kinesin was 12 µM
(Figure 34B) which is much higher than the one observed for the in situ analysis using
HeLa cells. This could have been a result of the buffer being used (PIPES) binds zinc and
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could be causing this to be an artificially high concentration of zinc due to the buffer
binding up all the free zinc. We switched to a HEPES buffer which does not coordinate
zinc as PIPES does and performed the same ATP vs zinc concentration curve finding a
similar IC-50 value (8 µM) (Figure 34C). To confirm the PIPES was not coordinating the
zinc we performed a zinc binding curve using FluoZin-3 in the HEPES (Figure 34E) or in
PIPES (Figure 34D) buffer and found the same dissociation constant for both buffers
~1.5 nM. The IC-50 value may be artificially inflated compared to the in situ value
partially due to the buffers used for the ATPase end point assay binding zinc up to the
nano molar concentrations acting as a zinc buffer. Another potential factor inflating the
IC-50 value of the in vitro assay compared to the in situ work is because the microtubule
concentrations are different. The in vitro assay uses far higher concentrations of
microtubules than what is found in the cell and the microtubules in the cell likely already
have zinc bound to them unlike the artificial microtubules used in the in vitro assay. The
microtubules used in the in vitro ATPase assay can act as a chelator binding up excess
zinc preventing the zinc from binding to the specific interaction site that causes the
observed zinc induced motility inhibition. Microtubules have been shown to bind zinc at
many locations, up to 60 sites on one alpha-beta tubulin dimer [227]. This effect directed
our focus to the microtubule as the potential zinc interaction site. This is the only
component left in the in vitro assay that has not been evaluated. The microtubule would
make sense as a candidate for zinc interaction with many zinc binding locations and
being one location that would affect the motility of everything analyzed in this work thus
far.
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Figure 34: Kinesin ATPase Assay. (A) Detection mechanism for inorganic phosphate.
(B) ATP hydrolysis curve for kinesin in PIPES buffer and HEPES buffer (C). Zinc
binding curve in PIPES buffer (D) and HEPES buffer (E).
We expanded our use of the ATPase End Point kinesin kit by analyzing kinesin
microtubule stimulated ATPase activity. When increasing the microtubule concentration
with a set zinc concentration the concentration of zinc required to inhibit kinesin motility
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was increased as the microtubule concentration increased (Figure 35). The equation used
to plot these curves is a Michaelis-Menton derived equation kobs=[(x(kcatkbasal)/((Km+x)+kbasal)]2 [237]. We used a Michaelis-Menton equation because of how
exceptionally well it models enzymatic function to monitor enzyme kinetics (motor
protein). The Km (1/2 Vmax) had a direct relationship with zinc, as the zinc concentration
increased so did the Km value. The Km value increases with increased zinc concentrations
which means more substrate (microtubules) are required to result in the same ATPase
activity for kinesin. This leads to the microtubules being the probable interaction site for
zinc inhibition since the kinesin concentration remained unchanged and only increased
microtubules restored motility when zinc was increased supporting the microtubules as a
site for zinc inhibition. The Kcat (Vmax) had an inverse relationship with increased zinc the
Kcat value lowered correlating to decreased function of the kinesin. This would match
what we have observed where increased zinc decreases the function (motility) of the
motor protein kinesin. Unfortunately the Kbasal could not be confirmed using the assay.
The Kbasal value would indicate if zinc is altering the unbound microtubule kinesin motor
mechanochemical cycle clearly exhibiting if zinc is interacting with the microtubules,
kinesin, or both. The Kbasal values are so low with kinesin nothing could be accurately
determined from the Kbasal values. The kinesin motility dropped off significantly when
reaching 30 µM where despite high concentrations of microtubules full kinesin function
was not restored. This could be a result of the zinc directly acting on the kinesin motor at
this high of a zinc concentration.
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From this we were able to ascertain that the zinc inhibition is acting on either the
microtubules or the motor proteins. Although the microtubules are considered further
since there would only be one target site for zinc to inhibit as opposed to two sites
(kinesin & dynein). Also as mentioned kinesin and dynein as vastly different proteins
which would be unlikely to contain similar zinc binding sites. Another factor that will be
discussed shortly is the kinesin motor protein has no known zinc binding locations further
supporting the microtubule as the zinc interaction site. Our work shifted to evaluating
how zinc interacts with microtubules.

Figure 35: Kinesin Microtubule Stimulated ATPase Activity. Kinesin activity
increases at higher microtubule concentrations.
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Table 11: Km Values for Different Zinc Concentrations.
[Zn2+]

Km ([MT] µM)
0
0.037
114 pM
0.056
9.57 nM
0.299
30 µM
0.116
To focus on the microtubules as a zinc interaction site we expanded our in vitro
analysis to single molecule tracking of yeast dynein on bovine microtubules. This
analysis was performed through collaboration with Steven Markus’s lab at CSU. We had
gone to their lab to see how everything is performed and plan the experimental design to
evaluate the observed zinc inhibition and provided buffered zinc concentrations.
This in vitro analysis provided pivotal information on the location where zinc is
inhibiting motility. The assay allows microtubules to adhere to a glass coverslip and yeast
dynein is flowed into the chamber with the adhered microtubules. Yeast dynein was used
for simplicity due to cytoplasmic dynein requiring dynactin a multiplexed protein as well
as shorter walking distances [238]. Yeast dynein also has very similar structural and
sequence homology to cytoplasmic dynein. The dynein has a fluorophore bound to the
protein and the movement can be monitored via TIRFM (total internal reflection
fluorescence microscopy). Yeast dynein velocity (Figure 36A & B) and displacement
(Figure 36A & C) were heavily reduced once exceeding 44 nM labile zinc, falling within
physiological concentrations of labile zinc. This closely matches the observed
concentrations found in our in situ analysis using HeLa cells. The fraction of active
motors dropped off to nearly zero once the zinc concentration reached 44 nM (Figure
36D). The active motors are the motors actively moving along microtubules, this shows
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that the active motors are no longer there (moving along microtubules) once reaching 44
nM. The displacement and velocities may still remain high at 44 nM but the number of
motor proteins moving at these speeds or distances is nearly zero, then once exceeding
this concentration no motor proteins are active. This puts the concentration of labile zinc
causing inhibition of dynein walking on microtubules between 10 nM and 44 nM again
matching what was observed in situ for the IC-50 concentrations.
Zinc appears to be inhibiting cellular trafficking via two mechanisms, one being the
ability of dynein to walk on microtubules and two the ability of dynein to land on
microtubules. The former is shown in the active motors graph (Figure 36D). The active
motors are the dynein motors walking along microtubules which decreases at higher zinc
concentrations (>10 nM). The second way zinc appears to be inhibiting motility is by
blocking dynein from landing on microtubules shown in the landing plots of active
motors and total motors (Figure 36E & F, respectively). This clearly shows that zinc is
preventing the dynein from binding to the microtubules once reaching 44 nM
concentration. This points to the microtubule being the location where zinc is inhibiting
cellular motility. The IC-50 values were determined using the landing rates of dynein and
found to be ~6.5 pM, well below physiological cytosolic zinc concentrations (Figure 36G
& 36H). This value may be artificially low due to low microtubule concentrations used to
perform these experiments (< 200 nM microtubules) relative to physiological
concentrations of microtubules (5-10 µM). As shown in the ATPase end point assay
microtubules can bind excess zinc making the concentration of zinc probably higher than
what is predicted here in vitro. The zinc inhibition is very potent, where zinc does not
152

need to bind to every tubulin dimer only every 10-20 tubulin dimers to exhibit its
inhibitory effect on the cellular trafficking. The importance of this assay is in
demonstrating zinc inhibition is occurring at the microtubule. The zinc appears to be
preventing the motors from landing on the microtubules and does not affect their speeds,
supporting the microtubule as being the sole zinc interaction site. This can be observed in
the average speeds not changing despite increasing the zinc concentrations. Only when
no motors are able to land on the microtubules does the speed change to zero. The
number of motors walking on microtubules is diminished greatly by increasing zinc
concentrations by as little as 0-120 pM zinc (Figure 36E). This effect can also be
indirectly observed in all the kymographs where the baseline has many more moving
organelles or motor proteins then the zinc treatment kymographs have significantly less
organelles or motors on the kymographs. The decreased motility could also be a result of
a small number of motor protein binding sites still being available on the microtubules
which allow the motors to bind but then the zinc occupies the next tubulin dimer
preventing movement effectively stopping the motor proteins that can successfully bind
to the microtubule.
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Figure 36: In Vitro Analysis of Yeast Dynein on Bovine Microtubules. (A)
kymograph of dynein at various zinc concentrations. (B) Velocity & displacement (C) of
yeast dynein on microtubules. (D) Fraction of active dynein motors on microtubules. (E)
The landing rate of active & total (F) motors onto microtubules. (G) IC-50 of yeast
dynein landing rate onto microtubules for total dynein motors. Contributed by our
collaborator Steven Markus from CSU.
We expanded this work to look at the effect zinc has on yeast microtubules. All the
previous single molecule work was used bovine microtubules. The same zinc inhibitory
effect was found when using yeast microtubules. The same trends were found as with the
bovine microtubules although the landing rates (active motors) were more significantly
decreased compared to bovine microtubules. The landing rate reached zero at 10 nM zinc
instead of 44 nM zinc as observed with the bovine microtubules. This also indicates there
could be species dependent variability in how pronounced zinc inhibits cellular
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trafficking. The inhibitory effect zinc has on motor proteins landing rate appears to be
universal across species. After establishing a location for zinc interaction in inhibiting
cellular trafficking we worked toward identifying the precise zinc binding residues on the
microtubule.
We decided the best method to determine the precise location where zinc interacts to
inhibit cellular trafficking on microtubules was saturation mutagenesis of a specific
amino acid identified to bind zinc. First we needed sites where zinc could potentially bind
on microtubules. To determine these sites we first used four different zinc-protein
binding algorithm programs (Zinc Explorer [239], PredZinc [240], ZincBinder [241] &
Zinc Machine [242]) and ran the sequence of α tubulin through the algorithms. These
programs only evaluate cysteine, histidine, glutamate, and aspartate (CHED) as possible
zinc coordinating amino acids. The algorithms listed off all the CHED proteins from the
most likely to bind zinc to least likely, these lists were cross referenced to produce the
most likely candidates for zinc binding sites on α tubulin, refer to Appendix D for listed
predictions. The identified sites were C20, C25, C305, H309, C376, E284, E411, H393,
& E417. All of these were regarded as high potential zinc binding amino acid locations
on α tubulin derived from the zinc binding programs. Additional sites were chosen for
mutation based on papers citing these as being zinc binding locations while also being
required for sheet formation of tubulin dimers, H192, D424, & E420 [243]. Zinc can
form zinc sheets instead of microtubules when tubulin dimers are in the presence of high
concentrations of zinc, these zinc binding locations were also evaluated as potential sites
for zinc induced inhibition of cellular trafficking. The zinc algorithms suffer from the
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same issues molecular modeling programs suffer from as discussed in chapter 1. The
algorithms are not able to evaluate every aspect that contributes to a zinc binding location
therefore some are missed. To avoid missing zinc binding sites additional zinc binding
sites were chosen based off logical deductions.
Further we reviewed literature to find where the zinc could be binding on the
microtubules. The first tubulin structures imaged were of zinc “sheets” not the tubes
which form microtubules using electron microscopy to map the surface of the tubulin.
These were believed to be the structure of tubulin despite these being completely
artificial structures formed by micromolar additions of ZnSO2 [227]. Zinc sheets do not
resemble microtubule structures beyond the sheet structure compared to tube structure.
The protofilaments form in anti-parallel directions while normal microtubules form
protofilaments in parallel with all the α tubulin on one end of the microtubule (minus
end) and all the β tubulin on the opposite end of the microtubule (plus end). These
original images could not identify a zinc binding location although a later structure
identified what appears to be a zinc ion in the structure of tubulin dimer [220]. This zinc
ion appears at the interface between two α tubulin proteins in the antiparallel structure.
The zinc ion is coordinated through four amino acids two from each α tubulin at the
interface, H192 and E417; and H283 and E284 refer to Figure 37 below for a
representation of the coordination.
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Figure 37: Depiction of Zinc Binding Site. Shows the antiparallel alpha tubulin with
the four coordinating zinc amino acids on each alpha tubulin (H192 & E417) (H283 &
E284). The structures were used from 1JFF from PDB structure determined by [220].
Chimera constructed the image.
Each location was mutated and evaluated first by co-transfection with the mutant α
tubulin mCherry construct and mito-eGFP. Alpha tubulin mutants where the morphology
of the microtubules was lost were not used for analysis due to the mutant microtubules
not forming preventing evaluation of zinc induced inhibition. C20N, C20P, C305F,
C305L, E411T, E411P, E411S, and E417R mutants all prevented the formation of
microtubules and were not used for analysis. When monitoring the motility of
mitochondria in HeLa cells after the addition of zinc we observed there were no
statistically significant changes between all of the mutants tested, Figure 38A. We
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deciphered the reason we did not observe any statistically significant change in the
reduction of inhibition of mitochondrial motility is because endogenous α tubulin was
competing with the mutant α tubulin diluting the effects the mutant would have on the
inhibition.
Our next method to determine a mutant that would alter the inhibition of cellular
trafficking observed by zinc addition was to transfect the cells with the mutant α tubulin
mCherry construct and observe the movement of the microtubules not an organelle. The
microtubules have a lot of movement caused by the pulling of the motor proteins on the
microtubules hence we can observe decreased landing of motor proteins on the
microtubules [244, 245]. This eliminated the artifact of motility occurring on the wild
type microtubules. We compared the microtubule motility across all the mutants
described in the previous method and found no statistically significant reduction in zinc
induced inhibition of cellular trafficking, refer to Figure 38B. Up to this point we had
been performing all experiments at 37 ˚C to closely resemble physiological conditions
and organellar, motor protein, and microtubule motility is substantially faster at this
temperature as opposed to room temperature. We deemed this was causing variations in
our measurements. The issue is buffers, drugs, and the incubation chamber change
temperature slightly which was causing small shifts in the motility of the observed
component preventing small error bars and statistical significance. The incubation
chamber also caused artifacts by moving the image frame when opening and removing
the incubation chamber lid. To avoid these artifacts we transitioned to imaging
microtubules at room temperature.
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The microtubule motility was monitored at room temperature and Figure 38C found
two mutants that have significant reduction in the zinc induced inhibition, H192N &
H283T. Both of these sites were not predicted by the different zinc algorithm programs to
be zinc coordinating sites. Although both of these sites were logically what were
predicted to be the zinc coordinating amino acids and shown in the crystal structure of the
zinc sheets to bind zinc. The crystal structure predicted four amino acids would be used
to coordinate zinc, H192, E417, E284 and H283. The E284 amino acid showed no change
in the reduction in motility despite being linked in the H283 amino acid coordination of
zinc which may be because histidine has superior binding to zinc compared to glutamate.
The E417 position could not be evaluated due to mutations at this position prevented the
formation of microtubules. This is a helpful indicator this site is particularly important to
maintain the tubular structures of microtubules. This work supports the zinc binding
location that is causing the inhibition of motor protein binding to microtubules is between
the four amino acids H192, E417, and H283, E284 on the α tubulin subunit of
microtubules.
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Figure 38: Identification of Zinc Interaction Site on Microtubules. (A) The reduction
in baseline mitochondria motility after addition of 20 µM ZnCl2 and 2.5 µM pyrithione.
No statistical significance between any of the mutants compared to the wild type
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reduction in motility. (B) Reduction in Microtubule Motility at 37 ˚C. The reduction in
baseline microtubule motility after addition of 20 µM ZnCl2 and 2.5 µM pyrithione at 37
˚C. No statistical significance between any of the mutants compared to the wild type
reduction in motility. (C) Reduction in Microtubule Motility at Room Temperature. The
reduction in baseline microtubule motility after addition of 20 µM ZnCl2 and 2.5 µM
pyrithione at room temperature. Statistical significance was performed using a one way
ANOVA post hoc Tukey, n=3-6. * represents p < 0.05; ** represents p < 0.01; ***
represents p < 0.001; **** represents p < 0.0001.
Mitochondrial motility was analyzed in primary rat hippocampal neurons when
TRPML1 is overexpressed and activated using a synthetic agonist ML-SA1 with similar
potency as the endogenous agonist phosphatidylinositol-3,5-bisphosphate [246].
Mitochondrial motility was found to be reduced after activation of TRPML1 and
recovered following treatment with TPA, Figure 39A. TPA was used for two reasons one
its lower affinity for calcium to ensure that calcium concentrations were not affected and
two the faster kinetics compared to TPEN [225, 226]. The mitochondrial tracks were
broken down into components (ranges), using the computer program R [247] with the
mclust package [248], where the mitochondrial speeds are most commonly found under
each treatment condition (baseline, MLSA-1, and TPA) refer to Figure 39C-D. There are
four components for baseline and TPA treatment indicating a fourth higher speed
category for mitochondria although when treated with MLSA-1 there are significantly
reduced speeds not reaching this fourth category, refer to Figure 39A & B. The majority
of mitochondria fall under the first component category for the TPA treatment compared
to baseline or TPA treatment which aligns with the majority of the mitochondria tracks
slowing down significantly. TPA was able to restore the motility of the mitochondria
after zinc release from the lysosomes (Figure 39A & B). We found zinc release from the
lysosomes through the TRPML1 channel can affect cellular trafficking.
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Figure 39: Mitochondrial Motility in Rat Hippocampal Neurons Following Activation
of TRPML-1. (A) The proportion of mitochondria tracks within each of the components.
(B) Average speed for each component. (C-D) Parameterized Gaussian mixture model of
each sample determining the number of components for the system optimizing between 1
and 9 components for baseline, MLSA-1, and TPA respectively. (F-H) Density graph of
the number of lysosomes at each speed for baseline, MLSA-1, and TPA respectively.
N=3.
4.4 CONCLUSIONS
We have shown in a top down approach that cellular trafficking in cells is regulated
by labile zinc from the organelles to the zinc interaction site at microtubules. Zinc was
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shown to inhibit microtubule based trafficking of organelles and motor proteins. Zinc was
revealed to bind microtubules resulting in what we presume is a conformational change
in the motor protein binding domain of the microtubule preventing motor proteins from
landing or walking on microtubules. We confirmed unequivocally zinc regulates
microtubule based trafficking in cells through a variety of microscopy and biochemical
techniques.
We were able to determine that zinc inhibits cellular trafficking by interacting with
four amino acid residues on the α tubulin monomer of microtubules. This explains why
the microtubule cellular based trafficking in inhibited when zinc concentrations are
increased. The H192 and H283 amino acid residues on α tubulin were confirmed as the
zinc binding residues where zinc binds to cause the inhibition of cellular trafficking. We
hypothesize that E283 and E417 also coordinate the zinc ions although E417 mutant
disrupted the microtubule structure therefore we were unable to evaluate this site through
this method of analysis. Although the mere fact the mutation disrupted microtubule
structure indicates this amino acid is essential to properly form tubules. E283 was not
statistically significant although this may be a result of glutamate not coordinating zinc as
avidly as histidine. We propose these four amino acids coordinate the zinc ions in the
microtubule structure [220]. The exact mechanism of how zinc inhibits the microtubule
cellular based trafficking is hypothesized to be by altering the microtubules structure
altering the motor protein binding site on α tubulin which prevents the motor proteins
from landing and walking on the microtubules. This mechanism to prevent motor
proteins from landing appears to be universal across different organisms with this
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occurring in yeast, bovine, human, and rat species. Previous papers have shown that
higher concentrations of zinc will stabilize microtubules but begin to cause
conformational changes in the tubulin structure which causes alters the quaternary
structure of the microtubules [227-229, 249]. The conformational changes are reversible
with the removal of zinc which explains why the movement of organelles and motor
proteins can be restored with the removal of zinc. Although longer incubation times with
zinc appear to have a denaturing or deactivating effect on the tubulin which requires
longer times after removal of zinc for the protein to return to the native conformation
[227]. This may explain why there is a time dependent effect of the reversal of high
concentrations of zinc, the longer the high zinc is incubated the smaller the reversal of the
motility inhibition. These four residues would explain this conformational change since
they are distant from the motor protein binding domain of tubulin causing an allosteric
effect through a conformational change of the tubulin dimer.
The zinc induced inhibition of cellular trafficking was shown to be within
physiological concentrations of zinc. The IC-50 for zinc induced inhibition of cellular
trafficking is in the low nano-molar range, a range which has been reached by zinc
release from the lysosomal TRPML-1 channel [88]. Activation of the TRPML-1 channel
uncovered the channels ability to influence organelle motility and the channels role as a
regulator of cellular trafficking. Prior to this work there has been no evidence to suggest
that TRPML-1 channel or zinc contribute to cellular trafficking. This finding could
provide novel therapies in treatments of diseases such as MLIV disease.
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Increased influx of labile zinc ions has been shown to cause neuronal death under
ischemic events, [47, 157] where it was previously understood to be caused by
mitochondrial dysfunction leading to mitochondrial induced apoptosis [4]. Cellular
apoptosis may not be a result of mitochondrial dysfunction but rather a result of
preventing cellular trafficking. Another example where the zinc concentration could
increase is oxidative stress can cause zinc release from zinc binding proteins like
metallothionien proteins or glutathione increasing the intracellular zinc in localized
environments [91]. Redox reactions and zinc dynamics could be mechanisms the cell
uses to modulate cellular trafficking that prior to this finding were unknown. Through the
advent of superior zinc sensors additional avenues are waiting to be uncovered that
modulate zinc concentrations to regulate cellular trafficking. Zinc concentrations are
reported qualitatively and not quantified due to lack of zinc sensors capable to provide
accurate measurements of zinc dynamics. New zinc sensors have begun to flood the
research environment allowing these previous roadblocks to be abolished. Zinc biology is
a rapidly changing field with more and more discoveries of zincs role within the cell
elevating the importance of zinc.
Another potential area of study where this finding could become increasingly
important is the synaptogenesis of developing neurons. Studies have demonstrated zinc is
connected to synaptogenesis, neuron development, and synaptic plasticity [250]. Zinc
may help shape neuronal function through modulating cellular trafficking in neurons
during these critical developmental stages. During this time period the neurons cellular
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trafficking is even more important leading to regulators such as zinc playing an enormous
role in synaptogenesis or defects in synaptogenesis such as in Downs syndrome [251].
This work has shown that zinc provides a novel regulatory role in cellular trafficking.
This is enormous due to the cellular trafficking within the cell still being elucidated this
offers a novel mechanism to slow down, stop, or speed up transport. Cellular transport is
vital for cell survival, and needs to be regulated to delivery cargo at specific
spatiotemporal locations. This aspect of the cell regulates exocytosis, endocytosis, energy
distribution, nutrient delivery, material transport, and many more aspects required to cell
survival. The fact that cellular trafficking is regulated by zinc provides a universal
mechanism of regulating cellular transport and places a newfound importance on
biological zinc.
While focusing on mitochondrial zinc dynamics and zincs interaction with
microtubule-based cellular trafficking we stumbled upon a link between mitochondrial
microtubule-based trafficking being impeded by increased polyamine concentrations. A
hallmark of Alzheimer’s disease are dysfunctional mitochondria which ultimately
contribute to cell apoptosis. Polyamines are also elevated in the brains of Alzheimer’s
disease patients. Many avenues have been explored to determine the exact mechanism or
critical biomarkers for Alzheimer’s disease with limited success. Some of these avenues
indicate polyamines as a potential marker or mechanism to treat Alzheimer’s disease.
Polyamines are aliphatic amines with a positive charge at physiological pH. Polyamines
have been found to modulate a wide array of cellular functions from gene expression to
immune response although no investigation has linked polyamines to alter mitochondrial
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motility. This decreased mitochondrial motility caused by polyamines could be a
contributing factor to mitochondrial dysfunction. Providing a link to pursue polyaminemitochondrial interaction as a potential therapy for Alzheimer’s disease.
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CHAPTER FIVE: MITOCHONDRIAL MOTILITY AFFECTED BY
POLYAMINES A POTENTIAL MECHANISM UNDERLYING DOWN
SYNDROME-ALZHEIMER’S DISEASE
5.1 INTRODUCTION
Down Syndrome (DS) is a genetic condition where a partial or full extra copy of
chromosome 21 is expressed resulting in triplication of the amyloid precursor protein
(APP) gene. Down Syndrome was first described by J. Langdon Down in 1866 [252] and
later the cause was identified as trisomy of chromosome 21 by Lejeune in 1959 [253].
This is the most common chromosome disorder in humans with 1 in 1000 babies born
each year with Down syndrome [254]. Studies have found that virtually all individuals
with DS have sufficient neuritic plaques and neurofibrillary tangles to neuropathological
diagnosis of Alzheimer’s disease (AD) by the age of 40 years old [255, 256]. Increased
APP results in an increased incidence of AD pathology in individuals with DS [257-259].
Senile plaques contain β-Amyloid (Aβ) protein which is a downstream product from a
precursor protein β-Amyloid precursor peptide (APP) is located on chromosome 21. The
APP protein is overexpressed in trisomy of chromosome 21 leading to increased Aβ and
rising the theory that the Aβ plaques could cause AD [260]. Studying the AD pathology
in DS individuals is a superb platform to study the mechanisms of AD pathology due to
the increased production of the Aβ peptide [261-263].
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AD is currently the most prevalent neurodegenerative disease affecting the human
population. AD was first described in 1907 by Alois Alzheimer and was the first
neuropsychological characterization of the disease documented hence bearing his name
for the disease [264]. Despite being discovered at the turn of the century research into the
dementia related pathology only accelerated since 1980, over 70 years later. AD accounts
for more than half of patients with dementia neurological pathologies. The medial
temporal lobe (MTL) consisting of the hippocampus & entorhinal cortex is the major
region that deteriorates as the disease progresses [265]. AD is characterized by
oligomerization of extracellular amyloid-β (Aβ) plaques as well as intracellular
accumulation of a protein named Tau forming neurofibrillary tangles. These Aβ deposits
are localized at synapses and are not ubiquitous throughout the brain remaining
concentrated in the MTL. The plaques and tangles instigate the loss of synapses and
eventual neuron death ultimately leading to the progressive cognitive decline observed in
AD patients. Many avenues have been explored to determine the mechanism underlying
the pathogenesis of AD with partial success.
Some of the less explored avenues include amino acid catabolism and polyamines,
which might may underlie the mechanism leading to AD pathology [266-269].
Polyamines (PA) are ubiquitously expressed in all tissues of all animals and plants [270]
and have diverse roles in numerous cellular processes such as gene expression [259],
immune response, apoptosis, cell division, differentiation, proliferation, DNA and protein
synthesis, and homeostasis [271, 272]. However, little investigation into polyamines
effects on AD has been performed. PAs are aliphatic polycation amines at physiological
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pH associated with a positive charge [273]. The positive charges associated with PAs
allow them to interact with negatively charged macromolecules such as DNA, RNA, and
certain amino acids [274]. The most common PAs present in mammalian are putrescin,
spermidine, and spermine. These polyamines are biosynthesized from the amino acid
arginine. Cells will begin by using mitochondrial arginase to convert arginine to
ornithine, which is then decarboxylated by ornithine decarboxylase (ODC) converting the
amino acid to the PA putrescin. Putrescin requires an amino propyl group that is
enzymatically synthesized by S-adenosylmethionine (SAM) acting as a substrate to react
with SAM decarboxylase forming putrescin. Putrescin and the amino propyl group are
substrates for the enzyme spermidine synthase to generate the polyamine spermidine.
Another amino propyl group is incorporated by the same mechanism described above
with spermine synthase to form the final polyamine spermine [275]. Refer to Figure 40
for PA biogenesis. PAs have been linked to aging and have been postulated to serve a
role in the progression of AD.
Increased polyamine concentrations have been found in AD brains. A similar pattern
has been found in DS related AD brains [266]. We hypothesize that polyamine
concentrations increase due to increased beta amyloid proteins leading to increased
oxidative stress, which has been suggested to increase the activate ornithine
decarboxylase (ODC), the rate liming enzyme in the biosynthesis of polyamines [262].
Previous work has found the ODC enzyme function increases, leading to a production of
higher concentrations of PAs in the brains of AD patients compared to controls [276].
These higher PA concentrations are believed to be linked to the activation of the NMDA
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receptor causing memory loss. This was confirmed in some studies where Aβ was
injected into mice cerebrospinal fluid increasing PA concentrations and NMDA
activation resulting in memory deficits which were reversible upon addition of NMDA
antagonists [277, 278]. These studies suggest that increased PAs facilitate the production
of Aβ plaques and cause cognitive decline [275]. We found increased polyamine
concentrations in our mice DS cell lines, which might underlie the mechanism of the
decreased mitochondrial motility also observed in the DS cell lines. Furthermore, we
have shown that the increased concentrations of polyamines decreased mitochondrial
motility. In addition, we revealed decreased mitochondrial motility in primary cultured
rat hippocampal neurons when exposed to polyamines.
Flawed bioenergetics of the cell is a hallmark of neurodegenerative diseases including
AD implicating mitochondria as a nexus between the disease and the disruption of
bioenergetics. Mitochondriopathies are diseases where the mitochondria is at the origin of
the insult for the disease, AD has been classified as a mitochondiropathie. Some of the
first indicators AD had mitochondrial dysfunction was altered glucose metabolism in the
brain [279]. A location of mitochondrial dysfunction appears to be in the electron
transport chain, leading to a production of higher concentrations of reactive oxygen
species that will cause more damage to the cell [280]. Many of the electron transport
chain (ETC) enzymes are dysfunctional in AD brains such as cytochrome c oxidase
[281], pyruvate dehydrogenase complex [282], and the Krebs cycle α‐ ketoglutarate
dehydrogenase complex [282]. Although it is still debated if the altered bioenergetics
observed in AD brains is the cause or a consequence of the primary insults leading to the
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AD pathology, there is a clear connection between AD and dysfunctional mitochondria,
which contribute to neuronal apoptosis rendering the mitochondria a primary target to
study in relation to AD and polyamine interactions.
PA production can be decreased using an FDA approved drug
Difluoromethylornithine (DFMO) for hyper proliferative (cancer) and infectious disease
treatments. DFMO is the fluorinated ornithine analog performing the function as a
suicide inhibitor of ODC preventing PA production [283] (Figure 40). Although all
eukaryotic cells require PAs, rapidly dividing cells have a higher demand for PAs to
divide and function at such a high metabolic rate consequently blocking the production of
PA production prevents rapid division of cells. We can realign the use of DFMO inhibitor
to inhibit ODC and prevent the production of PA to determine if AD pathologies can be
improved (Figure 41). We found DFMO restores mitochondrial motility in our DS mouse
model. A mouse neuronal model a normosomic control cell line was used to establish a
reference point for polyamines and Aβ aggregation. Mitochondrial motility and
polyamines have never been linked prior to these results indicating a novel mechanistic
pathway for the underlying pathology of AD in DS brains. This could set the grounds for
targeting the polyamine pathway to halt the progression of AD pathology in DS
individuals.
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Figure 40: Biogenesis of Polyamines and Pathway of Difluoromethylornithine
(DFMO) Inhibition of ODC Enzyme.

Figure 41: Proposed Mechanistic Relationship between Aβ1-42 & Polyamines.
Putrescine is synthesized from ornithine through a decarboxylation reaction catalyzed by
ornithine decarboxylase (ODC). Spermidine and spermine are derived from putrescine by
the addition of either one or two amino propyl groups, respectively. In Down Syndrome
(DS) the overproduction of Aβ1-42 is hypothesized to upregulate polyamine synthesis by
increasing expression of the rate-limiting ODC enzyme. In turn, greater intracellular
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concentrations of polyamines are believed to increase Aβ1-42 aggregation with associated
decreased mitochondrial motility.
5.2 METHODS
PRIMARY RAT HIPPOCAMPAL NEURON CULTURE AND
TRANSFECTION
All primary neuron culture was prepared and provided by lab mates. Neuron
transfection was performed according to the methods described in chapter 4.
PLASMID CONSTRUCTION
For mammalian expression, the sensor was constructed in the mammalian vector
pcDNA3.1 by PCR cloning. To construct mito-mCherry, three repeats of the coding
sequence for the first 29 amino acids of the human cytochrome c oxidase subunit 8a
(mitochondrial precursor; accession number NP_004065) was utilized for mitochondrial
matrix targeting and incorporated into pcDNA3.1 vector using HindIII. The mCherry
fragment was inserted between BamHI and EcoRI sites.
LAMP1-RFP (Addgene #1817), GCAMP5 (Addgene #: 31788) and CMV mitoRGEC01 (Addgene #: 46021) were purchased from Addgene.
H1B & HTK MOUSE CELL LINES CELL CULTURE AND TRANSFECTION
The H1b and the HTk cells were obtained from Dr. Pablo Caveides, Faculty of
Medicine, University of Chile, Santiago, Chile. The H1b cells were derived from the
hippocampus of normal mouse foetus, and the HTk cells were derived from the
hippocampus of trisomy 16 mouse foetus[284]. Mouse neuron cells (H1b & HTK) were
maintained in 1:1 ratio of high glucose Dulbecco’s Modified Eagle Medium (DMEM) to
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Ham’s F-12 medium (Sigma Co.) with 10% inactivated adult bovine serum (ABS), 2.5%
fetal bovine serum (FBS), 1 g/L bicarbonate, and glucose adjusted to 6 g/L at 37˚C, 5%
CO2. The cells were split once a week using Trypsin (Invitrogen) to detach the cells. Cell
media was replaced twice a week.
Transfection protocol was performed as follows. The cells were split at high density ~
150000 cells/ml and added to a 2 ml imaging dish. On day 2 the cells were transfected.
The transfection protocol follows the same methods described above for the primary rat
hippocampal cells using lipofectamine 3000. The single difference is differentiation
media (Neurobasal-B 27 (Gibco, NYSE-TMO), Forskolin (FK) (10 µM), bFGF 100
ng/mL (ProSpec-Tany) added to the cell culture media described above) will be added
back to the cells after washing out the lipofectamine from the cell culture media as
described [285]. Allow the cells to incubate with the differentiation media for 48 hours.
When difluoromethylornithine (DFMO) was applied, it was added 48 hours after addition
of the differentiation media in a 5 mM working concentration. All cells were imaged 72
hours after transfection.
LIVE CELL MICROSCOPY
Cells were imaged 48 hours post-transfection, and cells were washed three times with
the indicated imaging buffer immediately before imaging. All imaging was performed on
an inverted Nikon/Solamere CSUX1 spinning disc confocal microscope with a 40x 1.4
NA oil immersion objective. Data was collected using MicroManager software and
analyzed with Fiji (ImageJ).
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CELL IMAGING
Hanks salt imaging buffer (HHBSS) pH 7.4 was used for imaging buffer. The image
acquisition was every 2.5 seconds using a 561 nm laser with the laser power set to 5%
and the exposure time at 50 ms. The imaging was performed at 37 ˚C. The mouse cell
lines were imaged using the same parameters except the image acquisition was every 10
seconds.
For the neuron imaging polyamine concentrations of 1:1000 dilution from 1 M stock
polyamine concentrations were added to the imaging dishes for a working concentration
of 1 µM. The polyamines used were putrescin, spermine, and spermidine.
For all motility imaging the same specifications were used for motility experiments
described in chapter 4.2 for neurons. The same procedures described in chapter 4.2 for
motility of HeLa cells was used for mitochondrial motility in H1b and HTk mouse
neurons.
DATA ANALYSIS
Data analysis was performed using Fiji (ImageJ) and Excel spread sheets. The
construction of graphs and statistical analysis Kaleidagraph (Version 4.5.3, Synergy
Software) and JMP (JMP®, Version 13.0. SAS Institute Inc.) were used. All t-tests were
preceded by an f-test to analyze variance equality. T-tests were then performed with
consideration for the determined variance equality or inequality.
Image analysis of mitochondrial motility utilized two programs. Imaging of the
hippocampal normosomic and trisomic mouse cell lines (H1b & HTK respectively) used
an ImageJ plugin called Mito_Motility to determine the percent change in mitochondrial
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motility between two frames in an image stack, the plugin was designed by Kurt De Vos,
et al [235]. Refer to Appendix A for a detailed method.
Mitochondrial dynamics were observed in rat hippocampal neurons using the ImageJ
kymograph program Kymolyzer [286] developed in the Schwarz lab. Refer to Appendix
B for a detailed method.
POLYAMINE QUANTIFICATION USING MICELLAR ELECTROKINETIC
CHROMATOGRAPHY WITH LASER INDUCED FLUORESCENCE
DETECTION (MEKC-LIFD)
Capillary electrophoresis was used as opposed to other chromatography techniques
such as high performance liquid chromatography (HPLC) due to its precision in resolving
elution peaks down to the yoctomolar (10-24) range [287]. Conventional HPLC with mass
spectrometry are not as reliably in resolving simultaneously the different polyamines. For
this reason, capillary electrophoresis was used to separate and quantify PA’s in the cell
lysate samples. Micellar electrokinetic chromatography (MEKC) utilizes the concept of
capillary electrophoresis (CE) a separation method utilizing sub micro or nanofluidic
channels, but extends the application to neutral analytes. The major difference between
MEKC and traditional zone CE is that there is no stationary phase, MEKC utilizes a
pseudo-stationary phase by using micelles and a surfactant such as SDS. This
psuedostationary phase allows the neutral analytes being separated to form a partitioning
between the micelle migration and the electro-osmotic flow (EOF). This makes the
neutral analytes elute at different times depending on their partitioning between the
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micelle and the EOF. This method is dependable and utilizes very small volumes of
solution (nL) to separate out the neutral analytes [288].
REAGENTS
The following chemicals or solutions were used for running samples through MEKCLIFD. Fluorescein isothiocyanate Isomer 1 (FITC), sodium carbonate, sodium bicarbonate,
& putrescine, sodium dodecylsulphate (SDS), acetone, sodium tetraborate, formic acid,
HPLC grade acetonitrile. All the reagents were prepared using 18Ω ultrapure MiliQ water.
DERIVATIZATION PROCEDURE
One milligram of FITC was dissolved in 1 milliliter of acetone. This solution was used
to chemically bind to the polyamines amine groups, allowing the polyamines to be detected
through fluorescence of FITC. Identification of the elutant using laser induced fluorescence
detection is the detection method for this instrument. A 20 mM carbonate buffer at pH 10
was prepared with 5 ml of 200 mM NaHCO3 and 5 ml of 200 mM Na2CO3 in 90 ml of 18
Ω ultrapure water. This solution performs two functions one buffering the anionic solution
to maintain the migration of micelles and EOF toward to the positive cathode and to
maintain the pH above 9 for FITC to stay bound to the PA’. At a pH below 8 the FITC will
no longer bind the amine groups. The 1 ml of 20 mM carbonate buffer was mixed with 1
ml of 1 mg/ml FITC in acetone to obtain a 1.28 mM FITC derivatizing solution (1:1
mixture). A known amount of this solution was added to standards and samples. The
solution is light sensitive and was always covered in aluminum foil to prevent bleaching
of the FITC. The mixture of FITC/Acetone and 20 mM carbonate buffer were reacted with
the samples or standard solutions for a minimum of 16 hours before analysis.
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MEKC-LIFD INSTRUMENT
The MEKC-LIFD instrument was built in-house with a Glassman High Power Supply
model PS-MJ30P04400X88 (Glassman High Voltage Inc.), a collinear fluorescence
detector equipped with a Hamamatsu Photo Multiplier Tube Model H-9306 (Hamamatsu
Co.) and a Cobolt solid state, 488 nm, continuous wave laser model 0488-06-01-0060-100
(Cobolt MLD). The signals were collected by a National Instruments data acquisition card,
model PCI-6221 (National Instruments Co.) in a computer programmed with custom-made
software both for acquisition and processing. Contributed by Daniel Paredes.
SAMPLE TREATMENT
The cells were lysed by removing the cell culture media and rinsing the cells with -20
˚C 1X PBS buffer two times. Following rinsing, the cells were lysed with -20 ˚C ethanol.
The cell lysates were collected and mixed with acetonitrile to precipitate out the proteins
using 10 µl of each in a 1:1 mixture. The samples were then centrifuged at 375 g for 5
minutes. The supernatant was kept and reacted with the derivatizing solution described
earlier in a 1:1 ratio. 10 μl of the supernatant was reacted with 10 μl of the derivatizing
solution. After allowing the solution to react for a minimum of 16 hours out of light the
samples and the standards were ready for MEKC analysis.
RUNNING PROCEDURE
The samples were hydrodynamically injected by applying a negative pressure of −10
to -15 psi for 1 second at the cathodic end of a fused silica capillary model TPS 025375,
polyimide coated, 350 μm external diameter, 25 μm internal diameter and 60 cm long
(Polymicro Technologies Inc.) while the anodic end of the capillary was immersed into the
179

test solution. The estimated injection volume was 800 pL. The running buffer was
composed of 40 mM Sodium Borate and 20 mM SDS at pH 9.0 determined from a previous
study [289]. The SDS will help form the micelles in the running buffer and the pH > 9
allows the FITC to remain bound to polyamines. The capillary was washed
hydrodynamically for 6 min with a 1 M sodium hydroxide solution to remove any
particulates that accumulated in the capillary from previous runs and followed by a run
with ultrapure water for 6 min, finally the capillary was filled with the running buffer for
6 min to condition the capillary. The solution takes ~6 minutes to run through the capillary
with a hydrodynamic pressure of -18 PSI. After injection, the anodic end of the capillary
was immersed in a reservoir containing the running buffer and equipped with a PlatinumIridium electrode while the cathodic end remained in the running buffer reservoir of the
cathode. A positive, 27 kV were applied at the anode for the electrophoretic separation and
the data was collected for 30 minutes.
DATA ANALYSIS
The data was analyzed using PicoAnalytical software that is capable of filtering a
moving average digital filter and has both horizontal and vertical displacement
capabilities for automatic electropherograms alignment. When the Fourier Transformed
Compton Profile (FTCP) was not well resolved, the software deconvolved the peaks and
calculated the best fitted Gaussian curve to calculate the area under the curve and
determine the concentration by correlating with the standard curve of each PA. The
statistical comparisons were made using Kaleidagraph V 4.5.3 for analysis of variance
(ANOVA) post hoc Tukey.
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MITOCHONDRIAL FUNCTION TEST
The mitochondrial function test was performed using Mitochondrial ToxGloTM Assay
by Promega. This kit is a cell-based assay that utilizes multiplexed chemistry for analysis
of mitochondrial dysfunction as a result of testing procedures. Overall the kit will lyse the
cells and treat the lysate with a combination of luciferin, ATPase inhibitors, protease
inhibitors, and Ultra-GloTM Luciferase to detect the ATP production of the cells. The
following procedure was used for analysis of the cells mitochondrial function.
Mitochondrial function was performed by addition of 20 µl of the 5X Cytotoxicity
reagent to each well using a multichannel pipette. Shake on an orbital shaker for 1 minute
at 500 rpm. Add 100 µl of the ATP detection solution to each well using a multichannel
pipette to ensure close timing with the addition. Mix by using the orbital shaker for 5
minutes at 500 rpm. Measured the luminescence using a Tecan plate reader with the gain
set for 90% saturation.
Following 24 hours of treatment for respective triplicates the mitochondrial function
was measured again and recorded.
Hippocampal mouse neuron cell lines were used from Pablo Caveides lab. The
normosomic (H1b) and trisomic (HTK) cell lines were tested for mitochondrial function.
The cell lines were split following protocols described for HeLa cell splitting and plated
at equal concentrations for both cell lines and all the treatment conditions. The treatment
conditions consisted of controls for each cell line (no treatment), treatment with 10%
DMSO (Control should kill cells), treatment with DFMO. 50 µl of each cell lines cells
were plated at 200,000 cells/ml to a 96-well cell culture plate. In between each addition
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of cells the stock solution of suspended cells was pipetted up and down 3 times to ensure
an even distribution of cells. Cell clumping can adversely affect the results by having
variable numbers of cells in each well resulting in mitochondrial function varying
dramatically due to cell count not function. Cells were allowed to adhere for 24 hours.
The cell media used to suspend the cells is a 1:1 ratio of high glucose Dulbecco’s
Modified Eagle Medium (DMEM) to Ham’s F-12 medium (Sigma Co.) with 10%
inactivated adult bovine serum (ABS), 2.5% fetal bovine serum (FBS), 1 g/L bicarbonate,
and glucose adjusted to 6 g/L. After 24 hours this media was replaced with the
differentiation media consisting of the same media as above supplemented with
Neurobasal-B 27 (Gibco, NYSE-TMO), Forskolin (FK) (10 µM), & bFGF 100 ng/mL
(ProSpec-Tany). The cells were incubated in differentiation media at 37 ˚C and 5% CO2
for 48 hours. After 48 hours the treatments were added to the respective wells, three
replicates were performed for each treatment. At this point prior to treatment 3 replicates
of each treatment condition (without treatment) were recorded for mitochondrial
function.
5.3 RESULTS/DISCUSSION
Initially to probe PA’s impact on mitochondrial motility, PA’s were increased
exogenously to healthy primary hippocampal cells to determine if there was an impact on
mitochondrial motility. PA’s have been shown to be taken into the cell through
endocytosis [290, 291] allowing PA’s to interact with mitochondria upon exogenous
application. The PA’s were added into the HHBSS solution used to image the primary rat
hippocampal neurons and compared to the baseline speed of the mitochondria prior to PA
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addition. The mitochondrial speeds were monitored in the axons. We found the
mitochondrial speed decreased after the addition and incubation with spermidine and
spermine. Putrescin did not statistically reduce the mitochondrial speed although it
appears that the effect may be mild but still decrease mitochondrial speed. One
interesting pattern observed was the speed of the mitochondria decreased based on the
polyamine added with more dramatic inhibition of speed from putrescin to spermidine to
spermine (Figure 42). The more amino propyl groups are contained in the backbone of
the PA, the more pronounced the decrease in the mitochondrial motility. This potentially
link the charge on the PA to the decreased mitochondrial speed. This provides an inverse
correlation between positive charges and mitochondrial motility.

Figure 42: Primary Cell Culture Rat Hippocampal Neurons Supplemented with
Polyamines. A-C show baseline mitochondrial motility in total movement length over 10minute time periods using the program Kymolyzer compared to the total movement
length after a 20-minute incubation with polyamines. D-F show the kymographs from the
mitochondrial motility before polyamine addition (baseline), directly after polyamine
addition (Putrescin, Spermidine, Spermine respectively), and after a 20-minute incubation
with each respective polyamine. Experiments were performed in primary cell culture rat
hippocampal neurons, and imaging was performed along the axons of the hippocampal
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neurons. N=3 for each PA evaluated. Statistical analysis was performed using two way Ttest, * represents p < 0.05; ** represents p < 0.01; *** represents p < 0.001; ****
represents p < 0.0001.
Mitochondrial motility was analyzed using a mouse cell line derived from mouse
hippocampal fetus neurons developed out of Pablo Caveides lab [284]. These cell lines
are unique and extraordinarily useful for our purposes due to one cell line being a
normosomic (derived from wild type mice) cell line (H1b) and one being a trisomic cell
line (HTK). Despite on being normosomic and the other being trisomic both cell lines are
from the same species and cell type. The mitochondrial motility of these two cell lines
(normosomic and trisomic) were compared with each other as shown in Figure 43 below.
The HTK cell line had lower mitochondrial motility than the H1b cell line. This
correlates with our findings that DS cell lines have increased polyamine concentrations
(Figure 44). Even more intriguing we discovered that 24 hour incubation with DFMO,
which inhibit the synthesis of PA’s rescued mitochondrial motility of HTK above
baseline, matching the levels of H1b mitochondrial motility. Potentially the reduction in
polyamines caused by the inhibition of the ODC enzyme restored the mitochondrial
motility.
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Figure 43: Mitochondrial Motility Restoration using DFMO in DS (Trisomic)
Hippocampal Mouse Neurons. Mitochondrial motility was calculated for control
normosomic hippocampal mouse neurons and trisomic hippocampal mouse neurons.
Both were treated with difluoromethylornithine (DFMO) an ornithine decarboxylase
inhibitor. DFMO improved the mitochondrial motility back to normal levels when
introduced into the trisomic hippocampal neurons. DFMO decreased mitochondrial
motility in normosomic hippocampal neurons (not shown). Mitochondrial motility was
calculated from the program ‘Total_Motility’ described in the methods section every 10
seconds. Statistical significance was calculated using a t-test, p < 0.0001 ****, n=3.
Next we wanted to quantify the polyamine concentrations in the mouse neuronal cell
lines to determine if the mitochondrial motility is decreasing as PA’s increased. We
analyzed the PA concentration using a capillary electrophoresis in the modality of micelle
electrokinetic chromatography-laser induced fluorescence detection (MEKC-LIFD). The
concentrations of Putrescine in the H1b cell line were statistically lower than the HTK
cell line, indicating the trisomic cells has higher putrescine concentrations than the
normosomic cell line (Figure 44). Spermidine did not show to be statistically significant
increased in the HTK as compared to the H1b cell lines, but a trend to be increased was
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observed (Figure 44B). With increased n counts this might show a statistical significant
increase. The DFMO lowers the polyamine concentrations in the HTK cell line to the
levels of the normosomic H1b cell line, Figure 44. In addition we confirmed the link
between the polyamine concentration and trisomy of chromosome 21 increasing the
amount of Aβ1-42 produced. HTK cells produced more PA’s as well as Aβ1-42. A finding
by Dr. Guido Vacano not shown here was the ODC protein concentration was higher in
HTK cells compared to H1b cells as well as APP and Aβ. The higher production of Aβ142

increased the concentrations of the ODC protein which consequently matched our

hypothesis to convert ornithine to polyamines. This finding combined with our findings
support our hypothesis that triplication of the APP gene which induces elevated Aβ leads
to increased polyamine production slowing down mitochondrial motility. This aligns with
directly adding the polyamines to the extracellular solution or cell culture media causing
a significant decrease in the mitochondrial motility. In both scenarios, the PA
concentration is increased leading to decreased mitochondrial motility.
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Figure 44: Polyamine Content from Normosomic and Trisomic Hippocampal
Neurons. Treatment of DS hippocampal neurons with the ODC inhibitor DFMO
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decreases polyamine concentrations, restoring polyamine concentrations to physiological
concentrations in the normosomic hippocampal neurons. There is significantly higher
polyamines in the trisomic cell lines. Statistical significance was performed using a one
way ANOVA post hoc Tukey, * represents p < 0.05; ** represents p < 0.01; ***
represents p < 0.001; **** represents p < 0.0001, n=3. Contributed with the help of
Daniel Paredes.
At this juncture we wanted to identify the potential mechanism by which polyamines
might decrease the mitochondrial motility. A similar endeavor was undertaken in Chapter
4 with identification of the zinc interaction site for zinc induced inhibition of cellular
trafficking. We explored if PA’s would influence other organelles beyond mitochondrial
motility. We performed a similar experiment as before with the addition of exogenous
polyamines to primary rat hippocampal neurons. Although we observed lysosomal
motility, it was unaffected by incubation with spermine the most potent PA found in this
work for inhibition of mitochondrial motility observed (Figure 45A). This result confirms
PA induced inhibition of motility appears to be specific to mitochondria. We further
investigated this specificity by imaging lysosomes in differentiated and undifferentiated
HTK and H1b cells using TIRF microscopy imaging performed by Anarkali Mahmood
(Data not shown). We discovered there was no change in the speed of lysosomes between
the trisomic and normosomic mouse cell lines. Again this confirms that the PA induced
inhibition of motility is specific to the mitochondria. Another interesting observation of
the mouse cell lines is the diffusion (motility), which was higher in the undifferentiated
cell lines than the differentiated cell lines. This may be caused by differentiated cells
containing neurites, which limit the diffusion of lysosomes. The central observation
remains to PA’s affecting specifically mitochondria not lysosomes. We reasoned the
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mitochondria must have a unique mechanism to interact with PA’s and decrease motility
unlike other organelles.

Figure 45: Mechanism of How Mitochondrial Motility is Inhibited. (A) There was no
significant change in the speed of lysosomes in primary rat hippocampal neurons speed
after incubation with spermine, indicating motor proteins and microtubules are not
responsible for decreased motility, n=3. (B) The calcium concentrations were not altered
after incubation with spermine in the mitochondria (Mito-RGEC01)or the cytosol
(GCAMP5) of HeLa cells, n=3. No statistical significant differences were found between
any of the measurements. A two way T-Test was used for statistical analysis.
One possible protein that could link mitochondrial dynamics to PA’s is the Miro/Trak
complex. This complex is what attaches the mitochondria to the microtubules allowing
mitochondria to be transported on microtubules. Increased calcium can bind the Miro
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protein causing the Miro/Trak complex to dissociate from the motor protein preventing
movement of the mitochondria [23] (Figure 46). Miro regulates the binding of
mitochondria to these Trak protein complexes which have been shown to be regulated by
calcium and GTP. There are also various splices of the Miro protein indicating there may
be multiple molecules that affect the binding of the Miro protein to the Trak protein
complex potentially PA’s. The EF hands (calcium binding domain) of the Miro protein
bind the calcium and which then causes the protein complex to dissociate halting
mitochondrial movement. The exact nature of how the Miro/Track/Kinesin all dissociate
from the microtubule is still undefined. Similar interactions exist between Drp1, Miro,
and calcium. When calcium is low, fusion is predominantly occurring between
mitochondria although when calcium levels rise there appears to be a suppression of
Drp1 when Miro binds calcium and dissociates from the Miro/Trak protein complex.

Figure 46: Mitochondria Attachment to the Miro/Milton Complex. The mitochondria
rely on motor/adaptor complex (Miro/Milton) to connect to the motor proteins which are
connected to the microtubules to move the mitochondria along these microtubules.
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We suspect the Miro/Trak complex could be the location where PA’s influence the
mitochondrial motility. Previous studies point to the polyamines altering calcium
concentrations of cells [292]. We monitored the calcium concentrations in the cytosol and
mitochondria of HeLa cells upon PA addition and found no significant changes to the
calcium concentration (Figure 45B). This may be an artifact intrinsic to imaging HeLa
cells and not neurons given there were no changes in either the mitochondrial or cytosolic
calcium concentrations. In consequence, we agreed the PA effect on mitochondria
motility is calcium-independent. Another potential mechanism for decreased
mitochondrial motility is the decreased mitochondrial function associated with AD
pathogenesis.
Studies have shown mitochondrial dysfunction due to dyshomeostasis of polyamine
concentrations within the cell [293, 294]. Mitochondrial function was quantified by
measuring the luminescence of cell lysates with a luciferase assay analyzing the ATP
production of cells. This experiment allowed us to evaluated the mitochondrial health of
the H1b and HTk cell lines with or without DFMO treatment and found no changes in
mitochondrial function after treatment with DFMO (Figure 47). Trisomic hippocampal
neurons (HTK) showed reduced mitochondrial function after 24 hours compared to
normosomic hippocampal neurons, which showed slightly increased mitochondrial
function after 24 hours. However, DFMO treatment did not restore the mitochondrial
function in trisomic hippocampal neurons (Figure 47). DMSO was used as a control
killing the cells.
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Figure 47: Mitochondrial Function in Normosomic and Trisomic Mouse Neurons.
Mouse neurons were differentiated and measured mitochondrial function over 24 hours.
Normosomic cell lines appear to have no change or a slight increase in mitochondrial
function while trisomic cell lines show a clear decrease in mitochondrial function. DFMO
does not restore the mitochondrial motility in the mouse cell lines. N=3, Statistical
significance was performed using two way T-Test, * represents p < 0.05; ** represents p
< 0.01; *** represents p < 0.001; **** represents p < 0.0001. Contributed with the help
of Randall Mazzarino.
We were unable to ascertain the specific interaction site for polyamines and
mitochondria that resulted in the decreased mitochondrial motility. Although there is a
clear inverse correlation between mitochondrial motility and polyamine concentrations.
5.4 CONCLUSIONS
We determined a clear inverse correlation between mitochondrial motility and
polyamine concentrations. This relationship has never been reported in previous
literature. The increased polyamine concentrations significantly decreases mitochondria
motility. The effect of PAs in mitochondria motility appears to be specific to
mitochondria, not affecting lysosome motility (Figure 42, 43, & 45). The polyamine
concentrations were shown to be significantly increased in the DS cell model. This
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suggest that the higher levels of polyamines present in AD patients could be decreasing
mitochondrial motility causing disproportionate energy distribution throughout the
neurons. Neurons as described in chapter 4 are more sensitive to improper bioenergetics
than normal cell types. This decreased mitochondrial motility may contribute to the cell
apoptosis observed in AD patients MTL neurons.
The precise interaction site of polyamines and mitochondria have not been
determined. It appears that the increased polyamines do not affect all microtubule-based
trafficking since lysosome motility was unaffected by increased polyamine
concentrations. The mitochondria have a specific Miro-Milton complex that is calcium
sensitive, binding mitochondria to the motor proteins kinesin and dynein. Previous
studies indicated that trisomic cell lines had changes in calcium concentrations, which
could impact the ability of mitochondria to remain attached to the motor proteins.
Calcium concentrations were unchanged in the cytosol and the mitochondria following
increased polyamine concentrations. This suggest that Miro-Trak complex is not at the
core of the action of Pas for decreasing mitochondrial motility.
Another potential cause for decreased mitochondrial motility is the mitochondria
becoming unhealthy due to the increase in polyamine concentrations. However,
mitochondrial function, which was evaluated with a luciferase assay production of ATP
was found to be decreased in the HTk cell lines as compared to H1b cell, was not restore
with DFMO treatment. Thus, suggesting the intracellular levels of PAs does not affect
ATP production. One potential explanation for this is that mammalian cells utilize both
aerobic and anaerobic (glycolysis) mechanisms to produce ATP. Either of these
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bioenergetics processes will compensate for the other if one is compromised. What might
be occurring is the mitochondrial aerobic function is improved after treatment with
DFMO, although the glycolysis is reduced producing what appears to be no increase in
ATP production or restoration of mitochondrial function. Although we would need
further analysis to show this is what is occurring.
One last potential mechanism how the PAs may be affecting mitochondrial motility is
electrostatic attractions. The PAs have a positive charge and the mitochondria are more
negatively charged inside the matrix than the cytosol. This would create an electrostatic
attraction between the positively charged PA’s and the negatively charged mitochondria.
The accumulation of positively charged PA’s may be interfering the binding of
mitochondria to motor proteins. This would explain the specificity for mitochondria since
other organelles are not negatively charged like mitochondria. Further testing is needed to
confirm this, although it could be the electrostatics surrounding the mitochondria
following polyamine solvation preventing the mitochondria from properly attaching to
motor proteins and moving. It has been found that the polyamines localize around the
mouth of VDAC channel present a voltage dependent block [295]. This could also cause
interactions that prevent the mitochondria from properly binding the motor proteins. PAs
have been linked to formation of the mitochondrial transition pore and release of
cytochrome c [296, 297]. This could decrease the mitochondrial health potentially
leading to decreased mitochondrial motility. However, given that a significant reduction
of mitochondria motility is observed within 20 minutes upon PAs application to the
hippocampal primary cell culture, strongly suggest that PAs might be affecting the
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physical interaction of the mitochondria with the microtubules. This is a plausible
mechanism warranting further studies.
There are many mechanisms the cell has to slow down microtubule-based cellular
trafficking whether through MAP proteins or inhibitors or activators of motor proteins
which may only be specific for mitochondria. Currently we do not know where the
polyamines are interacting with the mitochondrial to decrease motility although there is a
clear link between the polyamine concentration and mitochondrial motility. The
increased polyamines are connected to the triplication of APP, which result in
overproduction of Aβ and has been suggested to increase the activity of ODC leading to
increased synthesis of PAs. This finding provides an additional avenue by which neurons
might become dysfunctional in Down syndrome associated AD. Reducing polyamine
concentrations to normal concentrations may offer a novel therapy for treating AD
patients by restoring mitochondrial motility.
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CHAPTER SIX: CONCLUSIONS AND FUTURE DIRECTION
The first project optimized the GZnP sensor developing a vastly improved array of
zinc sensors. Through sensor optimization multiple new sensors with increased zinc
sensitivity, faster kinetics, and distinctive binding affinities for zinc were produced. The
new sensors increased our repertoire of available fluorescent zinc sensors. By expanding
our available tools to analyze zinc we expanded our ability to study biological zinc. We
obtained our goal to design zinc sensors that are comparable to currently available
calcium sensors in sensitivity, kinetics, brightness, and specificity. By optimizing GZnP
we created zinc sensors that are comparable to currently available calcium sensors such
as GCaMP and G-GECO sensors. There is still room for further development of this
sensor platform to enhance the DR, maximum sensor fluorescence, kinetics, and binding
affinity. In addition a red sensor variant is highly desirable to have multiple zinc probes
available to simultaneously image without spectral bleed through. In addition red sensors
are relatively pH insensitive which is advantageous for zinc biology due to many zinc
stores being acidic such as the endosome & lysosome.
The second project utilized the optimized zinc probes designed in the first project to
answer two zinc biology questions. The zinc probes were further modified to ratiometric
sensors to provide better quantification of zinc concentrations in different subcellular
compartments. The mitochondrial matrix zinc concentration was confirmed to be nearly
zero across four different cell types. The second question answered was the
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mitochondrial matrix is not a storage site for excess zinc, excluding the mitochondria
from buffering intracellular zinc concentrations. This work clearly shows the
mitochondria do not store excess zinc when the cell is stressed with high intracellular
concentrations of zinc. In addition under basal conditions the mitochondrial matrix has
~zero zinc. Without the enhanced zinc sensors developed in project one, project two
would have not been possible. Further work can be performed to determine where zinc is
sequestered during high intracellular zinc stress. The novel zinc sensors provide a perfect
platform to investigate the zinc dynamics during these events.
Project three utilized the enhanced zinc probes along with a multitude of other
techniques to identify zinc as a regulator of cellular trafficking. This is an unprecedented
connection linking zinc and cellular trafficking together. We performed a top down
approach demonstrating zinc inhibited cellular trafficking of organelles. Next we
established zinc inhibited the movement of both motor proteins kinesin and dynein.
Finally we discovered zinc interacts with microtubules to prevent the landing of motor
proteins on the microtubule preventing microtubule-based trafficking when zinc
concentrations increase. We identified the amino acid residues responsible for the zinc
interaction as H192 and H283 on the α-tubulin monomer of microtubules. This was the
first study connecting zinc to cellular trafficking. Future studies can determine the
processes zinc induced inhibition of cellular trafficking affects. One such process may be
synaptogenesis for neuronal development. Although any process where zinc
concentrations are found to be dynamic can be investigated to potentially control cellular
trafficking. The improved zinc sensors can resolve additional zinc pathways and further
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investigation can reveal if there is a link between the novel zinc pathways and cellular
trafficking.
Project four found the trafficking of mitochondria is correlated to polyamine
concentrations. We discovered there is an inverse relationship between polyamines and
mitochondrial motility. We were unable to identify the specific site linking polyamines
and mitochondria to each other although we eliminated many prospects. During this
project we established a pristine link between PA’s and mitochondrial motility in AD.
This link provides a new avenue to explore for AD therapies. Future studies can aim to
identify how PA’s alter the mitochondrial motility and then aim to design treatments for
AD using this novel pathway.
Overall this work advanced zinc cell biology by developing improved zinc sensors,
answering zinc biology questions, and discovering new relationships between zinc and
biology. In addition novel connections were found for the most common
neurodegenerative disease of our time AD, linking PA’s and mitochondrial motility. With
all of these developments and discoveries more questions than answers were unearthed
waiting to be answered in future investigation.
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APPENDICES
APPENDIX A: QUANTIFICATION OF ZINC CONCENTRATION IN
CYTOSOL, MITOCHONDRIAL MATRIX, AND IMS
This is a detailed procedure for the image analysis of the fluorescent GZnP2 probe
with a mCherry fluorophore attached to measure zinc concentrations in the cell cytosol,
mitochondrial matrix, and IMS.
Imaging analysis was performed by Fiji (Image J) [147]. Open an image stack of
mCherry-GZnP2 in Fiji.

Split the image stacks of the GZnP2 and mCherry sensor signals using the “Image”
tab then the “Color” Tab Click “Split Channels”.
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Both image stacks (green and red channel) were aligned to account for thermal and
mechanical drift in the xy directions using the Stackreg plugin with the Rigid Body
method in Fiji. This prevented any drift of the cell affecting the intensity of the signal
being misinterpreted as changes in zinc concentrations. Note running the Stackreg will
convert the color to black and grey on grey scale for the images.
Next an ImageJ plugin called “Time Series Analyzer” was used to measure the
intensity of the fluorescent signal in each channel over time. Regions of interest (ROI)
were chosen over the cells in the imaging frame as well as one for the background to
correct for changes in background fluorescence.
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For the quantitative analysis, image stacks for both GZnP2 and mCherry were
background corrected by generating a region of interest (ROI) on a blank area of the
imaged area and subtracting the fluorescence intensity of each channel from the
respective channel, e.g. IGZnP2(cell) – IGZnP2(background), and ImCherry(cell) –
ImCherry(background). The “Time Series Analyzer” program was run and the intensities
collected for both GZnP2 and mCherry for each respective cell for the duration of the
image stack were calculated by pressing the “Get Average” button.
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Each cell was background corrected for both the mCherry and GZnP2 channel. The
background corrected GZnP2 and mCherry images are used to calculate the
normalization ratio (R, i.e. GZnP2/mCherry) to eliminate any drift in the z plane from
being misinterpreted as changes in the zinc concentration. The calibration of the sensors
was plotted in the KaleidaGraph program version 4.5.3 by Synergy Software.
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The baseline mCherry-GZnP2 ratio (R), minimal ratio achieved using 100 µM TPEN
(Rmin), and maximal ratio (Rmax) obtained using zinc saturation (Zn-PTO) were used to
quantify cytosolic zinc concentration using the equation [Zn2+] = Kd [(R – Rmin) / (Rmax –
R)]1/n (Kd & n values were specific to the region being quantified, pH = 8 for
mitochondrial matrix and pH = 7.4 for the cytosol and IMS and characterized in vitro).
All in situ sensor calibrations were performed at RT. The same methods were used to
calculate the zinc concentrations in the mitochondrial matrix and IMS, the ROI were
drawn using the freehand tool to capture all the mitochondria for a single cell. Statistical
analysis was performed using the t-test in KaleidaGraph program. The error bars
represent the standard error of the mean.
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APPENDIX B: QUANTIFICATION OF CELLULAR TRAFFICKING
MEASURING MOTILITY IN KYMOGRAPHS OF NEURONS
Motility in neurons was measured using kymographs due to the nature of neurites
allowing the motility to be funneled down a straight line. Kymograph analysis provides a
wealth of information from speeds, to velocities (directionality), movement lengths,
number of moving particles, or any derivation therein. Motility analysis for neurites was
performed using ImageJ [147] and an ImageJ plugin “Kymolyzer” developed by the
Schwarz lab [224]. Prior to running the program all image stacks were separated
according to treatment (baseline, TPEN, etc.). This is accomplished by clicking the
“Image” tab then the “Stacks” dropdown menu then “Tools” and click on “Slice Keeper”.
Put the first to last image slice for each treatment of the full image stack and make sure it
is slicing every single frame not every other which the default is. The reason we must cut
the full image stack into the respective treatments is the Kymolyzer program can only run
for the entire image stack it processes and provide averages which would not indicate
changes between different treatments. Each stack was aligned using the ImageJ plugin
“Stackreg” with the transformation “Rigid Body” to correct for xy drift. After being
aligned the stacks were run through the Kymolyzer plugin. Prior to imaging the soma of
the neurons is identified for the directionality of the neurite motility (retrograde and
anterograde).
1. Run step 1 of kymolyzer: Plugins>Macros>Kymolyzer>Step1_MakeKymograph
a. Select the image stacks for a treatment that has been prealigned.
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i. If it is a dual channel image stack, the macro will ask the user to select any one
channel, which has the moving particles that are to be traced. The total time length of the
image stack will be required to calculate the kymograph and the data derived from the
kymograph.

b. The macro will then give a maximum projection image of that channel and ask to
user to trace a line to make the kymograph. At this point you can change the thickness of
the traced line that will be the average of the intensities to ultimately make the
kymograph by double clicking on the segmented line option. I change the thickness to be
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just wide enough to cover the neurite width any wider and the line average is majority
background and the particles fade especially with dimmer organelles such as lysosome.

i. At this stage the user can ask the macro to open up a file where drawing the line
will be easier (such as the GFP channel)
c. Macro will then make the kymograph and ask the user to change the brightness and
contrast of the kymograph as necessary. Click “Ok” once the desired brightness is
achieved.
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d. Step 1 is finished!

2. Run step 2 of kymolyzer: Plugins>Macros>Kymolyzer>Step2_Track
a. A folder selection window will open up as soon the step 2 is run.
i. Select the folder with the name of the image
b. Macro will open up the kymograph and ask the user the following:
i. Puncta Start Count:
1. At the start of each image this number should be 1
2. If, for some reason the step 2 has to be restarted with some particles being already
tracked in that image, then change the puncta start count to whatever number of particles
that have already been tracked +1 (so that it represents the present particle number being
tracked)
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ii. Show box size: This is the size of the box used to display the tracked particle. Start
with show box size as 5 and adjust as necessary
iii. After the setting the puncta start count and show box size press OK to start the
tracking
c. During the tracking process you can do the following at any point of the image:
i. Shift+LeftClick : adds points on a track
ii. Cntrl+leftClick: finishes the track
iii. Alt+leftClick: drops a straight line (depicting a stationary particle) till the end of
the movie.
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1. It is advisable not to use the Alt+LeftClick function to begin with. Only use it
once you know what to depict as stationary and what as moving (after going
through the step 3 atleast once).
iv. After the tracking of each puncta, a movie will popup showing how well the
puncta was tracked. Press OK if you are satisfied with the tracking.
v. Then go on the next puncta, by clicking “Yes” in the “For another track” dialog
vi. After the final puncta, click “No” on the same dialog box
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3. Run step 3 of kymolyzer: Plugins>Macros>Kymolyzer>Step3_Measure
a. A folder selection window will open up as soon the step 3 is run.
i. Select the folder with the name of the image
b. After folder selection, a window will pop-up asking for the image parameters:
i. Pixel Scale in um/pixel: length of each pixel in micro after maginification. This
information can be determined from the microscope specifications.
ii. Timescale (s): Time gap between two frames
The kymograph width and height should not be changed these should auto populate
with the correct values after the macro reads the metadata.
iii. Kymograph width (in pixels): generally the length of the line selection made
iv. Kymograph height (in pixels): generally, total number of frames in the movie.
c. After setting the scale parameters, the following two options have to be selected:
i. Calculate step (every 1 time points): Each track is divided into segments. This
value defines the number of frames to skip in between recording the position of each
particle, to divide the tracks (for example, in a movie with a 100 time points, a value of 5
will divide the track into 20 segments).
ii. Lower limit of velocity: lowest velocity of a particle at any segment below which,
it is considered as stationary. I set this to zero.
d. The best way to decide the values is to track two test particles, one that is
stationary and one that is motile. Then set the frame step gap and lowest velocity limit to
the lowest possible values such that the stationary particle is indeed recorded to be
stationary while movement is detected for the motile particle
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e. The raw data for all the particles in a kymograph can be found in the following
excel file: …pathTofolderWithImageName/RawPunctaFiles/Summary.xls
ii. Open up this file and check the tab “Move %” to see whether the stationary particle
is indeed recorded to be stationary.
iii. If not repeat the third step by increasing the lower velocity limit or the frame skip
gap.
f. This value should be changed in between different samples of the same experiment.
All the raw data can be pulled from the excel file labeled “summary”.
NON-NEURONAL CELL MITOCHONDRIAL MOTILITY CALCULATION
This protocol outlines in detail how to determine mitochondrial motility in cells other
than neurons where kymographs cannot be performed. The program being used is an
ImageJ plugin called “Total_Motility” developed by the Kurt De Vos lab[235]. This
plugin works by measuring the difference in mitochondrial area between two frames and
dividing this value by the total area of mitochondria. This will offer a percent movement
of mitochondria per a frame. This program works well at identifying oblong shapes
which typically works well for mitochondrial morphology.
Open the image stack with the mitochondria tagged channel. Image stacks were
aligned using the ImageJ plugin “Stackreg” with the transformation “Rigid Body”
correcting for drift in the xy direction. The image stack was cropped to choose a single
cells mitochondria using the free hand tool. When cropping cut out any areas of the cell
that are out of focus, later when thresholding the image faded areas are difficult for the
program to threshold properly.
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Threshold the image by clicking on “Image” then click the dropdown menu “Adjust”
then click on “Threshold”. The image stack was thresholded using the default threshold
method AKA “Isodata_IJ” method. Click the option “Dark Background” then click
“Apply”. A new prompt dialogue box will pop up, do not calculate the threshold for each
image use the initial calculation to have a fair comparison between all images. Leave the
box checked for “Black Background”.
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Following thresholding the image stack noise was reduced using the median filter
“Despeckle” an ImageJ plugin under the “Process” tab then the “Noise” dropdown menu.
This removes speckling from the thresholding. Then the image stack was run through the
Total_Motility plugin showing the thresholded image, the difference between two frames,
and the quantified percent motility.
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NON-NEURONAL CELLS LYSOSOME, ENDOSOME, AND VAMP2
MOTILITY
This will detail the protocol used to analyze lysosome, endosome, and VAMP2 vesicle
motility in non-neuronal cells. The “Total_Motility” plugin works but is optimized for
oblong shapes which these organelles are sphereical and a better system was developed to
track their motility. The image stack is loaded into Fiji, for this example LAMP1mCherry (lysosome) in HeLa cells will be used. Prior to running the program all image
stacks were separated according to treatment (baseline, TPEN, etc.). This is accomplished
by clicking the “Image” tab then the “Stacks” dropdown menu then “Tools” and click on
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“Slice Keeper”. Put the first to last image slice for each treatment of the full image stack
and make sure it is slicing every single frame not every other which the default is. The
reason we must cut the full image stack into the respective treatments is the particle
tracking program can only run for the entire image stack it processes and provide
averages which would not indicate changes between different treatments. Image stacks
were aligned using the ImageJ plugin “Stackreg” with the transformation “Rigid Body”
correcting for drift in the xy direction. The image stack was cropped to choose a single
cells mitochondria using the free hand tool.

The image stacks noise was cleaned up using the Gaussian filtering in Fourier space
ImageJ plugin “Bandpass Filter” located under the tab “Process” then the dropdown
menu “FFT”. The limits for the size of the structures of interest were adjusted to 10-2
pixels correlating to 2.14-.43 µm in size approximately the size of lysosomes. This value
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will be adjusted depending on the particle size you are analyzing. Uncheck the two boxes
labeled “Autoscale after filtering” and “Saturate Image when Autoscaling” and check the
box “Process Entire Image Stack”. This plugin will filter out any objects falling outside
the size specifications you choose eliminating background noise significantly.

The background noise was reduced further using the ImageJ plugin “Background
Subtract” based on the rolling ball algorithm [298] located under the “Process” tab.
Change the size of the “rolling ball” to 3 pixels in diameter. This plugin works in essence
by imagining wherever a rolling ball could roll of a certain size will be designated
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background wherever the ball cannot travel is considered the object of interest. Adjust
accordingly for specific objects being analyzed.

Threshold the image by clicking on “Image” then click the dropdown menu “Adjust”
then click on “Threshold”. The image stack was thresholded using the “Moments”
method. Click the option “Dark Background” then click “Apply”. A new prompt dialogue
box will pop up, do not calculate the threshold for each image use the initial calculation
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to have a fair comparison between all images. Leave the box checked for “Black
Background”.

Following thresholding the image stack noise was reduced using the median filter
“Despeckle” an ImageJ plugin under the “Process” tab then the “Noise” dropdown menu.
This removes speckling from the thresholding.
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The “Particle Tracker 2D/3D” plugin was then used to track the particles speeds under
the “Plugins” tab and the “Mosaic” dropdown menu. This will bring up a prompt box if
the image is 3D, for all the image stacks performed for this work none were 3D so click
“No”. Another prompt dialogue box will populate requesting the particle detection
specifications. Set the “Radius” to 3 the “Cutoff” to 0 and the “Per/Abs” to 0.7. The
remaining default settings were used. The particle linking specifications can be changed
based on particular data sets although it was left as 2 for the link range and a
displacement of 10 and Brownian motion. This will run through all the images in the
stack which may take a while. A results dialogue box will populate. Click the tab “All
MSS/MSD to Table” this will bring up a dialogue box asking you to change the “Frame
Interval” to something other than zero, click “ok”. Change only the pixel width and
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height according to the microscope specifications for the magnification that was used and
the fram interval to the acquisition times between two frames. The results will then be
given for the particle speeds throughout the image stack.
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APPENDIX C: ANALYSIS OF COMPONENTS USING “R”
Begin by loading the computer software program R. This computer software can be
downloaded for free at http://cran.r-pro ject.org/
Once the program is downloaded the package “mclust” must be installed into the
computer. This is the program that will calculate the components of the system using a
mixed Gaussian function. This can be installed by clicking the “Packages” tab then
clicking the “Install Package(s)…” tab from the drop down menu. Find the package
“mclust” and install. Once installed into the computer the software R needs to load the
software everytime you start the software by clicking on the tab “Packages” then “Load
Packages” from the drop down menu. Once this is performed you are ready to begin
analyzing data.
The data from the software program “Kymolyzer” needs to be loaded into the R
program. R can only read text files not excel files. Therefore before loading the files
derived from Kymolyzer convert the files to a .txt file. Then load these into R by
inputting the command “dataset <- scan (file.choose())”. Which will bring up a prompt
box to load the files of interest.
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Once the data has been read by R it will say “Read X items”
Now we will determine how many “components” your univariate data set has. In
order to do this we will use the “densityMclust” function from the mclust package
previously installed. Input the following command into R: “dataset_model <densityMclust(dataset, G=1:9, modelNames=NULL, prior=NULL, control=emControl(),
initialization=NULL, warn=FALSE)”
We will also need the parameters for the output which can be retrieved with the
command: “dataset_model$parameters”
This will output all the parameters of the calculated components shown below:

239

The density mclust function will by default analyze the dataset between 1 and 9
components (G), with either constant variances or different variances. The parameters
were left at the default settings with 9 possible components for the dataset and leaving the
variances for the optimal fit. modelNames=NULL will analyze both E (constant
variances) and V (different variances), and finds the ‘best’ overall fit.
Description of the returned values:
1. attr(,"modelName")
[1] “V”
If you inputted modelNames=NULL, then this value means that the best model it
could find to fit your data set is one with different variances for each component.
2. attr(,"parameters")$pro
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[1] 0.3123456 0.3023054 0.1966528 0.1886961
In the case of a 4-component data set (illustrated here), four values are returned
describing the proportion (“pro”) of each (in this case, ~31%, ~30%, ~19%, and ~18%
for the 1st, 2nd, 3rd, and 4th components, respectively).
2. attr(,"parameters")$mean
1

2

3

4

0.0009198442 0.0038618539 0.0117697282 0.1934740257
In the case of a 4-component data set, here are the 4 means (0.0009, 0.0038, 0.011,
and .193 µm/s) for each components speed.
4. attr(,"parameters")$variance$sigmasq
[1] 2.433642e-07 1.427590e-06 1.459027e-05 2.308891e-02
These are the variances values or sigma squared. To obtain the standard deviations,
square root these values.
These values provide all the components the proportions of each component as well
as the average speed for each component. Although graphical representations of the
dataset are nice to confirm what the program calculated. Input the command:
plot((dataset_model), xlim=c(0,0.01))
The xlim command will adjust the x-axis which can be changed to best view the
plots.
to plot the density mclust function. Three plots are possible BIC for the best
component determined from 1 to 9, density function for a plot of the density of
mitochondrial tracks at certain speeds, and diagnostic which was not used.
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The BIC plot provides the best interpretation of the calculated components. Basically
where the highest BIC value lies is the highest correlation for the dataset for that many
components. Input the command “1” to retrieve the BIC plot. In the case of this set it is
optimal for 4 components.
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To retrieve the density plot input the command “2”. These plots you can see where
the components were calculated through the peaks. In this case there are 4 optimal
components and there are 4 peaks in the dataset.

Following these plots all the data is available to be interpreted.
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APPENDIX D: PREDICTION RESULTS FROM ZINC ALGORITHM
PROGRAMS
Appendix D Table 1: Zincbinder Prediction Result
Zinc
Binding
Residue
C
H
C
C
H
E
H
H
H
C
H
H
C
C
H
H
C
C
C
C
C
C

Position

Zn Binding
Score

4
8
20
25
28
55
61
88
107
129
192
197
200
213
266
283
295
305
315
316
347
376

1.5
1.5
0.4
0.4
1.9
0.2
0.3
0.5
1
0.9
0.4
0.3
0.6
0.7
0.2
0.3
0.8
1.5
0.5
0.7
0.6
1.2

Appendix D Table 2: Zinc Explorer Prediction Result
AA
&
Position
E3
C4
H8
C20

Score

Description

0.208647
0.261433
0.321097
0.455949

NO
NO
NO
YES
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E22
C25
E27
H28
D33
D39
D46
D47
E55
H61
D69
E71
D76
E77
H88
E90
E97
D98
H107
E113
D116
D120
D127
C129
H139
E155
D160
E168
E183
H192
E196
H197
D199
C200
D205
E207
D211
C213
D218

0.233913
0.457186
0.269017
0.334304
0.209778
0.105601
0.147903
0.178926
0.194402
0.179375
0.242295
0.251222
0.259463
0.154559
0.299331
0.135963
0.182321
0.244097
0.273298
0.205133
0.337126
0.270236
0.164639
0.477733
0.263905
0.199757
0.261336
0.151069
0.220488
0.401923
0.169668
0.289239
0.209252
0.305752
0.238154
0.25779
0.167909
0.4737
0.18771
245

NO
YES
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
YES
NO
NO
NO
NO
NO
YES
NO
NO
NO
NO
NO
NO
NO
YES
NO

E220
D245
D251
E254
H266
E279
H283
E284
E290
C295
E297

0.158318
0.132508
0.197715
0.198189
0.361645
0.119179
0.324007
0.270458
0.154876
0.34321
0.200272

C305

0.548478

D306
H309
C315
C316
D322
D327
D345
C347
D367
C376
E386
D392
H393
D396
H406
E411
E414
E415
E417
E420
E423
D424
E429
D431
E433
E434

0.217402
0.211275
0.309683
0.467673
0.229953
0.172654
0.241314
0.407846
0.170978
0.445165
0.173775
0.159043
0.18585
0.167768
0.418916
0.211676
0.219363
0.196619
0.17415
0.201976
0.143774
0.216997
0.228211
0.304683
0.187322
0.257806
246

NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
YES High
Confidence
NO
NO
NO
YES
NO
NO
NO
YES
NO
YES
NO
NO
NO
NO
YES
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO

D438
E441
E443
E445
E446
E447
E449
E450

0.197459
0.208392
0.209271
0.13483
0.140095
0.166035
0.119469
0.139383

NO
NO
NO
NO
NO
NO
NO
NO

Appendix D Table 3: PredZinc Prediction Result
Residue

Sequence
#

GLU
GLU
ASP
GLU
GLU
ASP
GLU
GLU
GLU
GLU
GLU
ASP
ASP
ASP
GLU
GLU
GLU
GLU
GLU
GLU
HIS
GLU
GLU
GLU
GLU

411
55
98
71
450
392
183
155
434
449
290
396
205
218
113
429
97
207
445
22
28
443
284
3
90
247

Score
0.137
0.119
0.113
0.025
0.024
0.019
0.016
0.016
0.014
0.012
0.011
0.011
0.011
0.01
0.009
0.008
0.008
0.008
0.007
0.007
0.007
0.006
0.006
0.005
0.005

GLU
CYS
GLU
ASP
ASP
CYS
HIS
GLU
GLU
GLU
HIS
CYS
ASP
GLU
GLU
CYS
HIS
GLU
ASP
CYS
HIS
GLU
GLU
CYS
ASP
GLU
ASP
GLU
GLU
ASP
HIS
CYS
ASP
HIS
HIS
CYS
GLU
ASP

417
25
414
120
69
316
283
297
386
77
88
305
431
279
196
315
197
254
322
213
139
168
423
295
199
415
438
447
27
46
192
129
345
8
266
347
441
211
248

0.005
0.005
0.004
0.004
0.004
0.004
0.004
0.004
0.003
0.003
0.003
0.003
0.003
0.002
0.002
0.002
0.002
0.002
0.002
0.002
0.002
0.002
0.002
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001

ASP
GLU
HIS
HIS
ASP
ASP
GLU
CYS
ASP
ASP
HIS
GLU
CYS
CYS
HIS
ASP
GLU
ASP
ASP
ASP
HIS
ASP
ASP
ASP
CYS
ASP

251
420
393
406
33
306
433
20
116
160
107
220
376
200
309
424
446
47
367
39
61
76
127
245
4
327

249

0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0.001
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

